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Nanocomposites, in which two or more different nanosized entities arranged in a 
controlled manner, have been widely investigated in recent years. Nanocomposites 
combine the properties and advantages of each component, exhibiting 
multifunctionality or novel properties that are not found in single-component structure. 
Among various nanocomposites, nanocomposites containing mesoporous silica and 
gold nanorod are considered as the most highly researched field owing to their novel 
properties of single-component structures. Gold nanorod is well-known for its large 
two-photon action cross section (10
4
 GM), high two-photon luminescence, large-scale 
preparation, biocompatibility, chemical inertness and tunable longitudinal plasmon 
band. Moreover, mesoporous silica nanoparticles possess large surface area, high pore 
volume, low cytotoxicity and easy surface functionalization. Therefore, this kind of 
nanocomposite has great potential in various applications. The aim of this study was 
to prepare this nanocomposite and systematically explore this nanocomposite in 
two-photon imaging, photodynamic therapy and drug delivery for simultaneous 
diagnosis and therapy in vitro. 
 Novel multifunctional nanocomposite that combine two functionalities (a gold 
nanorod core and a porphyrin-doped mesoporous silica shell) into one entity was 
prepared in Chapter 2. Due to the encapsulation of mesoporous silica, the porphyrin 
can be well protected against the external bioenvironment. In addition, the generated 
singlet oxygen by porphyrin molecules can be easily released from the silica. This 
multifunctional nanocomposite generates singlet oxygen with relatively higher yield 
 II 
compared to free porphyrin. Therefore, this multifunctional nanocomposite is an 
attractive candidate for simultaneous photosensitization and two-photon imaging as 
well as imaging guided therapy. 
 Gold nanorods were prepared and their dual capabilities for two-photon imaging 
and two-photon photodynamic therapy have been demonstrated in Chapter 3. These 
gold nanorods exhibit large two-photon absorption action cross-sections, about two 
orders of magnitude larger than small organic molecules, which makes them suitable 
for two-photon imaging. They can also effectively generate singlet oxygen under 
two-photon excitation, significantly higher than traditional photosensitizers such as 
Rose Bengal and Indocyanine Green. The two-photon photodynamic therapy effect 
and two-photon fluorescence imaging properties of PVP coated gold nanorods have 
been successfully demonstrated on HeLa cells in vitro using fluorescence microscopy 
and indirect XTT assay method. These gold nanorods thus hold great promise for 
imaging guided two-photon photodynamic therapy for the treatment of various 
malignant tumors. 
 A systematic study of the gold nanorod enhanced one- and two-photon 
fluorescence intensity of a nearby molecule with varied silica shell thickness was 
investigated in Chapter 4. Porphyrin molecules, a kind of fluorophores, were 
covalently bound on the surface of silica coated gold nanorods which were prepared 
by sol-gel method in a two-step process. This nanocomposite displayed rather long 
chemical stability and easy variable distances between the fluorophores and metal 
nanoparticles. By changing the thickness of silica shell, the highest porphyrin 
 III 
fluorescence enhancement factors were 2.1-fold and 11.8-fold for one- and 
two-photon fluorescence, respectively. In addition, the fluorescence lifetimes of 
fluorophores were decreased with reducing silica shell thickness. The potential 
application of Au NR/SiO2-T790 as effective two-photon fluorescence probe and 
photosensitizer for two-photon imaging-guided photodynamic therapy in vitro were 
demonstrated on HepG2 cell under two-photon irradiation. As a result, the excellent 
chemical stability, decreased lifetime and enhanced one- and two-photon fluorescence 
make gold nanorod-fluorophores to be an attractive platform for metal-enhanced 
fluorescence imaging and bioapplications. 
 Au NR/SiO2-PFBV core-shell nanoparticles with different silica shell thickness 
from 8.6 to 48 nm were prepared to systematically investigate Au NR enhanced one- 
and two-photon excitation fluorescence of PFBV in Chapter 5. The one- and 
two-photon excitation fluorescence intensity of PFBV were found to strongly depend 
on the silica shell thickness that separates Au NR and PFBV molecules. The optimum 
OPEF enhancement was found to occur at shell thickness of 24 nm with enhancement 
factor of 1.5, while the optimum TPEF enhancement was found to occur at shell 
thickness of 15 nm with enhancement factor of 29. The application of these 
nanoparticles as effective imaging agents for two-photon cell imaging and 
nano-photosensitizers for TP-PDT with improved efficiency has been demonstrated on 
HepG2 cancer cells using XTT assay. The remarkable two-photon excitation 
fluorescence enhancement property of these Au NR/SiO2-PFBV nanoparticles makes 
them promising agents for two-photon imaging guided two-photon phototherapy. 
 IV 
 Aside from its application in two-photon imaging and photodynamic therapy, 
nanocomposite containing mesoporous silica and gold nanorod could also be used in 
drug delivery system. In Chapter 6, a pH-responsive drug delivery platform based on 
folic acid (FA) grafted mesoporous silica coated gold nanorods (FA-Au NR/mSiO2) 
was constructed by combining two-photon imaging property of gold nanorod and 
pH-responsive property of drug inside mesoporous silica shell. The anticancer drug 
(TMPP) was loaded in the mesoporous silica shell by hydrophobic interaction which 
could be disrupted when the pH was beyond the pKa of TMPP (2~3). The two-photon 
imaging capability of this nanocomposite was also studied in vitro by using HepG2 
cancer cells. Therefore, such a versatile theranositc system as nanocomposite 
containing mesoporous silica and gold nanord is expected to have wide biomedical 
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Chapter 1  
Introduction 
Nanomaterials are defined as materials with size less than 100 nm,
1-3
 which 
have received considerable interest in recent years owing to their fascinating 
physical and chemical properties including large surface area, well defined 
structure, high reactivity and easy dispersibility. At nanoscale level, these 
nanomaterials with unique properties could create novel material composites by 
exploring new properties between these nanomaterials. Nanocomposites, in 
which two or more different nanosized entities arranged in a controlled manner, 
have been investigated in both the stability and surface chemistry of each part 
as well as unique physical and chemical properties that are not possible from 
one material alone. Such nanocomposites have several advantages: firstly, the 
interfacial interactions at nanometer scale between the individual components 
in nanocomposites, could result in enhanced or novel properties that are not 
found in single-component structures.
4,5
 The second advantage is that 
nanocomposites usually exhibit multifunctionality, which combine the 
properties and advantages of each component.
6,7
 Therefore, nanocomposites 
are considered as the most highly researched field owing to their novel 














 etc.  
 Clever combination of different types of nanomaterials will lead to novel 
2 
 
nanoparticle with enhanced properties or multifunctionality. Tang et al 
21
 
reported the fabrication of water-soluble conjugated polymers coated silver 
nanosphere, in which silica serves as a spacer layer to modulate the distance 
between nanoparticle and polymer. This nanocomposite displays enhanced 
fluorescence, which has potential application in selective biological imaging. 
However, the preparation process of water-soluble conjugated polymer is 
complicated and the two-photon fluorescence of this polymer is low. Samia et 
al
22
 published that phthalocyanine modified Quantum Dots (CdSe) generate 
singlet oxygen through fluorescence resonance energy transfer and triplet 
energy transfer mechanisms. Quantum Dots have much higher two-photon 
cross sections but are cytotoxic to living organisms, and thus makes them 
unsuitable for imaging or diagnosis and therapy in vivo. Therefore, it is 
desirable to fabricate novel nanocomposites, which are easy to prepare, and 
they aslo exhibit high two-photon luminescence as well as excellent 
biocompatibility. 
 The emergence of nanocomposites containing mesoporous silica and gold 
nanorods seems to circumvent this problem. Gold nanorod is notable for high 




 about two orders of magnitude 
larger than small organic molecules (1-100 GM). It also exhibits high 
two-photon luminescence,
24
 which is about 58 times stronger than that of 
single rhodamine molecule. Furthermore, gold nanorod is well known for its 
large-scale preparation, biocompatibility and chemical inertness. The 
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longitudinal plasmon band of gold nanorods is tunable from 580 to 1000 nm, 
which is consistent with the tissue transparency window. It could minimize 
absorption and scattering of tissue. Incorporating gold nanorod into 
mesoporous silica provides a platform for multimodal imaging or 
simultaneous diagnosis and therapy. Mesoporous silica nanoparticles possess 
large surface area and high pore volume which could load large amount of 
fluorophores or biomolecules.
12,25,26
 In addition, they display low cytotoxicity 
and easy surface functionalization. Therefore, nanocomposite containing gold 
nanorod and mesoporous silica nanoparticle becomes an ideal platform for 
constructing novel nanocomposite in imaging and simultaneous therapy. 
 In view of potential impacts of nanocomposites, nanocomposite 
containing mesoporous silica and gold nanorods should be prepared and 
various applications of this nanocomposite should be explored systematically. 
According to the feedback loop, such nanocomposite containing mesoporous 
silica and gold nanorods exhibits high two-photon cross section, strong 
two-photon luminescence and excellent biocompatibility, which could be 
widely used in two-photon imaging, photodynamic therapy and drug delivery 
for simultaneous diagnosis and therapy in vivo. 
 The subsequent sections will provide an overview of recent studies of 
gold nanorods and mesoporous silica nanoparticles, some fundamental 
knowledge of two-photon absorption materials, photodynamic therapy and 
drug delivery.  
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1.1 Gold nanorods 
Gold nanorods (NRs), with a broadly tunable aspect-ratio dependent 
longitudinal surface plasmon resonance (LSPR), are one of the most studied 
colloidal plasmonic nanostructures. In the following sections, related studies 
will be reviewed in three sub-areas: preparation of gold nanorods, optical 
proerties of gold nanorods and application of gold nanorods. 
 
1.1.1 Preparation of gold nanorods 





 and seed-mediated 
growth method.
31-35
 Using the electrochemical method to generate gold 
nanorods in the presence of surfactants was first introduced by Wang et al..
29
 
In this method, a gold plate is immersed in an aqueous electrolyte solution 
containing a mixture of surfactants such as cetyltrimethylammonium bromide 
(CTAB) and tetraoctylammonium bromide (TOAB). Gold is oxidized to ions 
at the anode and reduced to gold nanorods at the cathode. The length of the 
gold nanorods can be easily controlled by changing the ratio of the surfactant 
and the cosurfactant. Furthermore, gold nanorods can also be prepared by a 
photochemical process which reported by Esumi and Kim.
27,28
 In these 
methods, gold salt is reduced in the presence of surfactants by UV irradiation. 
However, the formation of rod-like gold particles was observed together with 
some spherical particles, and the length of rod-like gold particles was 
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increased with increasing UV irradiation time. It should be noted that it is not 
clear what is being oxidized in response. 
 The most commonly used technique to prepare mono-dispersed gold 
nanorods is seed-mediated growth method (Figure 1.1).
31-35
 Various reducing 
regents could be employed in the method, such as hydroxylamine, sodium 
citrate, and ascorbic acid. A systematic study has recently been reported by 
Murphy and co-workers.
33
 In this study, a solution of 3.5 nm gold seed 
particles is first prepared by reducing HAuCl4 with sodium borohydride 
(NaBH4) in the presence of citrate. The use of citrate only serves as the 
capping agent since it cannot reduce gold salt at room temperature. Then, a 
growth solution containing HAuCl4, C16TAB and freshly prepared ascorbic 
acid solution (a mild reductant), was added to a seed solution to generate gold 
nanorods. However, lots of gold nanospheres are formed in this method, but 
they could be readily removed (together with the excess surfactants) via 
centrifugation. Nikoobakht and El-Sayed
31
 further modified the seed-mediated 
method by using a cosurfactant mixture of C16TAB and 
benzyldimethylhexadecylammonium chloride (BDAC) and reported that the 
use of binary surfactant results in nanorods of fairly good uniformity, higher 
yield, and yet fewer byproducts. Most recently, Mulvaney and co-workers 
improved this method and investigated the factors affecting the formation of 
gold nanorods.
36
 By changing amount of seed, inversion agitation, coagulation 
of the seed, seed size and cosurfactant, the length of gold nanorods could be 
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adjusted from 25-170 nm. 
Au or Ag salt + NaBH4
citrate
+ metal salt + ascorbic acid 
CTAB
 
Figure 1.1 Representation of seed-mediated growth for gold and silver 
nanorods. 
 
 The mechanism for the formation of rod-like nanoparticles in an aqueous 
surfactant medium has also been investigated by several groups.
32,37
 It was 
proposed that the trimethylammonium head group of C16TAB can selectively 
bind to specific crystallographic facets of the seeds and rods. The tails of 
C16TAB can form a bilayer structure with each other through van der Waals 
interactions. These bilayers play an important role in promoting the formation 
of nanorods.
32
 Experimental studies also found that surfactants with longer 
chain lengths led to longer rods with higher yields as compared to shorter 
ones.  
 
1.1.2 Optical properties of gold nanorods 
Gold nanostructures have been attracted intensive research attention for their 
fascination surface plasmon resonance properties (SPR).
38
 SPR is an optical 
phenomenon originating from the interaction between an electromagnetic 
wave and the conduction electrons in a metal. (Figure 1.2) Irradiating with the 
incident light, the conduction band electrons in gold nanostructure will be 
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driven by electromagnetic field to generate coherent oscillate at certain 
resonant frequency when the nanoparticle is much smaller than the wavelength 
of light.
39
 Some of photons will be absorbed and converted into phonons or 
vibrations in the lattice. This process is known as absorption. Meanwhile, 
some of these photons will be released in all directions. This process is 
referred as scattering. In a word, the SPR of gold nanostucture included two 
components: scattering and absorption.  
 
Figure 1.2 Surface plasmon oscillation of metal nanoparticles. 
 
 For gold nanorods, electron oscillation could occur in two directions 
which depends on the polarization of the incident light. The gold nanorod will 
generate an absorption band in visible region centered at the absorption of 
gold nanospheres when the polarization of incident light along the short axis. 
This absorption band called the transverse plasmon band. When the electron 
oscillation along the long axis, it will induce an strong absorption band 
ranging from 600 to 1000 nm. It referred as the longitudinal plasmon band. 
However, the transverse plasmon band is insensitive to the nanorod size. The 
longitudinal plasmon band is sensitive to aspect ratio of gold nanorod, which 
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Figure 1.3 Tunable optical properties of gold nanorods by changing the aspect 
ratios. Gold nanorods of different aspect ratios exhibit different dimensions as 
seen by TEM (A), in different color (B) and different SPR wavelength (C). 
 
 The scattering of gold nanorods also related with particle aspect ratio and 
size, but it is not the focus of this thesis. 
 
1.1.3 Application of gold nanorods 
As we know, the SPR frequency depends on the dielectric constant of the 
surrounding medium. Therefore, the SPR wavelength, either absorption or 
scattering, provides great opportunity to monitor the changes of the 
surrounding environment of the nanoparticle and thus could be used for 
sensing. For gold nanorods, the anisotropic shape give higher sensitivity than 
spherical nanoparticles. Yu and co-worker have demonstrated a multiplex 
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biosensor assay using the different responses of gold nanorods to different 
targets.
40
 Human, rabbit, and mouse IgG were first conjugated to gold 
nanorods of different aspect ratios via a 11-mercaptoundecanoic linker. By 
observing of different shifts of the SPR wavelength of the nanorods, the 
binding of these three molecular probes to their respective complements 
(anti-IgGs) were monitored and differentiated. The limit of detection is found 
to be on the nanomolar scale. 
 Molecular imaging visualizes molecular or genetic phenomena in live 
cells, tissue, organs, and whole organisms. For gold nanorods, large surface 
area offers molecular multifunctionality for simultaneous disease targeting, 
imaging, diagnostic, and therapeutic applications. Furthermore, gold nanorods 
are photo-resistant and stable, offering long time operation for optical imaging. 
Li and co-workers imaged the cancer biomarker HER2 on MBT2 cell and 
CXCR4 on HepG2 by conjugating the nanorods to corresponding antibodies.
41
 
Kim and co-workers differentiated inflamed cells from control cells by using 
the gold nanorods conjugated to anti-intercellular adhesion molecule-1 
(ICAM-1) for the targeting of overexpressed ICAM-1 on inflammatory cells.
42
 
 Furthermore, when irradiated with wavelengths which overlap with their 
absorption bands, gold nanorods strongly absorb radiation throughout the 
visible and NIR and then dissipate this light energy as heat, resulting in 
significant increasing of local temperature. In 2006, El-Sayed and co-workers 
have prepared gold nanorods having a NIR absorption maximum of 800 nm 
10 
 
and conjugated them to EGFR monoclonal antibodies.
43
 Conjugated nanorods 
were incubated with both a nonmalignant epithelial cell line and two 
malignant epithelial cell lines. Antibody containing rods were found to bind 
with preference to the malignant cell lines. After that, cells were irradiated 
with a continuous 800 nm CW laser resulting in cell death at relatively low 
powers (80 mW). In addition, the gold nanorods could be visualized on the 
cell surface via Raleigh scattering using darkfield microscopy.  
 
1.2 Two-photon absorption materials 
Due to their special properties, TPA materials are widely used in different 
fields. In the following sections, related studies will be reviewed in three 
sub-areas: two-photon absorption, two-photon absorption materials and gold 
nanorods as two-photon imaging agent. 
 
1.2.1Two-photon absorption 
Two-photon absorption (TPA) is the simultaneous absorption of two photons 
of identical or different frequencies in order to excite a molecule from one 
state (usually the ground state) to a higher energy electronic state. The energy 
difference between the involved lower and upper states of the molecule is 
equal to the sum of the energies of the two photons. That means the 
fluorescent molecule will emit higher energy photon when it absorbs two 
lower energy photons. This two-photon absorption (TPA) can lead to emission 
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of radiation having shorter wavelength than the absorbed radiation. For 
example, a molecule absorbing a photon whose wavelength is 400 nm can be 
excited by absorbing two photons of wavelength 800 nm simultaneously. 
 This theoretical concept of exciting a molecule or atom by the 
simultaneous absorption of two photons in the same quantum event was first 
predicted by Maria Goppert-Mayer in 1931. For two-photon absorption to 
occur, an atom or molecule must first be excited by a photon to an 
intermediate virtual state of higher energy as shown in Figure 1.4. 
 
Figure 1.4 Jablonski energy diagram for one-photon and two-photon 
absorption. 
 
 Two-photon absorption usually requires the light with very high intensity, 
something that was a mere fantasy until the invention of lasers in the 1960s. In 
1961, two-photon absorption was experimentally verified by Kaiser and Garret 
with the two-photon excitation of CaF2:Eu
2+
 crystal using pulsed lasers with 
very high intensity.
44
 Two-photon absorption spectroscopy was then used to 
study the electronic structure of molecular excited states due to the difference 
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in selection rules with those of one-photon absorption.
45
 
 Besides selection rules, another difference between two-photon and 
one-photon absorption is that in one-photon absorption, the rate of the 
absorption is directly proportional to the light intensity. In contrast, 
two-photon absorption is proportional to the square of the light intensity, 
which is otherwise known as the power-squared dependence of two-photon 
excitation, thus two-photon absorption happens only when the light density is 
very high. This quadratic dependence of the transition probability on the laser 
light intensity allows us to achieve three-dimensional (3D) spatial resolution 
(Figure 1.5) for two-photon induced chemical or physical processes in 
materials. For a tightly focused laser beam, the intensity is maximal at the 
focus and it decreases quadratically with the distance (z) from the focal plane 
(the plane that is perpendicular to the axis of a lens and passes through the 
focal point) in the beam direction, for distances larger than the Rayleigh length. 
Therefore, the probability of which two-photon materials are excited therefore 
decreases very rapidly with the distance (as z
-4
) from the focal plane. This, 
together with the exponential distribution of the intensity within the focal 
plane, confines two-photon excitation in a small volume around the focus. In 
addition, the one-photon absorption of a material is typically weak in the 
wavelength range where two-photon absorption occurs, which allows exciting 
the material at a greater depth than that is possible with one-photon excitation. 
Furthermore, because the wavelength used for two-photon excitation is 
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roughly twice that for one-photon excitation, the loss of the light intensity due 
to scattering is reduced by about a factor of 16. Since Rayleigh Scattering 
cross section α is proportional to (1/λ)4,46 using near-IR light at higher λ in 
two-photon excitation would result in much less scattering, thus resulting in a 
high-resolution 3D imaging with increased penetration depth as compared to 
one-photon excitation using UV light. Two-photon absorption is thus 
particularly useful when used in biological specimens, since most biological 







Figure 1.5 One-photon and two-photon excitation. 
 
1.2.2 Two-photon absorption materials 
Two-photon absorption(TPA) is a third-order non-linear optical process. The 
energy absorbed through a two-photon process is quadratically proportional to 
the intensity of the incident light. This provides improved spatial selectivity in 
three dimensions down to one-wavelength resolution. Furthermore, TPA can 
14 
 
be induced by simultaneously absorb two photons with the same wavelength 
which ensures deep penetration into scattering media. These properties render 
TPA materials to be widely used in different fields, such as spectroscopy,
45,47
 





high-resolution fluorescence microscopy and characterization,
53-60
 
three-dimensional optical data storage,
50,51,61-67










 and new nanobiophotonics applications.
78,79
 
 π-c organic molecules are an important class of two-photon absorption 
materials. Among these, Porphyrins are the first two-photon absorption 
materials that people widely investigated. A simple porphyrin monomer that is 
aromatic, exhibits a small TPA cross section (<100 GM), owing to its 
18-electrons. The efficiencies of porphyrin are limited. Therefore, modifying 
the peripheral part of porphyrin with conjugative group or assembling 
porphyrin together have been investigated to enhance the TPA cross section 
values. 
Conjugated polymer is another type of two-photon absorption materials due 
to their extend delocalization π-electrons along the polymer backbone. It can 
enhance TPA cross sections. The largest TPA cross section (>10000 GM) has 
been reported for a ladder-type polymer with low flexibility, high planarity, 
and effective conjugation length. Conjugated polymers with large two-photon 
absorption cross sections are attractive for various applications. Yang and 
15 
 
co-workers reported alternating copolymers of 
poly(2,6-bis(p-dihexylaminostyryl)anthracene-9,10-diyl-alt-N-octoylcarbazole
-3,6-/2,7-DIYL) (P1/P2) with large two-photon cross sections.
80
 The solution 
TPA properties of the polymers in chloroform are measured by the two-photon 
induced fluorescence method using femotosecond laser pulses. The TPA cross 
sections are measured over the range of 700-900 nm. The maximal of cross 
section of P1 and P2 appear at ~800 nm are 1010 GM and 940 GM per 
repeating unit, respectively. It suggested that the polymers with large TPA 
cross section can be obtained by using the high TPA active units as building 
blocks. 
Nanoparticles such as novel metal and semiconducting nanoparticles have 
also been investigated for their two-photon absorption properties. Colloidal 
CdSe quantum dots exhibit large TPA cross section (from 2000 to 47000 GM). 
They appear to be promising probes for two-photon microscopy. Webb and 
co-workers reported the using of water-soluble cadmium selenide-zinc sulfide 
quantum dots for multiphoton imaging in live animals.
56
 These QD have 
two-photon action cross sections as high as 47,000 GM, which could be 
visualized through the skin of living mice, in capillaries hundreds of 
micrometers deep. Gold nanorods as two-photon absorption materials are 
particularly interesting. The TPA action cross sections of gold nanorods were 




 about two orders of magnitude larger than small 
organic molecules (1-100 GM). Gold nanorods have been demonstrated as 
16 
 
contrast agent for in vitro and in vivo two-photon luminescence imaging. Gu 
and co-workers reported that gold nanorods were conjugated with transferrin 
for efficient trageting, two-photon luminescence imaging and enhanced 
microsurgery of cancer cells (Figure 1.6).
81
 Gold nanorods are more efficient 
than Fluorescein isothiocyanate in three-dimensional imaging due to their 
large TPA cross section. In addition, the gold nanorod could also induce 
apoptosis of cancer cells due to the photothermal effect. 
Gold nanorods 1.0 mW Transferrin-FITC 30 mW
 
Figure 1.6 In-vitro two-photon luminous imaging of HeLa cells by using gold 
nanorods and transferrin-FITC. 
 
1.3 Photodynamic therapy 
Photodynamic therapy has been widely used in the clinic for the treatment of 
head and neck, brain, lung, pancereas, and skin cancers. In the following 
sections, related studies will be reviewed in three sub-areas: photodynamic 
therapy, two-photon photodynamic therapy and nanomaterials as 




1.3.1 Photodynamic therapy 
Photodynamic therapy (PDT) is a kind of non-invasive treatment for 
cutaneous malignanices
82,83
 and intraperitoneal tumors (colorectal cancer, 
pancreatic cancer, bladdercancer).
84-86
 PDT was first used in the treatment of 
psoriasis, rickets, vitiligo and skin cancer in ancient Egypt, India and China 
three thousand years ago.
87
 At the end of the nineteenth century in Denmark, 
Niels Finsen further proposed “phototherapy” to treat diseases, opening a new 
chapter of modern light therapy. In his investigations, smallpox pustules and 
cutaneous tuberculosis could be cured by red light and ultraviolet light 
exposure, respectively.
88
 Later, researchers observed that a combination of 
light and specific chemicals could induce cell death, which was described as 
“Photodynamic Action”.89,90 This study opens the door to the application of 
PDT in modern cancer therapy. The PDT process involves three necessary 
components: light, photosensitizer and tissue oxygen (singlet oxygen). 
Irradiating photosensitizer by laser with an appropriate wavelength, the 
photosensitizer is promoted from its ground state to its excited singlet state 
followed by intersystem crossing to a relatively long-lived excited triplet state. 
The photosensitizers in triplet excited state subsequently transfer the energy to 
the nearby tissue oxygen, resulting in the generation of various reactive 
oxygen species, such as singlet oxygen or free radicals. The generated singlet 
oxygen is a highly oxidative species that could react with various biological 






























Figure 1.7 Diagram of type II photochemistry in PDT. 
Compared with other conventional tumor therapy, PDT has been regarded 
as one of the most promising approaches to deal with cancer and has been 
extensively exploited to improve conventional tumor therapy in recent years.
91
  
PDT exhibits extraordinary advantages such as comparative non-invasion, 
relative low cost and no scarring left. However, it still suffers from some 
drawbacks. The current available PDT has low penetration depth of the visible 
light ascribing to the absorption and scattering of biological tissues. Tromberg 
et al reported that the incident light intensity will reduce to a limit of 1/e with 
increasing penetration depth. Generally, the penetration depth ranges between 
0.5 and 1.5 mm at the wavelength from 480 to 600 nm and gradually improves 
to 4-5 mm with the increase of wavelength (Figure 1.8).
92
 Therefore, it is 
desirable to explore a new therapy technique, in which light could penetrate 
deeper into the tissue. Recent studies on two-photon photodynamic therapy 
















Figure 1.8 Penetration depth of skin tissue at different wavelength. 
1.3.2 Two-photon photodynamic therapy 
The application of conventional PDT is hindered by a limited light penetration 
depth into tissues in the visible range and a lack of selectivity in the 
z-direction. However, in two-photon PDT, two long-wavelength photons are 
simultaneously absorbed by photosensitizers, which in turn, react with tissue 
oxygen to generate reactive oxygen species (ROS), such as singlet oxygen and 
other free radicals, leading to cell apoptosis.
93-95
 Therefore, TP-PDT has been 
proposed in 1990s by using porphyrin compounds including chlorins and 
phthalocyanines as the photosensitizer. Typically, porphyrins have a strong 
absorption maximum (Soret band) between 400 and 500 nm, and several very 
weak absorption bands in visible range.
96
 The range of porphyrins maximum 
absorption band corresponding to the combined energy of two photons in the 
wavelength range from 800 to 1000 nm, which is consistent with the 
biological transparency window. As a result, a 10-100-fold increase of light 
20 
 
penetration depth is achieved by using TP-PDT. Moreover, two-photon 
excitation is a nonlinear process that is quadratically dependent on the laser 
intensity. The excitation and treatment are confined at the focal point of laser 
beam, a comparatively small volume, localizing in both the transverse plane 
and along the laser beam. As a result, 3-D spatial selectivity is achieved in 
TP-PDT, which effectively prevents damages to nearby healthy tissues. All 
these advantages render TP-PDT as one of promising approaches in the 
treatment of malignant tumors and other diseases.
97
  
The first TP-PDT report was published in 1982.
98
 Andreoni et al 
investigated the cell survivals with hematoporphyrin derivatives (HpD) under 
irradiation using pulsed and continuous wave lasers. The pulse activated 
two-photon process has higher cytocidal efficiency than that of continuous 
wave laser. In 1986, Marchesini et al
99
 attempted TP-PDT using HpD as 
photosensitizer to carry out in vivo experiments in mice. In this study, 
Nd:YAG continuous wave laser and 7ns pulse laser at 1060 nm were used for 
comparison and the result was good that focused laser beam was sufficient for 
TP-PDT. However, these studies could not attract much attention because 
two-photon absorption (TPA) efficiencies of photosensitizers used were low 
and usually with TPA cross section value bellow 50 GM. For example, the 
TPA cross section value of hematoporphyrin derivatives (Figure 1.9) is known 
to be only ~2 GM.
100
 To sufficiently make use of the advantages of 
two-photon PDT, it becomes critical to develop photosensitizers with large 
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TPA cross sections and efficient two-photon induced singlet oxygen 
generation abilities. Many efforts have been made to improve the TPA 
efficiencies of photosensitizers through syntheses of new photosensitizers or 
chemical modification of porphyrins with large TPA cross sections. 
Conjugated porphyrins to form dimmers and oligomers displayed very strong 
two-photon absorption (~1000 GM).
101
 Ogawa et al reported that 
self-assembled conjugated porphyrin exhibited a large two-photon absorption 
cross section value of 7600 GM in chloroform which is 4000 times larger than 
that of monomeric analogues (hematoporphyrin, ~2 GM).
102
 Although these 
porphyrin derivatives present large two-photon absorption cross, they are 
prone to photo-induced degradation.
103
 In addition, porphyrin derivatives are 
hydrophobic and can aggregate easily in physiological environment, resulting 
in inhomogeneous distribution of photosensitizer in tumor cells. To overcome 
these limitations, it is desirable to load the photosensitizer in nanomaterials, in 
which photosensitizers can be well protected against photo-degradation, 


















































































































Figure 1.9 Structure of hematoporphyrin derivatives (HpD). 
 
1.3.3 Nanomaterials as photosensitizer carriers for two-photon 
photodynamic therapy 
Recently, there is an increasing interest in loading photosensitizer agents in 
biocompatible nanocomposites, including nanoparticles, nanocapsules, 
micellar systems, and conjugates. Nanomaterials as carriers are promising in 
several ways: 1) After loading with photosensitizers, nanomaterials could be 
hydrophilic, which facilitate their distribution in tumor cells. 2) The 
nanomaterials possess huge surface areas, which could be modified with 
various functional groups, displaying a diverse array of chemical or 
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biochemical properties. 3) The size of nanomaterials are usually in the range 
of sub-cellular and sub-micron, which could penetrate deeper into tissues 
through fine capillaries. Therefore, the development of nanomaterials as 
carriers of photosensitizer are desirable in PDT process. 
 Ceramic-based nanoparticles have several advantages over traditional 
organic carriers.
104-108
 During their preparation process, the size, shape and 
porosity of nanoparitcle can be easily controlled. Furthermore, the 
ceramic-based nanoparticles are extremely stable and could be soluble in water. 
More importantly, there is no swelling or porosity change in ceramic-based 
nanoparticles by changing pH value of environment. Roy et al
108
 prepared 
ceramic-based nanoparticles entrapped with the hydrophobic photosensitizing 
anticancer drug 2-devinyl-2-(1-hexyloxyethyl) pyropheophorbide by 
controlled hydrolysis of triethoxyvinylsilane in micellar media. Upon light 
irradiation, the entrapped photosensitizer is able to efficiently generate singlet 
oxygen using fluorescence spectroscopy and chemical methods. Such doped 
nanoparticles are efficiently taken up by tumor cells in vitro, and light 
irradiation of such impregnated cells results in significant cell death. These 
results illustrated the potential of ceramic-based matrixes as photosensitizer 
carriers for photodynamic therapy. However, ceramic-based nanoparticles 
have shells that are difficult to collapse and release the encapsulated 




 Metal nanoparticles as photosensitizer carriers
109-111
 have also been 





 chemical and biological sensors.
114,115
 Metal 
nanoparticles usually have small size ranging from 1 to few nanometers, and 
large surface area which could load large dose of photosensitizers. Hone and 
co-worker
111
 prepared phthalocyanine-stabilized gold nanoparticles with very 
small size (2 to 4 nm). These phthalocyanine-coated nanoparticles generate 
singlet oxygen with high quantum yields. The enhanced quantum yield could 
be attributed to the use of phase transfer reagent (tetraoctylammonium 
bromide), which increase the energy transfer to molecular oxygen to form 
singlet oxygen via the heavy atom effect of phase transfer reagent. In 2006, 
the same group
110
 demonstrated that the prepared phthalocyanine-nanoparticle 
conjugates were ideally suited for PDT of cancer indications. Irradiation of 
HeLa cells with the conjugates induced substantial cell mortality through 
singlet oxygen. The singlet oxygen generation efficiency was twice high 
compared to free phthalocyanine. More recently, they described the 
vectorization of AuNP-Pc conjugates for PDT of breast cancer cell lines by 
functionalizing the AuNPs surface with anti-HER2 monoclonal antibodies.
116
 
Therefore, anti-HER2 antibodies were found to enhance the selective targeting 
of this type of breast cancer cell and through the efficacy of the 4-component 
"antibody-Pc-PEG-AuNPs" conjugates for PDT applications. 
 Biodegradable polymer-based nanoparticles are polymers that are 
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degraded in a biological environment and thus release the photosensitizers. 
Their advantages lie in high photosensitizer loading, the possibility of 
controlling the drug release, and a large variety of materials and 
manufacturing process.
117
 As early as 1991, Labib A et al
118
 prepared 
tetrasulfonated zinc phthalocyanine (ZnPcS4) or aluminium naphthalocyanine 
entrapped into poly(isobutylcyanoacrylate) or poly(ethylbutylcyanoacrylate) 
nanocapsules or nanospheres by interfacial polymerization. The prepared 
nanocapsules and nanospheres size ranged from 150 to 250 nm, and 10 to 380 
nm, respectively. Photosensitizer binding in the nanoparticles was between 75 
and 80 %. In 1995, the same group used V-79 hamster cells as a model,
119
 and 
found that the nanocapsules enhanced cells localization of photosensitizers 
providing a high level of in vitro phototoxic acitivity. Allemann E et al
120
 
prepared hexadecafluoro zinc phthalocyanine formulated poly(ethylene 
glycol)-coated poly (lactic acid) nanoparticles by a "salting-out" method. The 
obtained nanoparticles possessed a large average diameter, up to nearly 1000 
nm, and the photosensitizer loading was very low, only 0.61%. The 
photodynamic activity of the photosensitizer-loaded nanoparticles was tested 
in EMT-6 tumor-bearing mice and compared with the same photosensitizer 
formulated in a Cremophor EL emulsion. It was found that the formulation of 
the biodegradable nanoparticle improved the PDT response of the tumor while 
providing prolonged tumor sensitivity towards PDT. 
 Therefore, nanomaterials as photosensitizer carriers hold great promise for 
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the future development of PDT. Such nanoparticles have potential clinical use 
in tumor imaging and PDT of cancer in deep tissues. PDT will be brought to 
the forefront of oncological diagnosis and intervention. 
 
1.4 Drug delivery 
Drug-delivery system is one of the most promising applications for human 
health care and represents an ever-evolving field for biomedical materials 
science. However, targeted delivery and controlled release of a drug to specific 
organs or cells is particular important because of its high therapeutic efficacy 
and low side effects. In the following sections, we will review related studies 
in three sub-areas: carriers in drug delivery, mesoporous silica nanoparticles as 
carriers for drug delivery and stimulus-responsive mesoporous silica 
nanoparticles system.  
 
1.4.1 Carriers in drug delivery 
Recently, nanocarriers are widely used in the targeted anti-cancer drug 
delivery, including polymeric nanoparticles, dendrimers, and liposomes 
(Figure 1.10). 
 Polymer-based drug-delivery systems have an important impact on drug 
therapies. In this approach, the drug is physically entrapped inside a solid 
polymer and be injected into the body. Early forms of this systems are 
non-degradable polymers, including silicone rubber, which could release small 
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molecular drugs for relatively long times.
121
 However, it does not permit ionic 
species or molecules with molecular mass over 400. The reason is that large 
molecules cannot diffuse through this polymer. Therefore, increasing the 
concentration of polymers could create interconnecting pores that the inside 
drugs could diffuse slowly.
122
 Early studies use ethylene-vinyl acetate 
copolymer or different hydrogels to develop biodegradable drug-delivery 
systems. Using lactic/glycolic acid copolymers, the release rate will be greatly 





Figure 1.10 Structure of polymeric nanoparticles, liposomes and dendrimers. 
 
 Among various synthetic biodegradable polymers with biocompatibility, 
PLGA (poly(D,L-lactide-co-glycolide)) is the mostly used one for clinical 
use
123
 as drug delivery carrier and therapeutic devices with confirmed 
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biocompatibility. PLGA is a block copolymer composed of polylactic acid 
block and polyglycolic acid block. By using paclitaxel as a prototype 
anticancer drug encapsulated in PLGA NPs, it was concluded that the NP 
formulation of paclitaxel has great advantages versus the commercial 
paclitaxel formulation. The side effects associated with toxic adjuvant 
contained in the commercial formulation can be avoided. In vitro cell viability 
experiment on cancer cells showed much higher cytotoxicity of paclitaxel in 
the NP formulation than that in the commercial formulation. The NP 
formulation can result in much greater therapeutic effects and sustained 
chemotherapy in vivo of the drug in the NP formulation.
124
  
 Dendrimers are another type of polymer and used as carriers in drug 
delivery applications. They have unique characteristics including 
monodispersity and modifiable surface functionality, along with highly 
defined size and structure. Patri and co-workers have prepared PEG-2000 
modified generation PAMAM dendrimers with varying degree of 
substitution.
125
 Methotrexate drug was encapsulated (loaded) to the prepared 
conjugates and investigated for drug release in a dialysis bag. The results 
found that PEG-dendrimers conjugated with encapsulated drug and sustained 
release of methotrexate as compare to unencapsulated drug. Asthana and 
co-worker also reported the preparation of amine terminated generation 4 (G4) 
PAMAM dendrimers by controlled releasing of the Flurbiprofen.
126
 Prepared 
dendrimer complexes observed that loaded drug displayed initial rapid release 
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(more that 40% till 3rd hour) followed by slow release. Pharmacodynamic 
study was performed using carrageenan induced pawedema model, revealed 
75% inhibition at 4th hour that was maintained above 50% till 8th hour. The 
dendritic formulation showed 2-fold and 3-fold increase in mean residence 
time and terminal half-life, respectively, as compared to free drugs 
 Liposomes, which are phospholipid bilayer vesicles with aqueous center, 
have received a lot of attention during the past 30 years and have been 
extensively reviewed in the past few years. 
127-130
 Liposomes possess several 
attractive biological properties: 1) They are biocompatibility; 2) They have 
two parts including hydrophobic and hydrophilic. The inside part is 
hydrophilic which entrap water-soluble pharmaceutical agents, while the 
bilayer phase is hydrophobic which contain water-insoluble pharmaceuticals 
into the lipid wall. 3) The size, charge and surface properties of liposomes that 
can be easily changed simply by adding new ingredients to the lipid mixture 
and/or by variation of preparation methods.
131
 Margalit et al. have prepared 
„bioadhesive‟ liposomes by anchoring epidermal growth factor, gelatin or 
collagen in the liposome surface using a cross-linking agent 
(glutaraldehyde).
132
 In preliminary cell culture studies (A431 cell line), they 
could demonstrate significant binding of these bioadhesive liposomes to cell 
surfaces while untreated liposomes did not bind. They could also show that 
diffusion of encapsulated material was essentially unhindered by the presence 
of the anchor, although gelatin appeared to provide an additional 
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„compartment‟ from which drugs (vinblastine, progesterone, fluconazole) 
were released with a different diffusion rate. 
 
1.4.2 Mesoporous silica nanoparticles as carriers for drug delivery 
Targeted delivery and controlled release of a drug to specific organs or cells is 
particular important because of its high therapeutic efficacy and low side 
effects. To circumvent this situation, several biodegradable materials, as 
mentioned in 1.4.1, have been used as “smart” drug delivery systems that can 
controllably release drugs in aqueous solution upon the structural degradation 
of the carrier triggered by various chemical factors, such as pH, under 
physiological conditions. But, it is difficult to achieve “zero” premature 
release of drugs in these structurally unstable “soft” materials. In many cases, 
inside drug molecules would start leaking out these materials as soon as the 
system was introduced in water.  
 Recently, research has focused on developing structurally stable drug 
delivery systems that are able to deliver a relatively large amount of drug 
molecules without any premature release problem to targeted tissues or even 
intracellular organelles. Among many structurally stable materials that have 
been investigated for drug delivery, mesoporous silica nanoparticle is the most 




Figure 1.11  TEM imagine of mesoporous silica nanoparticles. 
 
 Mesoporous material MCM-41 was synthesized in the 1990s. In 2001, it 
was first proposed as drug delivery carrier. Generally, the mesoporous 
materials are formed by supra-molecular assembling of surfactants, which 
template the structure during the synthesis process. The mesoporous structure 
are formed when the surfactant is removed. Such mesoporous structure 
possess several unique features. Firstly, it has an ordered pore network, which 
is uniform in size and allows good control of drug load and release kinetics. 
Secondly, the pore size of mesoporous silica can be tuned from 2 to 6 nm by 
changing the chain length of the surfactant, employing polymeric 
structure-directing agents, or solubilizing auxiliary substances into micelles. 
Different pore size could host different size of molecules, which is governed 





implies the potential for drug adsorption. Generally, the surface area is the 
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most determining factor for the amount of adsorbed drug. Finally, the surface 
of mesoporous silica could be modified with various functional group, which 
allows better control of drug loading and release. All these advantages render 
mesoprous silica to be an excellent candidate for control-release systems. 
 
1.4.3 Stimulus-responsive mesoporous silica nanoparticles system 
A series of mesoporous silica nanoparticles based controlled-release systems 














 Among them, pH-responsive controlled-release 
systems are of more interest due to the more acidic environment in tumor cells. 
Thus, the nanoparticles will release more drugs in cancer cells but not in 
normal cells in the same period, displaying more cytotoxicity toward tumor 
cells and less cytotoxicity to the healthy cells than free drug molecules. Xiao 
et al. reported pH-responsive carriers in which polycations are grafted to 
carboxylic acid modified SBA-15 silica rods by ionic interation (Figure 
1.12).
133
 When the pH is at mild acidity, the absorbed vancomycin is steadily 





Figure 1.12  pH-responsive storage-release drug-delivery system based on 
the interaction between negative carboxylic acid modified SBA-15 silica rods 
with polycations. 
 
 Light can also be introduced to trigger the drug release in modified 
mesoporous silica materials. Fujiwara and co-workers have developed a 
photocontrolled release system by modifying pore-entrance with coumarin 
groups (Figure 1.13).
136
 Generally, coumarin groups undergo reversible 
dimerization upon irradiation with UV light at wavelengths longer than 310 
nm and return to the monomer form by irradiation at 250 nm. The dimer form 
of coumarin modified the surface of mesoporous silica, could reduce the 
effective pore size and subsequently hinders the inside drug release from them. 
However, the pores will "open" the entrance and release the adsorbed drugs at 





Figure 1.13 Scheme of photo-switched storage-release controlled release by 
coumarin-modified MCM-41. 
 
 Therefore, mesoporous silica nanopaticles able to host, protect, and target 
drug molecules at the appropriate site could play an essential role in these new 
therapies. 
 From the above review, it can be seen that nanocomposites containing 
mesporous silica and gold nanorod display large two-photon cross section, 
high two-photon luminescence, excellent photosensitizing efficiency and great 
biocompatibility, which could be widely used in two-photon imaging, 
photodynamic therapy and drug delivery system. It is worthwhile to extend the 
nanocomposites containing mesoporous silica and gold nanorods for imaging 
or simultaneous diagnosis and therapy in vitro. This thesis proposes a 
modified method to prepare a novel multifunctional nanocomposite composed 
of a gold nanorod core and a mesoporous silica shell and apply this 
nanocomposite in two-photon imaging and simultaneous therapy. The 




1.5 Objective and Significance of thesis 
In the last sections (Section 1.1-1.4), recent advances in preparation and 
application of gold nanorod and mesoporous silica nanoparticle, as well as 
introductions of two-photon imaging, photodynamic therapy and drug delivery, 
are reviewed systematically. However, as mentioned above, there are still 
some drawbacks in two-photon imaging, photodynamic therapy and drug 
delivery, which are summarized as below: 
 Traditional and typical two-photon contrast agents (fluorescence dye) 
usually have small two-photon cross section (1-300 GM) and relatively 
low resistance to photo-induced degradation, which limits their 
application in two-photon imaging.  
 Most photosensitizers (porphyrin derivatives) in photodynamic therapy 
are hydrophobic which are very easy to aggregate in physiological 
environment. Furthermore, they have long lasting cutaneous 
photosensitivity and potential toxicity to healthy tissues. Therefore, all 
these aspects of porphyrin derivatives mentioned above, are unsuitable for 
photodynamic therapy.  
 Most drug-delivery carriers are biodegradable materials including 
polymeric nanoparticles, dendrimers, and liposomes. Their structures are 
unstable; as a result, inside drug molecules will leak out when these 
carriers are introduced in water, which is difficult to achieve „zero‟ 
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premature release of drugs. Moreover, the surface area of these carriers is 
small, which restricts their application in drug-delivery system.  
 Currently, very few studies have been reported on nanocomposites 
containing mesoporous silica and gold nanorod for two-photon imaging, 
photodynamic therapy and drug delivery for simultaneous diagnosis and 
therapy in cancer cells. 
 The aim of this study was to prepare nanocomposite containing gold 
nanorod for two-photon imaging, photodynamic therapy and drug delivery for 
simultaneous diagnosis and therapy. The specific objectives of this study 
were: 
 To design “smart” nanocomposites with enhanced properties or 
multifunctionality, nanocomposite containing gold nanorod and 
mesoporous silica will be prepared by a sol-gel method in a two-step 
process. Dual capability of two-photon imaging and photosensitization of 
this nanocomposite will also be studied in HeLa cancer cells. 
 To systematically study distance dependent metal-enhanced one- and 
two-photon fluorescence, nanocomposite containing a gold nanorod core, 
a variable thickness of silica shell, and a dye labeled layer will be 
prepared. The biological applications of this nanocomposite in 
metal-enhanced photodynamic therapy will also be studied. 
 To investigate drug delivery property of nanocomposties, folic acid 
grafted mesoporous silica coated gold nanorod will be prepared by 
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combining two-photon imaging property of gold nanorod and 
pH-responsive property of drug inside mesoporous silica shell. 
Dual-function of two-photon imaging and drug delivery of nanocomposite 
will also be studied in vitro by using HepG2 cancer cells. 
 
 The findings in this study may have significant impact on potential 
application of nanocompostie containing mesoporous silica and gold nanorod 
in two-photon imaging, photodynamic therapy and drug delivery.  
A modified sol-gel method in a two-step process is formed to prepare 
nanocomposite containing mesoporous silica and gold nanorod which is 
simple to operate. 
This nanocompostie exhibits high two-photon cross section, strong 
two-photon luminescence and excellent biocompatibility, by judicious 
choice of appropriate two-photon imaging contrast agent (gold 
nanorod), excellent carrier (mesoporous silica shell). 
The study may provide some preliminary results on their capabilities for 
two-photon imaging, photodynamic therapy and drug delivery in cancer 
cells. 
 
 This thesis focuses on the utilization of nanocomposite containing 
mesoporous silica and gold nanorod for numerical applications including 
two-photon imaging, photodynamic therapy and drug delivery in cancer cells. 
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The applications of this nanocomposite in real animals are not explored 
because life animal testing requires special approval from relevant authority. It 
is not central to this study and hence is beyond the scope of this thesis. 
 The following chapters will give some preliminary results of 
nanocomposite containing mesoporous silica and gold nanorod in potential 
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Chapter 2 
Nanocomposites Containing Gold Nanorods and Porphyrin 
Doped Mesoporous Silica with Dual Capability of Two-photon 
Imaging and Photosensitization 
 
2.1 Introduction 
Two-photon imaging has become an attractive bio-imaging technique due to its 
unique advantages over conventional one-photon imaging, such as high light-
penetration depth (up to one millimeter), 3-D imaging capability, low background 
fluorescence and reduced photo-damage to living tissues. Significant research efforts 











5 and metal nanoparticles.6 The applications of traditional organic 
fluorophores, such as fluorescent dyes, as two-photon imaging contrast agents have 
been limited by their relatively small two-photon cross sections, usually in the range 
of 1-300 GM. Quantum dots have been reported to display much larger two-photon 
cross sections. However, their cytotoxicity to living organisms has made them 
unsuitable for two-photon imaging in vivo. Metal nanoparticles, in particular gold 
nanorods, have been known as promising two-photon imaging contrast agents. Gold 
nanorods have been reported to exhibit high two-photon luminescence, about 58 times 
stronger than that of single rhodamine molecule.
7
 Furthermore, the longitudinal 
plasmon band of gold nanorods is tunable from 600 nm to 1000 nm,
8
 coincident with 
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the biological transparency window, which enables deep penetration depth into tissues.  
In addition, the gold nanorods are well known for their non-toxicity, biocompatibility 
and chemical inertness. All of these features render gold nanorod as an ideal candidate 
for two-photon imaging of tissue sample in vitro and in vivo. 
Photodynamic therapy (PDT) is an outstanding cancer therapy technique that has 
been widely used in the treatment of cutaneous malignanices
9
 and intraperitoneal 
tumors (colorectal cancer, pancreatic cancer, gastric carcinoma, bladder cancer).
10-12
 
PDT involves three necessary components: light, photosensitizer and tissue oxygen. 
Under laser irradiation at an appropriate wavelength, the photosensitizer can be 
promoted to the singlet excited state and subsequently undergoes intersystem crossing 
to the triplet excited state. The photosensitizers in the triplet excited state then transfer 
the energy to the nearby tissue oxygen, which results in generation of reactive oxygen 
species, such as singlet oxygen or free radicals. These reactive oxygen species can 
oxidize cell compartment components and cause irreversible damage to tumor cells. 
Therefore, PDT exhibit some advantages over conventional tumor therapy methods 
(chemotherapy and radiotherapy) owing to its comparative non-invasiveness, accurate 
targeting, relative low cost and absence of scarring.  
However, the photosensitizer delivery systems in PDT processes still suffer from 
several drawbacks. Most hydrophobic photosensitizers easily aggregate in the 
physiological environment, and the distribution of photosensitizer in tumor cells is not 
homogenous. Furthermore, photosensitizers have potential toxicity to healthy tissues. 
To overcome these limitations, recent work has been focused on loading the 
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photosensitizer in several colloid carriers, such as, liposomes and polymeric micelles. 
Using liposomes as carriers
13, 14
 can enhance tumor uptake and increase cytotoxicity 
to tumor tissues compared to pure photosensitizer dispersion. However, 
photosensitizers encapsulated in liposome may self-aggregate and lead to significant 
reduction of photosensitization efficiency. Using polymeric micelles as 
photosensitizer carriers, especially pH-responsive polymeric micelles, has also been 
recently investigated.
15, 16
 Although polymeric micelles have shown increased 
cytotoxicity against tumor cells in vitro than that of remophor EL formulation, the 
polymeric micelles retention is still poor. Therefore, it is desirable to develop new 
types of carriers, in which photosensitizers can be well protected against degradation 
and maintain high photosensitizing efficiency.  
Mesoporous silica nanoparticles are promising materials to circumvent 
drawbacks of photosensitizer delivery systems and have already been exploited as  









 as well as biomolecule immobilization.
24
 These mesoporous silica-
based nanoparticles
25, 26
 are advantageous over other carriers. High pore volume and 
large surface area make the doped photosensitizer easier to generate singlet oxygen. 
The generated singlet oxygen can also be easily released from the matrix. The doped 
photosensitizer molecules are well-separated with aggregation effects significantly 
reduced. Moreover, silica-based structures have good biocompatibility and high 
tolerance of many organic solvents. The surface of mesoporous silica structures can 
be easily functionalized for targeting tumor cells specifically in vivo. It is thus 
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attractive to use mesoporous silica nanoparticles as excellent carriers in PDT process. 
Here we present our effort in designing a highly effective multifunctional system 
with two-photon imaging and PDT capability by judicious choice of appropriate two-
photon imaging contrast agents, photosensitizers and carriers. To our best knowledge, 
no successful example of composite nanoparticles possessing both two-photon 
imaging and PDT functionality has been reported so far.  We have successfully 
designed a novel multifunctional nanocomposites (Au NRs/mSiO2-HP) composed of 
a gold nanorod core and a porphyrin doped mesoporous silica shell. This composite 
nanoparticle was synthesized by coating a porphyrin-functionalized silanization 
precursor onto a gold nanorod through base-catalyzed sol-gel process. In this 
nanocomposite, Au nanorod core can be used for two-photon imaging while the 
outside mesoporous silica shell acts as a porphyrin carrier for PDT. The nanoparticles 
display improved photosensitizing efficiency compared with free porphyrins and high 
two-photon luminescence efficiency. 
 
2.2 Experimental section 
2.2.1 Materials  
Cetyl trimethylammonium bromide (CTAB) and ascorbic acid were purchased from 
Alfa Aesar. Tetraethoxysilane (TEOS), silver nitrate (AgNO3), N,N’-Dicyclohexyl 
carbodiimide (DCC), 3-Aminopropyltrimethoxysilane (APTEOS), sodium 
borohydride (NaBH4), hydrogen tetrachloroaurate (III) hydrate (HAuCl4·3H2O), 9,10-
anthracenediyl-bis(methylene) dimalonic acid (ABDA), Hematoporphyrin (HP) were 
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purchased from Sigma Aldrich. All solvents are analytical grade and used without 
further purification. All aqueous solutions are prepared in de-ionized water. 
 
2.2.2 Characterization 
Transmission electron microscopic (TEM) images of the nanoparticles were 
obtained by using a JEOL 2010 microscope. UV-Vis absorption/extinction and 
fluorescence spectra were measured by using a Shimadzu UV-vis spectrophotometer 
and a Perkin Elmer LS50 spectrofluorometer, respectively. The two-photon excitation 
fluorescence measurements were performed by using a Spectra Physics femtosecond 
Ti: sapphire oscillator (Tsunami) as the excitation source. The output laser pulses have 
a tunable center wavelength from 770 to 860 nm with pulse duration of 40 fs and a 
repetition rate of 80 MHz. The laser beam was focused onto the samples that were 
contained in a cuvette with path length of 1 cm. The emission from the samples was 
collected at a 90° angle by a pair of lenses and an optical fiber that was connected to a 
monochromator (Acton, Spectra Pro 2300i) coupled with CCD (Princeton Instruments, 
Pixis 100B) system. A short pass filter with a cut-off wavelength of 700 nm was 
placed before the spectrometer to minimize the scattering from the pump beam. Two-
photon imaging of tumor cells with or without Au NRs/mSiO2-HP nanoparticles were 
taken by using an Olympus Fluoview FV300 confocal scanning microscope equipped 




2.2.3 Synthesis of Au nanorods 
The gold nanorods were synthesized according to a seed-mediated, surfactant-assisted 
procedure reported previously.
8
 Gold seed solution was first prepared by mixing 
CTAB (0.1 M, 5 mL) and HAuCl4 (50 mM, 0.03 mL). ice-cold NaBH4 (58 mM, 0.1 
mL) was then added and resulted in formation of a brownish-yellow solution. This 
brownish-yellow solution was kept at room temperature for at least 2 h. Gold seeds 
solution (0.2 mL) was subsequently added into a colorless “growth solution” that 
consists of CTAB (0.1 M, 100 mL), HAuCl4 (50 mM, 1.5 mL), AgNO3 (50 mM, 
0.224 mL) and approximately ascorbic acid (0.08 M, 1.5 mL). The reaction mixture 
was left undisturbed overnight. The obtained Au nanorods were purified by washing 
with de-ionized water to remove excess CTAB and re-dispersed in de-ionized water 
(70 mL).  
 
2.2.4 Synthesis of silica coated Au nanorods (Au NRs/SiO2) 
Ten mL of gold nanorods solution was centrifuged and re-dispersed in de-ionized 
water (20 mL). After that, NaOH solution (100 L of 0.1 M) was added upon stirring 
to disperse the NaOH solution in the gold nanorods solution homogeneously. Pure 
TEOS (6 L) was subsequently injected three times under stirring at 30 minute 
intervals. After stirring for 24 h, a silica layer was formed on the surface of the Au 
nanorods through hydrolysis and condensation of TEOS. The obtained Au NRs/SiO2 
nanoparticles were isolated by centrifugation, washed with de-ionized water several 
times, and then dispersed in de-ionized water for further use. 
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2.2.5 Synthesis of hematoporphyrin-doped mesoporous silica coated Au nanorods 
(Au NRs/mSiO2-HP)  
In order to make Au NRs/mSiO2-HP nanoparticles, hematoporphyrin first reacted 
with APTEOS in the presence of DCC to form the hematoporphyrin silanization 
precursor. In a typical procedure, HP (10 mg) was first added into DMF (1 mL) and 
stirred for 5 min before DCC (3.54 mg) was added. After the mixture was stirred for 
another 5 min, APTEOS (5 L) was added. The mixture was stirred for 20 h at room 
temperature to afford the hematoporphyrin-functionalized silanization precursor.  
The synthesis of Au NRs/mSiO2-HP nanoparticles was carried out by coating Au 
NRs/SiO2 nanoparticles with hematoporphyrin-functionalized silanization precursor. 
The prepared Au NRs/SiO2 nanoparticles were dispersed into a mixture consisting of 
appropriate amounts of CTAB, NaOH (0.1 M, 0.1 mL), and TEOS (18 L). After 
vigorous stirring, HP functionalized silica precursor (100 L) was added into the 
mixture. The reaction was allowed to further proceed for 24 h. The product was 
collected by centrifugation and washed at least 5 times with methanol to remove the 
extra CTAB.
27
 The obtained nanoparticles were dispersed in deionized water (1 mL). 
 
2.2.6 Detection of singlet oxygen generation 
Generation of singlet oxygen is usually detected by singlet oxygen emission at 1269 
nm
28
 or with singlet oxygen sensors such as (9,10-anthracenediyl- bis (methylene) 
dimalonic acid (ABDA),
29
 or 1,3-diphenylisobenzofuran (DPBF).
30
 Here the ABDA 
method was chosen to monitor the amount of singlet oxygen. In this method, ABDA 
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can react with singlet oxygen to yield an endoperoxide and causes a decrease of 
ABDA absorption centered at 380 nm. The three characteristic absorption peak (360 
nm, 380 nm and 400 nm) of the ABDA absorption spectrum can be easily 
distinguished even though the absorption spectrum of ABDA overlaps with that of HP. 
In our experiment, the solutions of Au NRs/mSiO2-HP and free HP were prepared by 
dispersing them in de-ionized water and were adjusted to the same concentration of as 
HP. ABDA (2 mg mL
-1
, 25 L) was then added to Au NRs/mSiO2-HP (2.5 mL) and 
free HP solutions separately. The mixture was irradiated at 633 nm HeNe laser, a 
typical wavelength used in photodynamic therapy.
31
 The generation of singlet oxygen 
was monitored by recording the decrease in ABDA absorption in different irradiation 
periods. 
 
2.2.7 Cell culture 
Human caucasian breast adenocarcinomal cell line (MDA-MB-231) was obtained 
from the Medicinal Chemistry Program, National University of Singapore and was 
cultivated in Dulbecco minimum essential media (DMEM) with 10% fetal bovine 
serum (FBS) and 1% penicilin/streptomycin at 37℃ in a humidified atmosphere with 
5% CO2. In a two-photon imaging experiment, cells were cultivated in 24-well plates 
at a density of 5×10
4
 cells/well and incubated for three days. Then, a suitable amount 
of nanoparticles were added into the cells and cultivated at 37℃ overnight. The cells 
were washed by PBS solution to remove the unbound nanoparticles and were imaged 




2.3 Results and Discussion 
2.3.1 Physical and optical properties of Au NRs/ mSiO2-HP nanoparticles 
The preparation procedures of Au NRs/mSiO2-HP nanoparticles are illustrated in 
Scheme 2.1. The detailed synthesis procedures are described in the Experimental 
Section. Au NRs were first prepared by using a seed-mediated, CTAB-assisted 
method.
8
 Nanorods with different aspect ratios can be obtained by changing the 
concentration of silver ions. Au NRs/mSiO2-HP nanoparticles were then obtained by 
using a sol-gel method in a two-step process.
17, 27
 The silica coated Au NRs were 
prepared via base-catalyzed hydrolysis of TEOS, and were then isolated from solution 
and re-dispersed in a CTAB solution. Au NRs/mSiO2 nanoparticles subsequently 
reacted with hematoporphyrin-functionalized silanization precursor, effectively 
doping HP molecules into the second silica layer via the formation of amide bonds. 
Au NRs/mSiO2-HP nanoparticles were finally obtained after removing CTAB 
templates by washing with methanol at least 5 times. In the nanocomposites prepared 
by using this two-step method, the mesoporous silica layer prevents direct contact 
between HP molecules and the Au NRs core, and thus prevents energy transfer from 
HP to Au NRs. The energy transfer process from HP to Au NRs will generally quench 
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Scheme 2.1 Preparation process of Au NRs/mSiO2-HP nanoparticles (A); and 
schematic illustration of singlet oxygen generation (B). 
 
Figure 2.1 shows the TEM images of the prepared Au NRs/mSiO2-HP 
nanoparticles. The Au NR core has a length of 45 nm and an aspect ratio of 3. The 
prepared Au NRs/mSiO2-HP nanoparticles exhibit good mono-dispersity. Figure 2.1b 
and 1c display the high resolution TEM images of composite nanoparticles coated 
with the first (1b) and second (1c) silica layers, respectively. The mesoporous silica 
shell on the surface of Au NRs is quite homogeneous and uniform, with a thickness of 
~13 nm. The mesopore shell is made of disordered mesoporous, similar to the 
previously reported results.
17, 27
 The mesoporous silica structure will, on one hand, 
enhance the doped photosensitizers generation of singlet oxygen and on the other 
60 
hand  facilitate the release of the singlet oxygen to the surrounding environment. 
 
Figure 2.1 TEM images of Au NRs/mSiO2-HP nanoparticles (a). Au NRs/mSiO2-HP 
nanoparticle coated with the first (b) and second (c) silica layers. 
 
The extinction spectra of Au NR/mSiO2-HP nanoparticles dispersed in aqueous 
solution is shown in Figure 2.2a. The extinction spectra of pure Au NRs and free 
hematoporphyrin at the same concentrations were also plotted on the same graph for 
direct comparison. It can be seen that its extinction spectra is a superposition of the 
extinction spectrum of Au NRs and the absorption spectrum of free HP solutions. 
Compared with Au NRs, the longitudinal plasmon band of Au NR/mSiO2-HP was 
slightly blue-shifted upon the deposition of mesoporous silica, while the transverse 
plasmon band remains almost unchanged. The slight blue-shift of LSPR band of Au 
NR/mSiO2-HP can be ascribed to smaller overall refractive index of the mesoporous 
silica coating around Au nanorod surface compared to that of CTAB coating.
32
 The 




to the HP absorption. These results confirm that HP has been successfully doped into 
the mesoporous silica during the “two-step” coating process. The amount of HP doped 
in Au NR/mSiO2-HP could be determined from its absorption spectrum. It can be 





 when the longitudinal plasmon band absorption of Au NRs was ~0.34, which 
corresponds to ~1900 HP molecules per nanopartilce. 
Typical fluorescence spectra of Au NR/mSiO2-HP nanoparticles and free HP with 
the same amount of HP materials are shown in Figure 2.2b. The fluorescence 
intensity of HP was quenched by a factor of 3 by the Au NR/mSiO2-HP nanoparticles. 
Two factors are responsible for the observed quenching. First, a large amount of HP 
molecules were contained in a thin silica shell and self-quenching is unavoidable. 
Secondly, the HP molecules and the Au NRs core are only separated by a thin silica 
layer (~10 nm), the energy transfer between HP and Au NRs might be still possible, 























































Figure 2.2 Extinction (a) and emission (b) spectra of Au NR/mSiO2-HP nanoparticles 
(dash), Au NRs (red line) and free hematoporphyrin (green line) at the same 
concentration and their photographs taken under white light (c) and UV light (d). The 
emission spectra were taken with excitation wavelength at 397 nm. 
 
Figure 2.2c and 2.2d show the pictures of Au NRs, Au NR/mSiO2-HP 
nanoparticles and free HP under room light and illumination with UV light, 
respectively. Under the room light, free HP solution is colorless, while Au NRs and 
Au NR/mSiO2-HP nanoparticles solutions display a typical dark red color of Au NRs. 
Under illumination with UV light, free HP solution and Au NR/mSiO2-HP 
nanoparticles emitted strong red fluorescence, whereas no fluorescence was observed 
from Au NRs solution. The Au NR/mSiO2-HP nanoparticles solution was less bright 
than the free HP solution, consistent with the emission spectra shown in Figure 2.2b. 
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The results further demonstrated that HP molecules have been incorporated into the 
outside mesoporous silica shell.  
 
2.3.2 Photosensitization ability of  Au NRs/mSiO2-HP nanoparticles 
An important requirement for application of photosensitizers in photodynamic 
therapy is high singlet oxygen generation efficiency. To assess the capability of singlet 
oxygen (
1
O2) generation of Au NR/mSiO2-HP nanoparticles, the photo-oxidation of 
ABDA was employed as a probe molecule to monitor the singlet oxygen generation. 
In this method, ABDA can react with the singlet oxygen to yield an endoperoxide, 
which causes a decrease of ABDA absorption centered at 380 nm. The photo-
oxidation of ABDA in the presence of Au NRs/mSiO2-HP nanoparticles was 
monitored for 75 min under the irradiation with a diode laser at 633 nm. As can be 
seen in Figure 2.3a, the absorbance of four characteristic peaks of ABDA gradually 
decreased with increasing illumination time. The capability of free HP to generate 
singlet oxygen was also recorded under the same condition for direct comparison 
(Figure 2.3b). The time dependent change of ABDA absorption of Au NRs/mSiO2-
HP and HP were directly compared as shown in Figure 2.3c. Although the emission 
efficiency of Au NRs/mSiO2-HP was quenched by nearly a factor of 3 compared to 
free HP molecules, the photo-oxidation efficiency of Au NRs/mSiO2-HP is slightly 
higher (by ~20%) than the same amount of free HP molecules. This results is in 
contrast with the usual results of reduced singlet oxygen efficiency by introducing 
metal nanoparticles.
35, 36
 The slightly higher photo-oxidation efficiency of ABDA of 
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Au NRs/mSiO2-HP nanocomposites compared with free HP at the same concentration 
may be derived from the following reasons. First, the mesoporous channel can 
increase the local concentration of photosensitizer molecules. At the same time, the 
large surface volume of mesoporous structure can absorb the target molecules 
(ABDA), which could increase the local concentration of target molecules and thus 
improve the photo-oxidation efficiency of ABDA.
25
 Secondly, the enhanced photo-
oxidation efficiency might be due to enhanced singlet oxygen generation efficiency, 
which might be induced by the heavy atom effect 
37, 38
 of Br atom in the CTAB 
molecules remaining in mesoporous silica. Photosensitizer (HP) from the singlet 
excited state to the triplet excited state could be promoted in the presence of Br atoms, 
resulting in enhanced singlet oxygen generation efficiency. 
65 




























































   HP
   AuNRs/mSiO2-HP
 
Figure 2.3 Absorption spectra of ABDA in the presence of Au NRs/mSiO2-HP 
nanoparticles (a) and the same concentration of HP solutions (b) under illumination 
by a 633 nm laser for different periods of time. (c) The change of absorption intensity 
of ABDA with Au NRs/mSiO2-HP nanoparticles and the same concentration of HP 
solutions. 
 
2.3.3 Two-photon imaging ability of  Au NRs/mSiO2-HP nanoparticles 
Au NRS were well known to be an excellent two-photon imaging agents. The 
prepared Au NRs/mSiO2-HP composite nanoparticles could also be used as two-
photon imaging contrast agent, in addition to their function as a photosensitizing 
66 
agent. Figure 2.4 shows the two-photon excitation luminescence of Au NRs and Au 
NRs/mSiO2-HP nanoparticles at the same concentration of particles by using a 
Spectra-Physics Ti:sapphire femtosecond laser with central wavelength at 780 nm. 
The two-photon luminescence intensity of Au NRs/mSiO2-HP nanoparticles is similar 
to that of pure Au NRs, suggesting their high two-photon imaging capability is 
maintained in the nanocomposites. The two-photon excitation emission of free HP 
molecules is about 2 orders of magnitude lower than that of Au NRs/mSiO2-HP 
nanoparticles (data not shown). 





























Figure 2.4 Two-photon emission spectra of Au NRs (a) and Au NRs/mSiO2-HP (b) 
solution. The excitation source is a femtosecond laser with central wavelength at 780 
nm. 
 
2.3.4 Two-photon imaging ability of  Au NRs/mSiO2-HP nanoparticles in vitro 
We have also further explored and demonstrated the application of Au 
NRs/mSiO2-HP nanoparticles in two-photon imaging of cell samples. The 
nanoparticles were incubated with MDA-MB-231 cells for 24 hr in a 24-well plate. 
The non-internalized nanoparticles were removed by washing with phosphate 
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buffered saline (PBS). Figure 2.5 shows the images of cells incubated with Au 
NRs/mSiO2-HP nanoparticles using bright field imgaing and two-photon fluorescence 
imaging methods as well as their overlaid images. The two-photon fluorescence 
imaging was performed by using a confocal microscope coupled with a femtosecond 
laser with central wavelength at 770 nm as the excitation source. It can be seen that 
the composite nanoparticles were mainly located at organelle, consistent with the 
previous study using Quantum Dots by Parak et al.
39
 The Au NRs/mSiO2-HP 
nanoparticles are easily ingested by endocytosis due to the excellent in vivo 
biocompatibility of mesoporous silica coating. The cells can be optically monitored 
by using Au NRs/mSiO2-HP nanocomposites with two-photon excitation confocal 
fluorescence microscopy. Furthermore, the HP molecules contained inside the 
nanocomposites can thus act as photosensitizing drugs. The nanocomposites could be 
potentially useful for (two-photon) imaging guided photo-dynamic therapy with deep 
penetration depth. 
    
 
Figure 2.5 Transmission (a), two-photon excitation emission (b), and overlaid (c) 




In summary, nanocomposites with a gold nanorod core and a photosensitizer 
(hematoporphyrin) doped mesoporous silica shell have been successfully synthesized. 
These novel composite nanoparticles are uniform in size and can be easily and 
homogeneously dispersed in aqueous solution. The mesoporous silica shells provide 
spatially well-separated hematoporphyrin in molecules in a benign environment, 
making photosensitizer well-separate from each other. This unique design facilitates 
the generation and release of singlet oxygen from the matrix, and thus enhances 
singlet oxygen production efficiency compared with pure photosensitizers in aqueous 
solution. The excellent two-photon luminescence property of gold nanorods integrate 
with enhanced singlet oxygen generation efficiency of doped hematoporphyrin to 
form a novel photosensitizer-loaded mesoporous silica vehicle, which make it a 
promising platform for efficient trafficking by optical monitoring, and real-time 
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Gold Nanorods as Dual Photo-Sensitizing and Imaging Agents 
for Two-photon Photodynamic Therapy 
 
3.1 Introduction 
Two-photon photodynamic therapy (TP-PDT) has emerged as a noninvasive treatment 
for malignant tumors and other diseases.
1,2
 In TP-PDT, photosensitizers are excited by 
simultaneously absorbing two long-wavelength photons to react with tissue oxygen to 
generate reactive oxygen species (ROS), such as singlet oxygen and other free 
radicals, leading to cell apoptosis.
3-5
 The key advantage of TP-PDT is deep 
penetration into biological tissues. The near-infrared excitation wavelength used in 
TP-PDT is coincident with the biological transparency window in the range of 700 to 
1000 nm, resulting in a 10 to 100-fold increase in the light penetration depth. 
Moreover, two-photon excitation is a nonlinear process that is quadratically dependent 
on the laser intensity. The excitation and treatment are confined at the focal point of 
laser beam, a comparatively small volume, localizing in both the transverse plane and 
along the laser beam. As a result, 3-D spatial selectivity and significantly reduced side 
effects are achieved in TP-PDT.  
 Despite these advantages, notable challenges exist with TP-PDT. The TP-PDT 
efficiency of conventional organic photosensitizers in clinical use is generally limited 





 Owing to their high resistance to photo-degradation, 
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 have attracted much 
attention as potential photosensitizers in TP-PDT. However, these nanomaterials have 
their own drawbacks such as cytotoxicity of QDs and poor absorption in the near-IR 
region of ZnO and TiO2. These disadvantages limit their clinical applications in 
TP-PDT. 
 Recently, metal nanoparticles such as Au, Ag and Pt, were found to sensitize the 
formation of singlet oxygen.
12
 With their superior photo-stability, resistance to 
enzymatic degradation, metal nanoparticles are expected to be excellent 
photosensitizers for PDT. However, spherical metal nanoparticles generally have 
small two-photon absorption cross sections and cannot be utilized in the novel 
TP-PDT to take its unique advantages. Gold nanorods (Au NRs) have emerged as 
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 about 2 orders of magnitude larger than small organic 
molecules (1-100 GM). Their two-photon luminescence is about 58 times stronger 
than that of single rhodamine molecule.
16
 Moreover, the gold nanorods are well 
known for its large-scale preparation, biocompatibility and chemical inertness. The 
longitudinal plasmon band of Au NRs is tunable from 580 to 1000 nm, which is 
coincident with the tissue transparency window. Au NRs thus hold great promises to 
act as excellent photo-sensitizers for TP-PDT.  
 In this work, we demonstrated that Au NRs displayed high singlet oxygen 
generation efficiency under two-photon excitation. Three different sizes of Au NRs 
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were prepared to investigate their singlet oxygen generation capability under one- and 
two-photon excitation. Under two-photon excitation, singlet oxygen generation 
efficiency of Au NRs is much higher than that of commonly used singlet oxygen 
photosensitizers such as Rose Bengal and Indocyanine Green. The high efficiency of 
these Au NRs in killing cancer cells under two-photon excitation was demonstrated in 
HeLa cells by using XTT assay (indirect method) and fluorescence microscopy (direct 
method). Their high two-photon imaging capability and high singlet oxygen 
generation efficiency make Au NRs excellent candidates as dual photosensitizing and 
imaging agents in two-photon photodynamic therapy, allowing imaging-guided 
therapy (Scheme 3.1).  
 
Scheme 1. Schematic representation of the anticancer activity of gold nanorods under 
two-photon excitation. 
 
3.2 Materials and methods 
3.2.1 Materials 
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 Cetyl trimethylammonium bromide (CTAB) and ascorbic acid were purchased from 
Alfa Aesar. Silver nitrate (AgNO3), sodium borohydride (NaBH4), hydrogen 
tetrachloroaurate (III) trihydrate (HAuCl4·3H2O), ascorbic acid, rose bengal (RB), 
Indocyanine Green (ICG), 9,10-anthracenediyl-bis(methylene) dimalonic acid 
(ABDA), ethidium bromide (EB), Polyvinylpyrrolidone (PVP, Mw~10,000) were 
purchased from Sigma Aldrich. All solvents are analytical grade and used as received 
without further purification. All aqueous solutions are prepared in de-ionized water. 
 
3.2.2 Preparation of Au NRs 
Au NRs were prepared according to a previously reported method.
23-25
 CTAB 
aqueous solution (0.1 M, 10 mL) was mixed with HAuCl4 (50 mM, 50 μL) and 
ice-cold NaBH4 (10 mM, 0.6 mL) to form a brownish-yellow seed solution. This seed 
solution was kept at room temperature for at least 2 h. In the growth solution, CTAB 
solution (0.1 M 10 mL) was mixed with HAuCl4 (50 mM, 0.1 mL), different amount 
of AgNO3 (10 mM, 63, 72 and 81 μL), HCl (1.0 M, 0.2 mL) and ascorbic acid (0.1 M, 
80 μL). After gentle mixing, the growth solution changed to colorless. The gold seed 
solution (25 μL) was then added into the growth solution and the reaction mixture was 
left undisturbed overnight. The obtained Au NRs were purified once by washing with 





3.2.3 Preparation of PVP coated Au nanorods 
Au NRs (3.0 mL) were centrifuged and dispersed in PVP solution (0.1 g/L, 3 mL). 
The solution was stirred overnight before it was then centrifuged and re-dispersed in 
de-ionized water (3 mL). 
 
3.2.4 Two-photon excitation fluorescence measurements 
The two-photon excitation fluorescence measurements were performed by using an 
Avesta TiF-50M femtosecond Ti: sapphire oscillators as the excitation source. The 
output laser pulses have a tunable center wavelength from 740 to 860 nm with pulse 
duration of 80 fs and a repetition rate of 84.5 MHz. The laser beam was focused onto 
the samples that were contained in a cuvette with path length of 1 cm. The emission 
from the samples was collected at a 90° angle by a pair of lenses and an optical fiber 
that was connected to a monochromator (Acton, Spectra Pro 2300i) coupled with 
CCD (Princeton Instruments, Pixis 100B) system. A short pass filter with a cut-off 
wavelength of 700 nm was placed before the spectrometer to minimize the scattering 
from the pump beam. 
 
3.2.5 Detection of singlet oxygen generation 
Singlet oxygen generation under one- and two-photon excitation were monitored by 
chemical oxidation of ABDA in the aqueous solution. ABDA can react irreversibly 
with singlet oxygen, which causes a decrease in the ABDA absorption band at 380 nm. 
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The sample solution was prepared by combing three Au NRs/PVP and RB with 
ABDA, respectively. The solutions were irradiated with CW laser or fs laser pulses at 
808 nm with the same power 50 mW. Their absorbance of the solution at 380 nm was 
recorded at 15 min intervals using a UV-Vis spectrometer. 
 
3.2.6 Cell culture 
HeLa cell line was chosen as the model system. The HeLa cancer cells were 
incubated in Dulbecco’s modified Eagle medium (DMEM) containing fetal bovine 
serum (10%), streptomycin (100.0 mg/L), and penicillin (100 IU/mL). Cells were 
maintained in a humidified atmosphere of 5% CO2 at 37 °C. 
 
3.2.7 Cytotoxicity of Au NRs/PVP 
Potential cytotoxicity of Au NRs/CTAB and Au NRs/PVP was determined by using a 
colorimetric XTT cell viability assay. In a cytotoxicity experiment, a suspension of 
HeLa cancer cells (100 μL) were plated onto 96-well plates, and grown for 24 h, then 
treated with aliquot of increasing Au NRs/CTAB and Au NRs/PVP concentration and 
maintained at 37°C overnight. After adding XTT regent, the absorbance of the cell 
suspension treated with Au NRs/CTAB, Au NRs/PVP and RB were compared to the 
untreated wells and their cell viability was determined (read at A460nm-A650nm) by 
using a microplate absorbance reader. 
 
 78 
3.2.8 Two-photon photodynamic therapy on cancer cells 
HeLa cancer cells were seeded on a 96 well plate and grown until 70~80% confluence, 
then treated with three Au NRs/PVP and RB suspension for 3 h in DMEM, followed 
by changing with fresh DMEM media. Cells were exposed to a femtosecond laser 
beam from 0 to 15 min irradiation period. The irradiated plates were returned to the 
incubator and cell viability was colorimetrically measured with the XTT assay. 
 The imaging of two-photon induced apoptosis of HeLa cells in vitro was 
conducted on a Leica TCS SP5 X confocal microscope equipped with a water 
immersion objective (Leica, HCX PL APO CS, 63×/1.2, W CORR). A femtosecond 
Ti-Sapphire oscillator with output laser pulses at 808 nm was used as the two-photon 
excitation source. Images were processed by using Leica Application Suite Advanced 
Fluorescence (LAS AF) software. Cells were seeded on glass-bottom dishes (Mattek). 
Three Au NRs/PVP and RB were then added and incubated for 3 h. The media were 
discarded and fresh DMEM media was added. Samples were exposed to the 
femtosecond laser illumination for 20 min. Cells were subsequently incubated with 
EB for 30 min to examine the cell viability. The cells were then washed with fresh 
medium and visualized in fluorescence microscopy. EB fluorescence signal was 
collected from 620-640 nm under excitation at 532 nm. 
 
3.2.9 Two-photon fluorescence imaging 
HeLa cancer cells were seeded on glass-bottom dishes and grown until 70~80% 
confluence. The solution of 808 nm Au NRs was added into the media and incubated 
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for 3h. After washing with the PBS buffer solution, new DMEM media were added. 
The cell images were taken using a home-built optical system based on a Nikon 
optical microscope (Eclipse Ti) equipped with an oil immersion objective (100×, NA 
= 1.25). A CW laser at 532 nm was used as the excitation source for EB staining 
imaging with emission selected by a 630 ± 10 nm band pass emission filter. A 
Ti-Sapphire oscillator at 808 nm was used as the two-photon excitation sources. The 
two-photon emission was detected by an avalanche photodiode before passing 
through a 750 nm short-pass dichroic mirror and a 750 nm short-pass filter.   
 
3.3 Results and discussion 
3.3.1 Physical and optical properties of Au NRs 
Au NRs were prepared by using a seed-mediated, CTAB-assisted method.
23,25
 The 
detailed preparation procedure is described in the Experimental Section. Au NRs 
with three different aspect ratios (Figure 3.1a-c) were obtained by changing the silver 
nitrate concentration. Transmission electron microscopy (TEM) images clearly show 
that the prepared Au NRs are highly mono-dispersed (Figure 3.1d). The average 
aspect ratios of three Au NRs were calculated to be ~3.5, ~4.0 and ~4.3, respectively. 
The longitudinal Plasmon bands of three Au NRs display a linear relationship with the 
aspect ratio based on histograms obtained from TEM images (Figure 3.1f). The 
aspect ratios of these three Au NRs estimated from their UV-Vis extinction spectra 
(Figure 3.1e) according to Gan’s theory26 are 3.6, 4.1 and 4.4, which are consistent 
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with the results of TEM analysis. The concentration of Au NRs in solution was 
estimated according to a previously reported method.
27
 Photoluminescence quantum 
yields of three Au NRs are on the order of 10
-4
 according to the calculation results by 
El-Sayed et al.
28
 Relevant photophysical properties of three Au NRs are summarized 
in Table 3.1. 


































































Figure 3.1 Transmission electron microscopy images (a-c), size distribution 
histogram (d), UV-Vis extinction spectra (e), and the relation between λmax of 





Table 3.1 Optical properties of three Au NRs in comparison with RB. 
samples AR 
a













































   550 1.95 0.84 21  0.18 
a




Measured in water solutions, the Au 
NRs with aspect ratio of 4 was used as a standard for two-photon cross section 
measurement of other two gold nanorods at 808 nm. 
d
Two-photon action cross section 
at 808 nm. 
e
Value taken from ref 28. 
f
Value taken from ref 22. 
g
Value taken from ref 
31. 
 
 Two-photon emission properties of three Au NRs with three different aspect ratios 
were measured by using a femtosecond laser with central wavelength at 808 nm as the 
excitation source. The emission spectra of Au NRs  (Figure 3.2a) are very broad in 
400 to 650 nm range and have nearly identical shapes, consistent with the previous 
assignment to the interband transition of Au NRs.
16
 To confirm the two-photon 
excitation nature of the emission, their excitation power dependencies were performed. 
The log-log plots of fluorescence intensity versus input laser intensity give a slope of 
2.0 ± 0.1 (Figure 3.2b), which indicates a two-photon excitation process. TPA action 
cross section of Au NRs with aspect ratios of 3.5 and 4.3 are calculated to be 2.2 × 
10
4
 and 2.8 × 10
4
 GM by using Au NRs with an aspect ratio 4 as the reference (TPA 




 The two-photon action cross sections of these 
gold nanorods at 808 nm are summarized in Table 3.1. 
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Wavelength (nm)  
Figure 3.2 Two-photon excitation emission spectra of three Au NRs under excitation 
at 808 nm. Inset plots their excitation power (Iin) dependent fluorescence intensity 
(Iout). 
 
3.3.2 Singlet oxygen generation under one- and two-photon excitation 
Efficient singlet oxygen generation is a prerequisite for application of photosensitizers 
in PDT. Recently, it has been demonstrated by various methods that gold 
nanoparticles can generate singlet oxygen under one-photon excitation.
12
 Here, the 
singlet oxygen generation capability of these Au NRs under one- and two-photon 
excitation was evaluated by a chemical method using (9, 
10-anthracenediyl-bis(methylene) dimalonic acid (ABDA) as the singlet oxygen 
probe. In this method, ABDA reacts irreversibly with singlet oxygen to yield an 
endoperoxide which causes a decrease in ABDA absorption centered at 380 nm. The 
photo-oxidation of ABDA in the presence of three Au NRs and RB under one- and 
two-photon excitation with the same power (50 mW) were monitored for 75 min. The 
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singlet oxygen generation efficiency was first evaluated by using a CW diode laser at 
532 nm (Figure 3.3a). The photo-oxidation rates of ABDA in the presence of three 
Au NRs are much slower compared to RB under the same experiment condition. RB 
is a commonly used photosensitizer with singlet oxygen generation yield of 0.76.
29
   
The singlet oxygen generation yields of three Au NRs were estimated to be ~0.1% 
(Table 3.2). In contrast, the photo-oxidation rates of ABDA under two-photon 
excitation using femtosecond laser pulses at 808 nm in the presence of Au NRs are 
much faster compared to RB of the same maximum absorbance (Figure 3.3b). The 
photo-degradation efficiency of Au NRs is in the order of 808 nm Au NRs > 835 nm 
Au NRs > 765 nm Au NRs. The trend is consistent with their two-photon induced 
singlet oxygen generation capability, which could be characterized by Δ ,
30
 the 
product of TPA cross section and singlet oxygen generation efficiency.  Larger Δ  
values imply higher two-photon singlet oxygen generation capability. As shown in 
Table 3.2,  values of three Au NRs are much higher than that of RB (16).29    
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Figure 3.3 Photo-degradation rate of ABDA in presence of 765 nm, 808 nm, 835 nm 
Au NRs and RB for 75 min under one-photon excitation at 532 nm using a CW diode 
laser (a) and two-photon excitation at 808 nm using a femtosecond laser (b). 
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Table 3.2. Singlet oxygen generation efficiency of three Au NRs and RB. 












808 nm Au NRs 3×10
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  ~0.1 3×10
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 Two-photon absorption cross section at 808 nm. 
b 
Singlet oxygen generation yield 
(Δ ) were calculated based on chemical method excited by 532 nm CW laser using 
RB as the standard. 
c
 Value taken from ref 22. 
d
 Value taken from ref 31. 
e
 Value 
taken from ref 29. 
 
 We have also compared the singlet oxygen generation capability of Au NRs with 
another photosensitizer, Indocyanine Green (ICG), under one- and two-photon 
excitation at 808 nm (Figures 3.4 and 3.5). ICG has one-photon absorption maximum 
around 780 nm. Under one-photon excitation at 808 nm (Figure 3.4), the singlet 
oxygen generation efficiency of ICG is slightly higher than 808 nm Au NRs. However, 
the singlet oxygen generation capability of 808 nm Au NRs is much higher than ICG 
under two-photon excitation at 808 nm (Figure 3.5). After irradiation of femtosecond 
laser pulses for 75 min, the ABDA in the presence of 808 nm Au NRs solution 
decreased to 83% of the initial amount, while ABDA in the presence of ICG solution 
with the same maximum absorbance remained nearly unchanged. Furthermore, the 
ICG is very unstable under both the one- and two-photon excitation (Figures 3.4b 
and 3.5b). In contrast, the gold nanorods have much higher photo-stability. The 
longitudinal plasmon band of 808 Au NRs remained nearly unchanged for a 
prolonged period of irradiation (Figure 3.4a and 3.5a). These results indicate that Au 
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NRs could generate singlet oxygen with high efficiency than traditional 
photosensitizers such as Rose Bengal and Indocyanine Green under two-photon 
excitation and thereby could be utilized as efficient photosenstizers for TP-PDT.  











































































Figure 3.4 Absorption spectra of ABDA in the presence of 808 nm Au NRs (a) and 
Indocyanine Green (ICG) (b) under illumination of a CW laser at 808 nm. The laser 
power is 50 mW. (c) Photo-degradation rate of ABDA in presence of 808 nm Au NRs 
and ICG. 
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Figure 3.5. Absorption spectra of ABDA in the presence of 808 nm Au NRs (a) and 
indocyanine green (ICG) (b) under two-photon excitation using femtosecond laser 
pulses at 808 nm. The laser power is 50 mW. (c) Photo-degradation rate of ABDA in 
presence of 808 nm Au NRs and ICG. 
 
3.3.3 In vitro cellular cytotoxicity  
The seed-mediated growth method for the preparation of Au NRs involves the use of 
positively charged CTAB as a template. However, CTAB surfactant is cytotoxic to 
cells, which limits the biomedical applications of these Au NRs.
32-34
 Several methods 





 and dendrimer functionalization.
38
 Here we modified Au NRs with 
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polyvinyl-pyrrolidone (PVP). The longitudinal plasmon band of three Au NRs 
slightly shifted to red after coating with PVP due to the change in refractive index of 
the particle surface, suggesting successful coating PVP on the surface of Au NRs 
(Figure 3.6). We have also investigated the stability of Au NRs/PVP in DI water and 
Dulbecco’s modified Eagle medium (DMEM) containing FBS. There was no change 
in their extinction spectra after 24 h (Figure 3.7), suggesting the formation of relative 
stable nanoparticle suspensions. 
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Wavelength (nm)  
Figure 3.7 Stability of Au NRs/PVP dispersed in DI water, DMEM containing FBS 
medium and DMEM medium after 24h. 
 
 To assess the cytotoxicity of the prepared Au NRs in dark, HeLa cells were 
selected to be assayed using the standard XTT method. XTT assay was performed 
after exposure of cells to Au NRs/CTAB and Au NRs/PVP for 24 h. The viability of 
cells is illustrated in Figure 3.8. Au NRs/CTAB exhibited high inhibitive effect 
toward cancer cells and their cytotoxicity increased with the increasing concentrations. 
The viability of the HeLa cells decreased significantly with the increasing 
concentrations of Au NRs/CTAB, falling to <10% when the concentration of Au NRs/ 
CTAB reached 10 pM. The strong dark cytotoxicity of Au NRs/CTAB to cells limits 
their applications in vivo, which is consistent with previous observations by other 
groups.
34,39,40
 In contrast, PVP-coated Au NRs exhibited almost no cytotoxic effect in 
the dark to HeLa cells even when the concentration reached as high as 100 pM. These 
results indicate that replacing the CTAB ligand with PVP can significantly reduce 
their cytotoxicity effects. The excellent biocompatibility of PVP-coated Au NRs 
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Figure 3.8 Cell viability of HeLa cells after incubation with increasing concentrations 
of Au NRs/CTAB, Au NRs/PVP, as determined by the XTT assay. 
 
3.3.4 Two-photon PDT effects to cancer cells 
The high singlet oxygen generation efficiency of Au NRs under two-photon excitation 
and low dark cytotoxicity of Au NPs/PVP motivated us to investigate their TP-PDT 
effects on cancer cells, which were examined by using the XTT assay method and 
fluorescence microscopy. TP-PDT experiments were carried out with HeLa cells 
treated with Au NRs/PVP having different aspect ratios and RB of the same 
absorbance (as a control). HeLa cells were incubated in the presence of three different 
Au NRs/PVP at a concentration of 40 pM for 3 h. Only a relatively short incubation 
time was needed due to the high uptake efficiency of these Au NRs by cancer cells 
because of their good biocompatibility. HeLa cells with Au NRs/PVP were irradiated 
by an unfocused femtosecond laser beam (beam area = 0.3 cm
2
) at 808 nm with an 
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energy density of 3.0 W/cm
2
 for 3, 6, 10, 15 min. 
 Colorimetric XTT metabolic activity assay was used to determine cell viability 
after irradiation. Figure 3.9 shows the viability of HeLa cells treated with Au 
NRs/PVP and RB after irradiation of different periods using femtosecond laser pulses. 
The cell viability without Au NRs/PVP (blank) remained almost 100% after laser 
irradiation for 15 min, demonstrating that the laser irradiation power was safe for 
these cells and didn’t cause any detectable damage. However, the cell viability 
incubated with Au NRs/PVP decreased dramatically with increasing illumination time. 
The cell viabilities at irradiation time of 3, 6, 10, 15 min are 93%, 81.6%, 36.3% and 
31.3% for 765 nm Au NRs/PVP, 73.2%, 32.8%, 26.7% and 18% for 808 nm Au 
NRs/PVP as well as 86%, 51%, 34.4% and 28.2% for 835 nm Au NRs/PVP, 
respectively. These results indicate that a significant portion of the cancer cells was 
damaged at this dosage of Au NRs/PVP even for a short period of time. All Au NRs 
displayed much higher TP-PDT effects than RB. The cells treated with RB under the 
same condition showed insignificant killing effect on cancer cells after laser 
irradiation for 15 min, owing to the low TPA cross section and consequently low 
singlet oxygen generation of RB under two-photon excitation. The TP-PDT efficiency 
of Au NRs with three aspect ratios is in the order of 808 nm Au NRs > 835 nm Au 
NRs > 765 nm Au NRs, consistent with their relative values of TPA action cross 
sections and two-photon excitation singlet oxygen generation capability (Δ) (Table 
3.2). These results clearly showed that Au NRs/PVP, especially the 808 nm Au 
NRs/PVP, display high singlet oxygen generation under two-photon excitation, and 
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Figure 3.9 Time dependent cell viability of HeLa cancer cells after incubation with 
765 nm Au NRs/PVP, 808 nm Au NRs/PVP, 835 nm Au NRs/PVP and RB under fs 
laser (two-photon excitation) illumination at 808 nm. [Au NRs/PVP] = 40 pM, RB 
has the same peak absorbance as Au NRs/PVP. The control experiment without any 
nanoparticles was also performed under the same irradiation conditions. 
 
  The TP-PDT effect of Au NRs/PVP has also been examined by monitoring 
fluorescence microscopy directly. HeLa cells were treated with Au NRs/PVP and RB 
(as a control) for 3 h and irradiated with an 808 nm femtosecond laser for 10 min, 
then incubated in the presence of 1.0 μM ethidium bromide (EB) for 30 min to stain 
the nuclei of dead cells. EB is a membrane impermeable dye that can be used to 
examine the membrane integrity of cells and identify cells at late stage of apoptosis. 
Intense red fluorescence from cell nuclei stained by EB was observed in the presence 
of three Au NRs/PVP after 10 min laser irradiation (Figure 3.10a-c), indicating 
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extensive HeLa cell death. The cell death is believed mainly due to the generation of 
reactive oxygen species by Au NRs/PVP under two-photon excitation. However, little 
cell death was observed in HeLa cells treated with RB exposed to the same dosage of 
femtosecond laser irradiation, evidenced by no EB staining as shown in Figure 3.10d. 
Without laser irradiation, both Au NRs/PVP and RB loaded HeLa cells didn’t show 
any EB staining signals (Figure 3.10e-h), revealing that Au NRs/PVP and RB alone 
didn’t pose any direct toxicity to cells. These results confirmed that HeLa cell death 
only occurred in the presence of Au NRs/PVP and femtosecond laser irradiation at the 
same time. These Au NRs/PVP can thus act as excellent TP-PDT 
nano-photosensitizers. 
a b c d
e f g h
 
Figure 3.10 Merged transmission and EB fluorescence images of Au NRs/PVP and 
RB-loaded HeLa cells after irradiation with (a-d) or without (e-h) an 808 nm 
femtosecond laser for 10 min with a power density of 3 W/cm
2
: 765 nm Au NRs/PVP 
(a, e), 808 nm Au NRs/PVP (b, f), 835 nm Au NRs/PVP (c, g) and RB (d, h). 
 
 93 
  Gold nanoparticles are known to effectively absorb near-infrared light by their 
strong plasmon resonance band and convert the absorbed energy into thermal energy, 
thus causing irreversible hyperthermic destruction to cancer cells.
20
 The 
photo-induced cell death could originate from the synergistic effect of photodynamic 
therapy (PDT) and photothermal therapy (PTT). It is generally difficult to extinguish 
PDT and PTT from gold nanorods. Under our experimental conditions (femtosecond 
laser irradiation), the primary cause in damaging the cancer cells is believed due to 
two-photon induced singlet oxygen generation instead of photo-thermal effect. The 
contribution of photo-thermal effects played a negligible role here, which can be 
demonstrated by strikingly different cancer cell killing effect by CW laser and 
femtosecond laser pulses of the same total power (Figures 3.9 and 3.11). Using a CW 
diode laser at 808 nm with the same power density (~3 W/cm
2
), all cell samples after 
incubation with three Au NRs/PVP and RB maintained nearly 100% cell viability 
under laser irradiation for up to 15 min (Figure 3.11). However, under femtosecond 
laser irradiation at 808 nm, the cell viability incubated with Au NRs/PVP decreased 
dramatically with increasing illumination time (Figure 3.9). The photo-thermal effect 
by same total power of CW laser and fs laser pulses are expected to be similar. The 
factor that their cancer cell killing efficiencies are strikingly different suggests that the 
photo-thermal effect played a negligible role here. We have also checked the 
temperature change of the cell incubation medium under femtosecond laser irradiation. 
Insignificant temperature change was observed in the cell incubation medium during 
the irradiation time of 20 min (Figure 3.12). Although photo-thermal effect has been 
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previously observed under high dosages of Au NRs,
38
 here a much lower dosage 
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Figure 3.11 Time dependent cell viability of HeLa cancer cells after incubation with 
765nm Au NRs/PVP, 808nm Au NRs/PVP and 835nm Au NRs/PVP under fs laser 
illumination at 808 nm. [AuNRs/PVP] = 40 pM, RB has the same peak absorbance as 
Au NRs/PVP. The control experiments without any nanoparticles were performed 






















Figure 3.12 Temperature change of the cell incubation medium under femtosecond 
laser irradiation. 
 
 One potential issue of application of Au NRs in cell application is aggregation of 
Au NRS upon up-taking by cells. Au NRs normally exist in aggregated status inside 
the cell. We have examined the effects of aggregation of Au NRs on singlet oxygen 
generation. The two-photon induced singlet oxygen generation of Au NRs was found 
to decrease slightly upon the aggregation (Figure 3.13). This is mainly due to 
decreased extinction of aggregated Au NRs at 808 nm compared to the un-aggregated 
ones. Aggregation effect is actually a very complicated problem and depends on many 
factors. Aggregation of metal nanoparticles generally resulted in enhanced two-photon 
photoluminescence
41,42
 and consequently enhanced two-photon induced singlet 
oxygen generation. Systematical studies of aggregation effects on singlet oxygen 
generation will be presented elsewhere. 
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Figure 3.13 UV-Vis spectra and singlet oxygen generation capability of isolated Au 
NRs and cysteine induced aggregated Au NRs under two-photon excitation using 
femtosecond laser pulses at 808 nm. The laser power is 50 mW. 
 
3.3.5 Two-photon imaging 
Au NRs have large TPA action cross sections (Table 3.1), an indicator of high 
brightness under two-photon excitation. Au NRs/PVP can thus be used for 
two-photon imaging in living systems considering the good biocompatibility of these 
Au NRs and high penetration depth of near-Infrared light. Figure 3.14 shows images 
of Au NRs/PVP loaded cancer cells after femtosecond laser irradiation and stained by 
EB. The one- and two-photon fluorescence imaging was performed using a Nikon 
microscope coupled with a CW laser at 532 nm and an femtosecond laser at 808 nm 
as the excitation source. Intense yellow emission signals were observed in the 
cytoplasm from the two-photon fluorescence image, indicating effective uptake of Au 
NRs/PVP (Figure 3.14b). At the same time, intense red emission signals from EB 
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were observed in the nuclei of the same cell (see the merged images in Figure 3.14d), 
suggesting that Au NRs/PVP could simultaneously act as photosensitizer and imaging 
agents for two-photon photodynamic therapy. 
 
Figure 3.14 Transmission (a), two-photon excitation emission (b) and EB 
fluorescence (c) images of 808 nm Au NRs/PVP loaded HeLa cells after irradiations 
by an 808 nm femtosecond laser for 10 min with power density of 3 W/cm
2




In summary, Au NRs with three different aspect ratios have been prepared by using a 
seed-mediated, CTAB-assisted method. The prepared Au NRs were found to exhibit 
much higher singlet oxygen generation efficiency than that of conventional 
photosensitizers such as RB and ICG under two-photon excitation, in spite of lower 
singlet oxygen generation under one-photon excitation at 532 nm of the same power 
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density. After coating with PVP, these Au NRs display good biocompatibility and 
improved cellular uptake, which allows these Au NRs to be used in TP-PDT. The use 
of these Au NRs/PVP as effective photosensitizers for TP-PDT in vitro were 
demonstrated on HeLa cell apoptosis under two-photon irradiation by using XTT 
assay (indirect method) and fluorescence microscopy (direct method). Furthermore, 
these three Au NRs/PVP nanoparticles could also be used as two-photon fluorescence 
probes for HeLa cell imaging under two-photon excitation. Therefore, Au NRs are 
promising candidates as dual two-photon photosensitizing and imaging agents for 
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Gold Nanorods Enhanced Two-photon Fluorescence of 




Metal nanoparticles such as silver (Ag) and gold (Au) are known to display many 
unique optical properties such as plasmon resonance. Plasmon resonance arises from 
the collective oscillations of the conduction electrons of metal surfaces or metal 
nanoparticles. Plasmons can be excited by incident light, which induce enhanced local 
electromagnetic fields and modulate optical properties of nearby chromophores. 
Those appealing characters of plasmon resonance make metal nanoparticles attractive 









MEF phenomenon has been demonstrated experimentally in metal nanoparticles in 
particular gold and silver nanospheres.
11-19
 Most of these studies were focused on 
solid substrates,
14,20-24
 relatively fewer studies had been reported on colloid-based 
system
11-13,16
 owing to poor controllability over the fluorophores around metal 
nanoparticles. Furthermore, most of MEF studies are focused on enhancement of 
one-photon excitation fluorescence. There are very few studies on enhancement of 
multi-photon excitation fluorescence. Multi-photon excitation fluorescence is 
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expected to display larger enhancement since it is proportional to a higher order 
function of local electric fields. However, there were almost no follow-up studies 
since Wenseleers et al. claimed five orders-of-magnitude enhancement of two-photon 
absorption for dyes on silver nanoparticle fractal clusters in 2002.
25
 A major challenge 
is difficulty in preparing highly reproducible nanostructures and differentiating 
different signal contributions. A very recent report by Sivapalan et al. indicated that 
the two-photon absorption of an organic dye was enhanced by ~40 times by the 
unaggregated gold nanorods in colloid suspensions.
26
 In addition to the discrepancy in 
enhancemnt factors in two-photon absorption, so far there was no report on metal 
enhanced two-photon excitation fluorescence. 





 tunable longitudinal plasmon band, large-scale preparation, biocompatibility 





 gene and drug delivery,
33,34
 
photo-thermal and photodynamic therapy.
35,36
 Incorporation Au NRs into 
metal-fluorophores system to investigate fluorescence enhancement has been reported 




 and embedded in the film.
41
 However, 
Au NRs based systems that display enhanced two-photon fluorescence are still rare.
26
 
Compared with traditional one-photon fluorescence enhancement, two-photon 
fluorescence enhancement has various advantages. The fluorescence emission of 
fluorophores is easy to be separated from the excitation light owing to the large 
effective anti-Stokes shift. The scattering of excitation light is greatly reduced ascribe 
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to the near-infrared excitation source, resulting low background fluorescence. Most 
importantly, two-photon excitation rate is proportional to the fourth power of electric 
field, which could be dramatically enhanced by strong local electric field of the 
plasmon resonance. It is attractive to develop AuNR-fluorophores composite 
nanostructures for various two-photon sensing and imaging applications. 
 Metal-chromophore interactions have been known to strongly depend on the 
morphology of metal naoparticles and metal-chromophores separation distance, which 
are critical to achieve enhanced optical properties. In this study, we conducted a 
systematic investigation of distance dependent one- and two-photon fluorescence 
enhancement in a core-shell nanostructure consisting of a gold nanorod core, a silica 
shell with controllable thickness, and a layer of porphyrin molecules. The composite 
nanoparticles were prepared by covalent binding porphyrin molecules with long 
hydrophobic alkyl chain and amino group modified silica coated gold nanorods via 
the formation of a stable amide band. The silica shell acted as a spacer to modulate 
the distance between gold nanorod and fluorophores. By adjusting the silica shell 
thickness from 13 to 42 nm, optimum fluorescence enhancement factors of 2.1 times 
and 11.8 times were observed for one- and two-photon fluorescence, respectively. The 
fluorescence lifetime measurements have been conducted to understand the 
enhancement mechanisms. Singlet oxygen generation capability of these core-shell 
nanoparticles under two-photon excitation have been evaluated in HepG2 cells. The 
improved efficiency in killing cancer cells and high two-photon imaging capability of 
these Au NR/SiO2-T790 nanoparticles were demonstrated. These gold 
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nanorod-fluorophores nanoparticles display excellent chemical stability, shortened 
fluorescence lifetime, enhanced two-photon fluorescence and singlet oxygen 
generation capability, which make them attractive nano-photosenstizers for 
two-photon photodynamic therapy and allow imaging-guided therapy. 
 
4.2 Experimental section 
4.2.1 Materials and Methods 
Cetyl trimethylammonium bromide (CTAB) and ascorbic acid were purchased from 
Alfa Aesar. Tetraethoxysilane (TEOS), silver nitrate (AgNO3), sodium borohydride 
(NaBH4), hydrogen tetrachloroaurate (III) hydrate (HAuCl4·3H2O), 
N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC), 
N-hydroxysuccinimide (NHS), 3-aminopropyltrimethoxysilane (APTEOS), 
trimethoxyl(octadecyl)silane (OTMS), meso-tetra(4-carboxyphenyl) porphyrin (T790), 
aqueous ammonia (25 %) were purchased from Sigma Aldrich. All solvents are 
analytical grade and used as received without further purification.  
Transmission electron microscopic (TEM) images were taken on a JEOL 2010 
microscope operating at an acceleration voltage of 200 kV. UV-Vis 
absorption/extinction and fluorescence spectra were measured with Shimadzu UV 
2550 Spectrometer and Horiba Jobin Yvon FluoroMax-4 Spectrofluorometer, 
respectively. The fluorescence lifetimes were measured by using a time-corrected 
single-photon counting (TCSPC) technique. The frequency-doubled output (420 nm) 
of an Avesta TiF-100M femtosecond Ti: sapphire oscillator was used as the excitation 
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source. The fluorescence intensity at 650 nm was collected by an optical fiber that is 
directed to an avalanche photodiode (APD). The signals were processed by a TCSPC 
module (PicoQuant, PicoHarp 300) with a temporal resolution of ~150 ps. 
 
4.2.2 Preparation of gold nanorods (Au NRs) 
Au NRs were prepared according to a previously reported method.
42-44
 CTAB aqueous 
solution (0.1 M, 10 mL) was mixed with HAuCl4 (50 mM, 50 μL) and ice-cold 
NaBH4 (10 mM, 0.6 mL) to form a brownish-yellow seed solution. This seed solution 
was kept at room temperature for at least 2 h. The growth solution is a mixture of 
CTAB solution (0.1 M 40 mL), HAuCl4 (50 mM, 0.4 mL), different amount of 
AgNO3 (10 mM, 0.34 mL), HCl (1 M 0.8 mL) and ascorbic acid (0.1 M, 0.32 mL). 
After gentle mixing of the solution, the growth solution changed the color to colorless. 
The gold seed solution (100 μL) was then added into the growth solution and the 
reaction mixture was left undisturbed overnight. The obtained gold nanorods were 
purified once by washing with de-ionized water to remove excess CTAB and 
re-dispersed in 40 mL of de-ionized water. 
 
4.2.3 Preparation of silica coated gold nanorods (Au NR/SiO2) 
A Au NRs solution (10 mL) was centrifuged and re-dispersed in deionized water (10 
mL). NaOH solution (0.1 M, 100 μL) was then added under stirring. Different amount 
of pure TEOS was subsequently injected three times under stirring at 30 min intervals. 
After stirring for different hours, a silica layer was formed on the surface of Au NRs 
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through hydrolysis and condensation of TEOS. The obtained Au NRs/SiO2 
nanoparticles were isolated by centrifugation, washed with deionized water several 
times, and then dispersed in deionized water for further use. 
 
4.2.4 Preparation of T790-doped silica coated gold nanorods (Au NR/SiO2-T790) 
Silica coated gold nanorod was first functionalized with long hydrophobic alkyl chain 
and amino group using OTMS and APTEOS. In a typical procedure, AuNR/SiO2 in 
ethanol solution (10 mL) was first added into ammonium hydroxide (25 %, 100 μL) 
and stirred for 5 min before OTMS in chloroform solution (2.5 %, 100 μL) was added. 
After the mixture was stirred for another 7 hrs, APTEOS in chloroform solution 
(25 %, 100 μL) was added. The mixture reacted overnight at room temperature to 
afford the amino group functionalized Au NR/SiO2. 
The Au NR/SiO2-T790 nanoparticles were prepared by coupling the amino group 
functionalized Au NR/SiO2 nanoparticles with T790. NHS (0.1 M, 5 μL), NHS (0.1 
M, 5 μL) and T790 (1mM, 0.5 mL) was first dissolved in DMF (4.0 mL). After 
vigorous stirring for 30 min, prepared amino group functionalized Au NR/SiO2 
nanoparticles (1.0 mL) were added into the mixture. The reaction was allowed to 
further proceed for 10 hrs and the Au NR/SiO2-T790 nanoparticles were collected by 
centrifugation. Excess T790 molecules were removed by centrifuging and washing 
the nanoparticles with DMF several times. The obtained nanoparticles were then 
dispersed in DMF for various spectral measurements or aqueous medium for 
photo-degradation and cell experiments. 
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4.2.5 Preparation of SiO2-T790 nanoparticles 
Silica nanoparticles were prepared according to Stöber method.
45
 Aqueous ammonia 
(25 %, 3.0 mL), pure TEOS (1.5 mL) were added into ethanol solution (50 mL). The 
mixture reacted overnight at room temperature. The SiO2-T790 was prepared by 
replacing Au NRs core with silica nanosphere. The prepared SiO2-T790 nanoparticles 
are quite monodisperse with a diameter of ~100 nm (Figure 4.3b). 
 
4.2.6 Two-photon excitation fluorescence measurements 
The two-photon excitation fluorescence (TPEF) measurements were performed by 
using Avesta TiF-100M femtosecond Ti: sapphire oscillator centered at 820 nm with 
an average power of 100 mW as the excitation source. The output laser pulses have 
pulse duration of 80 fs and a repetition rate of 84.5 MHz. The laser beam was focused 
onto the sample that was contained in a cuvette with path length of 1 cm. The 
emission from the sample was collected at a 90° angle by a pair of lenses and an 
optical fiber that was connected to a monochromator (Acton, Spectra Pro 2300i) 
coupled with CCD (Princeton Instruments, Pixis 100B) system. A short pass filter 
with a cut-off wavelength of 750 nm was placed before the spectrometer to minimize 
the scattering from the pump beam. 
 
4.2.7 Detection of singlet oxygen generation 
Singlet oxygen generation under one- and two-photon excitation were monitored by 
chemical oxidation of 9,10-anthracenediyl-bis(methylene) dimalonic acid (ABDA) in 
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the aqueous solution. ABDA can react irreversibly with singlet oxygen, which causes 
a decrease in the ABDA absorption band at 377 nm. The solutions containing Au 
NR/SiO2-T790 nanoparticles and ABDA were irradiated with at 420 nm (one-photon 
excitation) or fs laser pulses at 820 nm (two-photon excitation). Their absorbance of 
the solution at 377 nm was recorded at 1 min intervals using a UV-Vis spectrometer. 
For direct comparison, the experiments were performed on solution containing 
SiO2-T790 and ABDA under the same condition. 
 
4.2.8 Cell culture 
HepG2 cell line was chosen as the model system. The HepG2 cells were incubated in 
Dulbecco’s modified Eagle medium (DMEM) containing 10% fetal bovine serum, 
100.0 mg/L streptomycin, and 100 IU/mL penicillin. Cells were maintained in a 
humidified atmosphere of 5% CO2 at 37 °C. 
 
4.2.9 Two-photon photodynamic therapy on cancer cells 
HepG2 cells were seeded on a 96 well plate and grown until 70~80% confluence, then 
treated with Au NR/SiO2-T790 and SiO2-T790 suspension for 3 h in DMEM, 
followed by changing with fresh DMEM media. An unfocused femtosecond laser 
beam with beam area of 0.3 cm
2
, power density of 1.6 W/cm
2
 and repetition rate of 1 
kHz at 800 nm was used as the illumination source. Cells were exposed to the 
femtosecond laser beam from 0 to 8 min irradiation period. The irradiated plates were 
sent back to the incubator overnight and cell viability was colorimetrically measured 
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with the XTT assay. 
4.2.10 Two-photon fluorescence imaging 
HepG2 cancer cells were seeded on glass-bottom dishes and grown until 70~80% 
confluence. The solution of Au NR/SiO2-T790 was added into the media and 
incubated for 3h. After washing with the PBS buffer solution, fresh DMEM media 
were added. The two-photon imaging was conducted on a Leica TCS SP5 X confocal 
microscope using a femtosecond Ti-Sapphire oscillator as the excitation source. 
Images were processed by using Leica Application Suite Advanced Fluorescence 
(LAS AF) software. 
 
4.3 Results and discussion 
4.3.1 Physical and optical properties of Au NR/SiO2-T790 nanoparticles 
     The preparation procedure of Au NR/SiO2-HP nanoparticles is illustrated in 
Scheme 4.1. Au NRs were prepared by a seed-mediated, CTAB-assisted 
procedure.
42-44
 Au NR/SiO2-T790 nanoparticles were prepared by a sol-gel method 
using a two-step process.
46
 Firstly, mixture of TEOS and Au NRs solution reacted for 
different time periods to grow silica shell with various thicknesses on the surface of 
Au NRs. The surface of Au NR/SiO2 was subsequently modified with long 
hydrophobic alkyl chain and amino group using OTMS and APTEOS.
47
 Secondly, the 
use of APTEOS introduces amino groups onto the surface of Au NR/SiO2, which 
could offer bonding sites for fluorophores on the silica shell. Most cross-linker 
reagents have side reactions in aqueous solution during the coupling process, which 
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can be minimized by conducting the coupling reaction in DMF solution. The 
modification of long hydrophobic alkyl chain on the silica shell surface allows Au 
NR/SiO2 to disperse well in DMF solution for further reactions.
47
 Thirdly, T790 were 
covalently linked to the silica shell via formation of a stable amide bond using EDC 
and NHS.
48,49
 The conjugation of T790 molecules to Au NR/SiO2 nanoparticles was 
performed in DMF solution at room temperature overnight. The prepared Au 
NR/SiO2-T790 nanoparticles are quite stable and the T790 molecules will not be 
released from nanoparticles even after several months. This conjugation method 
allows incorporation of any amine-containing fluorephores into silica shell. It is an 









Scheme 4.1 Schematic preparation procedure of Au NR/SiO2-T790 nanoparticles. 
 
 Figure 4.1 shows typical TEM images of Au NRs, Au NR/SiO2, functionalized Au 
NR/SiO2 and Au NR/SiO2-T790 nanoparticles. The obtained Au NR have average 
length of 85 nm and width of 20 nm (Figure 4.1a) with an aspect ratio of 4.25. These 
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Au NRs exhibit a longitudinal plasmon band at 820 nm.  The TEM image of Au 
NR/SiO2 clearly shows that each particle consisted of a single Au NR core and a 
uniform silica shell. The thickness of silica shells can be determined from the utmost 
outside of the particle to the edge of Au NR. The silica shell thickness remained 
nearly unchanged during the subsequent further modification processes (Figure 4.1c, 
d). Metal enhanced fluorescence has been known to depends on the 
metal-chromophore separation distance.
11,50,51
 The silica shell was utilized to act as 
spacers to separate Au NR and T790 and adjust the separation distance to achieve 
optimum enhancement. The surface of silica shell offers bonding sites for conjugation 
with a large amount of T790. After coating with silica and T790, the longitudinal SPR 
band of Au NR slightly red shifted owing to higher refractive index of silica than that 
of aqueous media. 
 
Table 4.1 Optical properties of T790 and SiO2-T790 nanoparticles. 


















SiO2-T790 DMF 419 ~6.0 651 ~14.9 ~2 
a,b 
Quantum yield and TPA cross section at 820 nm: measured in DMF solutions. T790 
in DMF solution was used as the standard for both quantum yield and TPA cross 
section measurements. 
c








Figure 4.1 Typical TEM images of Au NRs (a), Au NR/SiO2 (b), functionalized Au 
NR/SiO2 (c), and Au NR/SiO2-T790 (d). 
 



















































































































































































Figure 4.2 Extinction spectra, one- and two-photon fluorescence spectra of 
SiO2-T790, Au NR/SiO2 and two typical Au NR/SiO2-T790 nanoparticles with silica 
shell thickness of 20 (a, b, c) and 34 nm (d, e, f). 
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Core-shell Au NR/SiO2-T790 nanparticles with thickness of silica shell thickness 
from 13 to 42 nm have been prepared by changing TEOS amount and reaction time 
(Figure 4.4a-e) to investigate the distance-dependent fluorescence enhancement 
effects. Figure 4.2 shows the results of two typical Au NR/SiO2-T790 nanoparticles 
with silica thickness of 20 and 34 nm. To quantitatively calculate the influence of 
enhancement effect of Au NRs in Au NR/SiO2-T790,  the SiO2-T790 in DMF 
solution was used as the control sample to ensure the identical environment of T790 
as that in the Au NR/SiO2-T790 nanoparticles. The absorbance and fluorescence 
maxima of SiO2-T790 in DMF solution remained at 419 nm and 651 nm, respectively 
(Figure 4.3), identical to those of T790 in DMF (Table 4.1) 




































































































Figure 4.3 Schematic diagram illustrates surface structure of SiO2-T790 (a).  TEM 
image of SiO2-T790 (b) and absorption-emission spectrum (max,abs ~ 419 nm 
andmax,em ~ 651 nm) (c). 
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Figure 4.2a-c shows the extinction, one- and two-photon fluorescence spectra of 
Au NR/SiO2-T790 nanoparticles with silica thickness of 20 nm. In addition to the 
strong SPR bands of Au NRs at 820 nm and 510 nm, the extinction spectrum of Au 
NR/SiO2-T790 shows an extra absorption peak at 420 nm owing to the absorption of 
T790 molecules. The amount of T790 covalently linked to silica shell could be 
determined from its absorption spectrum. The relative ratio of T790 to Au NR 
concentration was determined using NT790/ NAu NR=AT790/T790]/[AAu NR/Au NR], where 
AT790, T790, AAu NR and Au NR is the absorbance/extinction and molar extinction 
coefficients of T790 at 420 nm and Au NR at 820 nm respectively. The corresponding 










 It can be roughly 
estimated that each Au NR/SiO2(20nm)-T790 nanoparticle contains ~12500 T790 
molecules. The one-photon fluorescence spectra of both Au NR/SiO2-T790 and 
SiO2-T790 displayed similar spectra with two emission bands centered at 650 and 715 
nm. However, the fluorescence intensity of Au NR/SiO2(20nm)-T790 was quenched 
by ~2.8 times (equivalent to enhancement factor of 0.36) compared to that of 
SiO2-T790 (Figure 4.2b). The two-photon excitation fluorescence spectra of Au 
NR/SiO2-T79 show very different behaviors. In addition to the emission band 
centered at 655 nm arising from T790, another broad emission band centered at 530 
nm was also observed. This 530 nm band is due to two-photon photoluminescence 
(TPPL) of Au NR as the same emission band was also observed in Au NR/SiO2. The 
TPPL intensities of Au NR (530 nm band) in Au NR/SiO2 and Au NR/SiO2-T790 were 
nearly identical, indicating that the presence of T790 has no influence on TPPL of Au 
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NR. It is interesting to note that the two-photon fluorescence intensity of T790 at 655 
nm of Au NR/SiO2(20nm)-T790 was found to be enhanced by 11.8-fold relative to the 
corresponding SiO2-T790 control sample (Figure 4.2c).  
The Plasmon enhancement of another nanoparticle, Au NR/SiO2(34nm)-T790, was 
found to display different enhancement behaviors, with enhancement factor of 2.1 and 
4 for one- and two-photon excitation fluorescence compared to the control samples, 
respectively (Figure 4.2g&h). This is consistent with the previous results that metal 




4.3.2 One- and two-photon fluorescence enhancement of Au NR/SiO2-T790 
nanoparticles 
To systematically study the distance dependent enhancement effect, we have 
prepared a series of Au NR/SiO2-T790 nanoparticles with silica shell thickness of 13, 
20, 28, 34, and 42 nm by changing TEOS amount and reaction time (Figure 4.4a-e). 
The one- and two-photon fluorescence enhancement factors of different Au 
NR/SiO2-T790 nanoparticles in DMF solution are summarized in Figure 4.4f and 
Table 4.2. The optimum one-photon excitation fluorescence enhancement occurs at a 
shell thickness of 34 nm with enhancement factor of 2.1. Larger shell thickness result 
in decreased or nearly no fluorescence enhancement, e.g. enhancement factor of 1.1 at 
separation distance of 42 nm. Thinner shell thickness causes less fluorescence 
enhancement or even fluorescence quenching. The two-photon excitation fluorescence 
displays similar dependence on silica shell thickness. The optimum two-photon 
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fluorescence enhancement occurs at a shell thickness of 20 nm with enhancement 
factor of 11.8. Deviation from this optimum shell thickness resulted in a decreased 
enhancement factor.  
 














































Figure 4.4  TEM images (a-e), one- and two-photon fluorescence enhancement (f) 
of Au NR/SiO2-T790 with different silica shell thickness (13, 20, 28, 34, 42 nm) in 
DMF solution. The estimated two-photon excitation (TPE) enhancement is also 




Table 4.2 The structure, enhancement factor and single exponential analysis of 
fluorescence lifetime of SiO2-T790 and Au NR/SiO2-T790 with different silica shell 
thickness in DMF solution. 











Au NR/SiO2-T790 1 13 0.26 4.6 2.17 
Au NR/SiO2-T790 2 20 0.36 11.8 3.25 
Au NR/SiO2-T790 3 28 0.54 8 4.18 
Au NR/SiO2-T790 4 34 2.1 4 5.16 
Au NR/SiO2-T790 5 42 1.1 2 7.75 
SiO2-T790 - - - 7.79 
 
4.3.3 Fluorescence lifetime of Au NR/SiO2-T790 nanoparticles 



















Figure 4.5 Fluorescence lifetime decay (g) of Au NR/SiO2-T790 with different silica 
shell thickness (13, 20, 28, 34, 42 nm) in DMF solution. IRF is the instrument 
response function. 
 
To understand the fluorescence enhancement mechanisms, the fluorescence 
lifetimes of T790 in SiO2-T790 and different Au NR/SiO2-T790 nanoparticles (Figure 
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4.5) have been measured by using the time-correlated single photon counting (TCSPC) 
technique. The fluorescence decay of SiO2-T790 decay can be fed with a single 
exponential decay with lifetime of ~7.79 ns. The lifetimes of Au NR/SiO2-T790 in 
DMF solution were obtained to be 2.17, 3.25, 4.18, 5.16, and 7.75 ns for shell 
thickness of 13, 20, 28, 34, and 42 nm respectively (Table 4.2). The fluorescence 
lifetimes of T790 in Au NR/SiO2-T790 were shorter than that in SiO2-T790 without a 
metal core and became shortened gradually when silica shell thickness decreases. 
 In the presence of metal nanoparticles, three different metal-chromphore 
interactions will generally influence the fluorescence intensity of chromophores.  
First, local electric field amplification will cause increased excitation efficiency and 
consequently increased fluorescence intensity. The extent of enhancement depends on 
the overlap between the excitation wavelength and the Plasmon resonance. This 
enhancement effect does not change fluorescence lifetime of chromophores. The 
second factor is enhanced radiative decay rate and consequently increased 
fluorescence quantum yield and intensity, which generally result in a shortened 
fluorescence lifetime. This enhancement mechanism generally depends on spectrum 
overlap between the Plasmon resonance band and emission spectrum of 
chromophores. The third effect is the energy transfer from chromophore to metal 
nanoparticles, which generally quenches the fluorescence of fluorophores and 
shortened fluorescence lifetime. All three factors depend on the separation distance 
between the chromophore and metal nanoparticle, which result in strong dependence 
of both one and two-photon excitation fluorescence as observed in our studies. 
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 In our current studies, local electric field amplification is expected to play a 
negligible role in the one-photon fluorescence of T790 since the excitation 
wavelength 420 nm is far off-resonance with the Plasmon modes of Au NR. The 
one-photon fluorescence intensity quantum yield (=kR/(kR+kNR)) is mainly 
determined by the  interplay between enhanced radiative decay rates (kR) and 
nonradiative energy transfer rate (kNR) as SPR band of Au NR has significant overlap 
with the emission spectrum of T790. At very large separation distances, the radiative 
decay rate will not be affected and energy transfer process does not occur. The 
luminescence efficiency will not be affected by the presence of metal nanoparticles 
for very large separation distances. This is consistent with our observation of 
enhancement factor of 1.1 at 42 nm, the largest shell thickness studied here. As the 
separation distance decreases, radiative decay rates starts to increase, the fluorescence 
intensity and quantum yield () increase, accompanied by a shortening of 
fluorescence lifetime (=1/(kR+kNR)). As the separation distance further decrease, both 
radiative decay and nonradiative energy transfer rate increase. However, the 
nonradiative energy transfer rate increases more rapidly and takes a dominant role, 
consequently both the fluorescence quantum yield () and lifetime () decreases. 
Consequently, as the separation distance decreases, the overall effect of the 
one-photon fluorescence intensity will first increase, reach an optimum enhancement 
and then quenched again, while the fluorescence lifetime will decrease steadily. This 
is well consistent with our experimental observation (one-photon fluorescence in 




 The two-photon fluorescence is expected to follow the similar trend as the 
one-photon fluorescence. However, in the two-photon excitation case, the local 
electric field amplification will contribute additionally to enhance two-photo 
excitation efficiency and consequently enhance the two-photon fluorescence intensity 
due to the strong resonance of SPR modes of Au NR at the excitation wavelength of 
820 nm. Consequently a larger enhancement factor is expected for two-photon 
fluorescence than one-photon fluorescence. As two-photon excitation process 
involves absorption of two photons simultaneously, the excitation rate is proportional 
to the fourth power of the local electric field.
31,55
 The electric field contribution will 
increase rapidly as the separation distance increases. Consequently the optimum 
two-photon fluorescence occurs at a shorter separation distance compared to 
one-photon fluorescence. These are again where consistent with our experimental 
observation (Figure 4.5). In our studies on Au NR/SiO2-T790 nanoparticles, 
enhanced two photon fluorescence is due to the product of enhancement of 
two-photon excitation and enhancement in fluorescence quantum yield and enhanced 
fluorescence while enhanced one-photon fluorescence of TPP here is purely due to 
enhanced quantum yield. The enhanced excitation efficiency can thus be estimated by 
the ratio of two-photon fluorescence enhancement factor by one-photon fluorescence 
enhancement factor, as plotted in Figure 4.5. The two-photon excitation efficiency 
was found to strongly dependent on the silica shell thickness, with an optimum 
enhancement factor of 32.8 at silica shell thickness of 20 nm. This result is consistent 






4.3.4 Two-photon imaging 
Hematoporphyrin derivatives are commonly used photosensitizers
56
 in 
photodynamic therapy (PDT) processes. Two-photon photodynamic therapy has been 
known as a novel non-invasive cancer therapy technique with many unique 
advantages compared to its one-photon counterpart, such as 3-D localized treatment 
area, less side effect and deep penetration into biological tissues.
57-59
 Effective 
photosensitizers for two-photon PDT require high singlet oxygen generation under 
two-photon excitation.
59,60
 T790 is a widely investigated hematoporphyrin derivative 
with singlet oxygen generation yield of 0.47 but with small two-photon absorption 
cross section of ~2 GM.
61
 In the presence of Au NR, the two-photon fluorescence of 
TPP has been enhanced by up to 11.8-fold. The significantly enhanced two-photon 






The two-fluorescence imagining capability of the Au NR/SiO2(20nm)-T790 
nanoparticles was demonstrated on HepG2 cancer cells (Figure 4.6), which can be 
utilized to evaluate the uptake of Au NR/SiO2-T790 nanoparticles by cancer cells. The 
two-photon fluorescence imaging was performed using two-photon laser scanning 
confocal microscopy under excitation at femtosecond laser pulses at 800 nm with a 
600-650 nm band pass emission filter. After incubation for 3 h, an intense red 
emission signal was observed in the cytoplasm, indicating effective uptake of Au 
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NR/SiO2-T790. The intense red emission signal confirm the capability of these Au 
NR/SiO2(20nm)-T790 nanoparticles to act as promising two-photon imaging agents. 
a b c
 
Figure 4.6 Transmission (a) and two-photon fluorescence (b) images of HepG2 
cancer cells treated with Au NR/SiO2(20nm)-T790 nanoparticles. (c) is the merged 
image. 
 
4.3.5 Singlet oxygen generation under one- and two-photon excitaion 
 A prerequisite for application of photosensitizers in PDT is high singlet oxygen 
generation efficiency. The capability of singlet oxygen generation of Au 
NR/SiO2-T790 under one- and two-photon excitation has been evaluated by using a 
chemical method based on the endoperoxidation of 
9,10-anthracenediyl-bis(methylene) dimalonic acid (ABDA). Figure 4.7 shows the 
photo-oxidation rate of ABDA in water in the presence of Au NR/SiO2(20nm)-T790 
and SiO2-T790 under one- and two-photon excitation. Under one-photon excitation at 
420 nm, the photo-oxidation rate of ABDA in the presence of Au 
NR/SiO2(20nm)-T790 was found to be slower than that of SiO2-T790 with the same 
amount of T790. This is consistent with the lower one-photon fluorescence intensity 
of Au NR/SiO2(20nm)-T790 compared to SiO2-T790. The lower one-photon 
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fluorescence intensity and shorter excited state lifetime thus decrease its singlet 
oxygen generation capability. In contrast, the photo-oxidation rates of ABDA in the 
presence of Au NR/SiO2(20nm)-T790 under two-photon excitation using femtosecond 
laser pulses at 808 nm is much faster compared with SiO2-T790 (Figure 4.7b). This is 
again consistent with the enhanced two-photon fluorescence of Au 
NR/SiO2(20nm)-T790. Enhanced two-photon excitation efficiency of Au 
NR/SiO2(20nm)-T790 results in enhanced singlet oxygen generation efficiency. These 
results suggest that Au NR/SiO2(20nm)-T790 can generate singlet oxygen more 
effectively under two-photon excitation relative to SiO2-T790 with the same T790 
amount and thus could be used as an efficient photosensitizer in two-photon 
photodynamic therapy (TP-PDT). 
a b




















































Figure 4.7 Photodegradation rate of ABDA in the presence of Au 
NR/SiO2(20nm)-T790 and SiO2-T790 under one-photon excitation at 420 nm (a) and 
two-photon excitation at 820 nm (b).  
 
4.3.6 Two-photon photodynamic therapy effects to cancer cells 
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The two-photon photodynamic therapy effect of Au NR/SiO2(20nm)-T790 was 
evaluated on HepG2 cells by using the XTT assay (Figure 4.8). An unfocused 
femtosecond laser beam with beam area of 0.3 cm
2
 and power density of 1.6 W/cm
2
 at 
800 nm was used as the illumination source. HepG2 cells incubated with Au 
NR/SiO2(20 nm)-T790 (40 pM) were subjected to exposure of the fs laser 
illumination for different time periods. The cell viability was measured by 
colorimetric XTT metabolic activity assay after overnight incubation. The same 
experiments were performed on cells incubated with SiO2-T790 and cells without 
incubation with nanopartiles for direct comparison. The viability of cells without 
nanoparticles was almost 100 % after laser irradiation for 8 min, suggesting that this 
dose of laser irradiation power is safe for HepG2 cells. The viability of the cells 
treated with SiO2-T790 under the same condition only showed a little killing effect, 
with 5 % decrease in cell viability after laser irradiation for 8 min. In contrast, the 
viability of HepG2 cells treated with Au NR/SiO2(20nm)-T790 showed significant 
decrease with the increasing irradiation time: up to 50 % of cancer cells were killed 
after fs laser irradiation for 8 min. The significantly improved cancer cell killing 
efficiency is due to the enhanced singlet oxygen generation of Au 
NR/SiO2(20nm)-T790 compared to SiO2-T790 under two-photon excitation. These 
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Figure 4.8 Time dependent cell viability of HepG2 cancer cells after incubation with 
Au NR/SiO2-T790 and SiO2-T790 under fs laser (two-photon excitation) illumination 
at 800 nm. [Au NR/SiO2-T790] = 40 pM, SiO2-T790 has the same concentration of 
T790 as Au NR/SiO2-T790. The control experiments without any nanoparticles were 
also performed under the same irradiation conditions. 
 
4.4 Conclusion 
In summary, Au NR/SiO2-T790 core-shell nanoparticles with different silica shell 
thickness from 13 to 42 nm were prepared to systematically investigate Au NR 
enhanced one- and two-photon excitation fluorescence of T790. T790 was covalently 
linked to the surface of silica coated Au NR by forming stable amide bond. This 
conjugation method is a universal method for incorporating any fluorephores or  
biomolecules containing amine-reactive group onto silica shell. The one- and 
two-photon excitation fluorescence intensity of T790 were found to strongly depend 
on the silica shell thickness that separates Au NR and T790 fluorophores. The 
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optimum OPEF enhancement was found to occur at shell thickness of 34 nm with 
enhancement factor of 2.1, while the optimum TPEF enhancement was found to occur 
at shell thickness of 20 nm with enhancement factor of 11.8. The fluorescence lifetime 
of T790 decreased steadily from 7.75 to 2.17 ns as the shell thickness decreased down 
to 13 nm. The OPEF enhancement is attributed to the competition between increased 
radiative and non-radiative decay rates, while electric field amplification gives an 
additional contribution to the TPEF enhancement. Au NR/SiO2(20nm)-T790, which 
displayed the largest TPEF enhancement, were also found to exhibit significantly 
improved singlet oxygen generation capability under two-photon excitation. The 
application of these nanoparticles as effective  imaging agents for two-photon cell 
imaging and nano-photosensitizers for TP-PDT with improved efficiency has been 
demonstrated on HepG2 cancer cells using XTT assay. The remarkable two-photon 
excitation fluorescence enhancement property of these Au NR/SiO2-T790 
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Gold Nanorods Enhanced Two-photon Cross Section of Polymer 
for Two-photon Imaging Guided Photodynamic Therapy 
 
5.1 Introduction 
Two-photon photodynamic therapy (TP-PDT) is the process
1,2
 that photosensitizers 
are excited by simultaneously absorbing two long-wavelength photons to react with 
tissue oxygen to generate reactive oxygen species (ROS), leading to cell apoptosis.
3-5
 
It has two notable advantages: 1) TP-PDT is deep penetration into biological tissues. 
The near-Infrared excitation wavelength used in TP-PDT is coincident with the 
biological transparency window in the range of 700 to 1000 nm, resulting in a 10 to 
100-fold increase in the light penetration depth. 2) Two-photon excitation is a 
nonlinear process that is quadratically dependent on the laser intensity. The excitation 
and treatment are confined at the focal point of laser beam, a comparatively small 
volume, localizing in both the transverse plane and along the laser beam. Therefore, 
3-D spatial selectivity and significantly reduced side effects are achieved in TP-PDT.  
 However, in TP-PDT process, it becomes critical to develop photosensitizers with 
large TPA cross sections and efficient two-photon induced singlet oxygen generation 
abilities. Many efforts have been made to improve the TPA efficiencies of 
photosensitizers through syntheses of new photosensitizers or chemical modification 
of porphyrins with large TPA cross sections. Conjugated porphyrins to form dimmers 
and oligomers displayed very strong two-photon absorption (~1000 GM).
6
 Ogawa et 
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al reported that self-assembled conjugated porphyrin exhibited a large two-photon 
absorption cross section value of 7600 GM in chloroform which is 4000 times larger 
than that of monomeric analogues (hematoporphyrin, ~2 GM).
7
 Alternatively, 
resonance energy transfer schemes from materials with large TPA cross sections to 
photosensitizers have been made to enhance the TPA efficiencies of photosensitizers. 
Kim et al published energy-transferring organically modified silica nanoparticles, in 
which two-photon fluorescent dye nanoaggregates act as an donor and a 
photosensitizing PDT drug act as an acceptor. Under two-photon excitation, the 
co-encapsulating nanoparticles is amplified by factors of ~10 and ~30 for 
photosensitizer loading of 10 and 20 wt%, respectively.
8
 Although these porphyrin 
derivatives present large two-photon absorption cross, they are prone to 
photo-induced degradation.
9
 In addition, porphyrin derivatives are hydrophobic and 
can aggregate easily in physiological environment, resulting in inhomogeneous 
distribution of photosensitizer in tumor cells. To overcome these limitations, it is 
desirable to prepare photosensitizer with a simply method, in which it displays large 
TPA cross sections and efficient two-photon induced singlet oxygen generation 
abilities. 
 The emergency of metal nanoparticles seems to circumvent the problem 
mentioned above. Loading the photosensitizer onto the surface of metal nanoparticle 
exhibit several advantages for TPA cross section enhancement, such as 
photosensitizers can be well protected against photo-degradation, maintain excellent 
photosensitizing efficiency and high solubility in aqueous solution. Wenseleers et al. 
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reported five orders-of-magnitude enhancement of two-photon absorption for dyes on 
silver nanoparticle fractal clusters in the films using two-photon fluorescence 
microscopy measurement.
10 
Hernandez et al. subsequently reported a 157-fold 
enhancement of two-photon absorption of the chromophores using salt-aggregated 
spherical gold nanoparticles using Z-scan measurements.
11
 However, so far there is no 
report on chromophore with metal enhanced both TPA cross section and singlet 
oxygen generation.  
 In this contribution, we conducted a systematical investigation of distance 
dependent one- and two-photon excitation fluorescence enhancement in a core-shell 
nanostructure consisting of a AuNR core, a silica shell with controllable thickness, 
and a layer of water soluble conjugated polymer molecules. The gold nanorod was 
chosen for its longitudinal plasmon band is located in the near infrared, which is 
coincidence with the two-photon excitation wavelength. Electromagnetic-field will 
greatly amplitude around the Au NR and excite the photosensitizer more powerfully. 
The water soluble conjugated polymer (PFBV) was designed and synthesis for its 
high singlet oxygen generation yield (0.46). The silica shell acted as a spacer to 
control the distance between Au NR and fluorophores. By adjusting the silica shell 
thickness from 8.6 to 48 nm, optimum fluorescence enhancement factors of 1.5 times 
and 29 times were observed for one- and two-photon excitation fluorescence, 
respectively. The two-photon imaging capability of Au NR/SiO2-PFBV nanoparticles 
were demonstrated on HepG2 cancer cells. Moreover, the improved singlet oxygen 
generation capability of these core-shell nanoparticles under two-photon excitation 
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have been also evaluated in HepG2 cells. The improved efficiency in killing cancer 
cells and enhanced two-photon imaging capability makes these Au NR/SiO2-PFBV 
nanoparticles attractive for two-photon photodynamic therapy and allow 
imaging-guided therapy. 
 
5.2 Experimental section 
5.2.1 Materials and methods 
Cetyl trimethylammonium bromide (CTAB) and ascorbic acid were purchased from 
Alfa Aesar. Tetraethoxysilane (TEOS), silver nitrate (AgNO3), sodium borohydride 
(NaBH4), hydrogen tetrachloroaurate (III) hydrate (HAuCl4·3H2O), aqueous ammonia 
(25 %) were purchased from Sigma Aldrich. All solvents are analytical grade and used 
as received without further purification. For polymer synthesis, solvents and 
chemicals were purchased from Sigma-Aldrich and used as received without further 
purification unless otherwise noted. THF was dried and distilled under sodium. 
2,7-Diformyl-9,9-di(6’-bromohexy) fluorene12 and 1,4-bis(diethylphosphinatyl 
methyl)-2,5-dibromobenzene
13
, were prepared according to the reported procedures.   
1
H NMR spectra were recorded on 300 MHz AC Bruker spectrometers. Mass 
spectra were measured by using an AEI M850-MS spectrometer. GPC analysis was 
carried out on a Waters Styragel system using polystyrene as the calibration standard 
and THF as eluent. The fluorescence quantum yield of the polymers were measured 
by using fluorescein in aqueous solution (pH = 11) as the standard. Transmission 
electron microscopic (TEM) images were taken on a JEOL 2010 microscope 
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operating at an acceleration voltage of 200 kV. UV-Vis absorption/extinction and 
fluorescence spectra were measured with Shimadzu UV 2550 Spectrometer and 
Horiba Jobin Yvon FluoroMax-4 Spectrofluorometer, respectively.  
 
5.2.2Poly(9,9-bis(6’’-(bromohexyl)fluorene-2,7-ylenevinylene-co-alt-1,4-(2,5-dibr
omophenylene)) (PFBV-Br).  
2,7-Diformyl-9,9-di(6’-bromohexy) fluorene (0.5 mmol) and 
1,4-bis(diethylphosphinatyl methyl)-2,5-dibromobenzene (0.5 mmol) in dry THF (20 
mL) was stirred at room temperature. After potassium tert-butoxide (2 mmol) was 
slowly added, the solution was stirred for 4h at room temperature before being 
quenched with dilute aqueous HCl (20 mL). The solution was then poured into 
methanol (250 mL) under stirring. The precipitate was collected by filtration. The 
crude polymer was dissolved in THF, precipitated in methanol three times, and then 
dried under vacuum to give a yellow solid product. 
1
H NMR (300MHz, CDCl3, δ): 
7.98-7.31 (m, 12H) , 3.27 (br, 4H), 2.05 (br, 4H), 1.65-1.58 (br, 4H), 1.22-1.10 (br, 
8H), 0.61 (br, 4H); GPC: Mn = 4200, Mw = 5300, PDI = 1.26. 
 
5.2.3Poly(9,9-bis(6’’-(N,N,N-trimethyl-ammonium)fluorene-2,7-ylenevinylene-co-
alt-1,4-(2,5-dibromophenylene)) (PFBV). PFBV-Br were dissolved in THF (20 mL). 
Trimethylamine (5 mL, 30%) in ethanol was then added. The mixture was stirred for 
48 h at room temperature. The solid products PFBV was obtained after evaporation of 
the solvent at vacuum. 
1
H NMR (300MHz, DMSO-d6, δ): 8.24-7.44 (m, 14H), 3,18 
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(br, 4H), 2.97 (br, 18H), 2.01 (br, 4H), 1.47 (br, 4H),1.10-1.06 (br, 8H),  0.53 (br, 
4H). 
 
5.2.4 Preparation of ionic polymers (PFBV)  
PFV-Br was dissolved in 20 mL of chloroform. 5 mL of trimethylamine solution in 
ethanol (30 %) was then added. The mixture was stirred for 48 h at room temperature. 
The solid product (PFBV) was obtained after evaporation of the solvent at vacuum. 
 
5.2.5 Preparation of gold nanorods (Au NRs) 
Au NRs were prepared according to a previously reported method.
14-16
 CTAB aqueous 
solution (0.1 M, 10 mL) was mixed with HAuCl4 (50 mM, 50 μL) and ice-cold 
NaBH4 (10 mM, 0.6 mL) to form a brownish-yellow seed solution. This seed solution 
was kept at room temperature for at least 2 h. The growth solution is a mixture of 
CTAB solution (0.1 M 40 mL), HAuCl4 (50 mM, 0.4 mL), different amount of 
AgNO3 (10 mM, 0.34 mL), HCl (1 M 0.8 mL) and ascorbic acid (0.1 M, 0.32 mL). 
After gentle mixing of the solution, the growth solution changed the color to colorless. 
The gold seed solution (100 μL) was then added into the growth solution and the 
reaction mixture was left undisturbed overnight. The obtained gold nanorods were 
purified once by washing with de-ionized water to remove excess CTAB and 




5.2.6 Preparation of silica coated gold nanorods (Au NR/SiO2) 
A Au NR solution (10 mL) was centrifuged and re-dispersed in deionized water (10 
mL). NaOH solution (0.1 M, 100 μL) was then added under stirring. Different amount 
of pure TEOS was subsequently injected three times under stirring at 30 min intervals. 
After stirring for different hours, a silica layer was formed on the surface of Au NRs 
through hydrolysis and condensation of TEOS. The obtained Au NR/SiO2 
nanoparticles were isolated by centrifugation, washed with deionized water several 
times, and then dispersed in deionized water for further use. 
 
5.2.7 Preparation of Polymer-absorbed silica coated gold nanorods (Au 
NR/SiO2-PFBV) 
Au NRs (100 L) were centrifuged and dispersed in PFBV solution (0.1 g/L, 3 mL). 
The solution was undisturbed overnight before it was then centrifuged for at least 
three times and re-dispersed in de-ionized water (100 L). 
 
5.2.8 Preparation of SiO2- PFBV nanoparticles 
Silica nanoparticles were prepared according to Stöber method.
17
 Aqueous ammonia 
(25 %, 3.0 mL), pure TEOS (1.5 mL) were added into ethanol solution (50 mL). The 
mixture reacted overnight at room temperature. The SiO2-PFBV was prepared by 
replacing AuNR core with silica nanosphere. The prepared SiO2-PFBV nanoparticles 
are quite monodisperse with a diameter of ~100 nm. 
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5.2.9 Two-photon excitation fluorescence measurements 
The two-photon excitation fluorescence (TPEF) measurements were performed by 
using Avesta TiF-100M femtosecond Ti: sapphire oscillator centered at 820 nm with 
an average power of 100 mW as the excitation source. The output laser pulses have 
pulse duration of 80 fs and a repetition rate of 84.5 MHz. The laser beam was focused 
onto the sample that was contained in a cuvette with path length of 1 cm. The 
emission from the sample was collected at a 90° angle by a pair of lenses and an 
optical fiber that was connected to a monochromator (Acton, Spectra Pro 2300i) 
coupled with CCD (Princeton Instruments, Pixis 100B) system. A short pass filter 
with a cut-off wavelength of 750 nm was placed before the spectrometer to minimize 
the scattering from the pump beam. 
 
5.2.10 Cell culture 
HepG2 cell line was chosen as the model system. The HepG2 cancer cells were 
incubated in Dulbecco’s modified Eagle medium (DMEM) containing fetal bovine 
serum (10%), streptomycin (100.0 mg/L), and penicillin (100 IU/mL). Cells were 
maintained in a humidified atmosphere of 5% CO2 at 37 °C. 
 
5.2.11 Two-photon photodynamic therapy on cancer cells 
HepG2 cancer cells were seeded on a 96 well plate and grown until 70~80% 
confluence, then treated with Au NR/SiO2-T790 and SiO2-T790 suspension for 3 h in 
DMEM, followed by changing with fresh DMEM media. An unfocused femtosecond 
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laser beam with beam area of 0.3 cm
2
, power density of 1.6 W/cm
2
 and repetition rate 
of 1 kHz at 800 nm was used as the illumination source. Cells were exposed to the 
femtosecond laser beam from 0 to 8 min irradiation period. The irradiated plates were 
sent back to the incubator overnight and cell viability was colorimetrically measured 
with the XTT assay. 
 
5.2.12 Two-photon fluorescence imaging 
HepG2 cancer cells were seeded on glass-bottom dishes and grown until 70~80% 
confluence. The solution of Au NR/SiO2-T790 was added into the media and 
incubated for 3h. After washing with the PBS buffer solution, fresh DMEM media 
were added. The two-photon imaging was conducted on a Leica TCS SP5 X confocal 
microscope using a femtosecond Ti-Sapphire oscillator as the excitation source. 
Images were processed by using Leica Application Suite Advanced Fluorescence 
(LAS AF) software. 
 
5.3 Results and discussion 
5.3.1 Synthesis and characterization of polymer 
Figure 5.1 displays the synthesis routes of the water conjugated polymer used in our 
experiment.Poly[9,9-bis(6''-bromohexyl)fluorene-2,7-ylenevinylene-co-alt-1.4-(2,5-di
bromophenylene)] (PFV-Br) was synthesized by using a previously reported method 
via the Witting-Horner condensation reaction between dialdehyde and 




 Water soluble cationic conjugated polymers PFBV was obtained by 
quaternization of the neutral polymers PFV-Br in excess of trimethylammonium in 



























Figure 5.1 Sythesis procedures of the water soluble conjugated polymer PFBV. 
 
5.3.2 Physical and optical properties of PFBV  
The optical properties of water soluble conjugated polymer and gold nanorod in 
aqueous solution are shown in Figure 5.2. The absorption maxima of PFBV is located 
at 408 nm, while the corresponding emission maxima is located at 492 nm. The 
quantum yields (QYs) of PFBV was measured to be 11.5% in water, and 48% in 
methanol, respectively. Compared with high QY of PFBV in methanol, the relatively 
low QY of PFBV in water is due to the small aggregation formed by the hydrophobic 
conjugated backbone, resulting in the quenching of intrachain singlet excition.
19-22
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Figure 5.2 Structure, normalized absorption and fluorescence spectra of PFBV and 
gold nanorod. 
 
 Two-photon excitation properties of the cationic polymer was measured by using 
femtosecond laser pulses from 750 to 850 nm (Figure 5.3) in water. The maximum 
TPA cross section was located at ~760 nm for PFBV. This is important for practical 
applications because the central wavelength of the most readily available femtosecond 
laser source is located at ~800 nm. The maximum TPA cross section value per repeat 
unit reached 75 GM for PFBV. This is attributed to the introduction of bromine group, 
leading to more degree of distortion from planarity. All the optical properties of 
Polymer were summarized in Table 5.1. 
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Figure 5.3 Two-photon excitation spectra of PFBV in water. The TPA cross section 
values were calculated base on per repeat unit of the polymers (GM per RU). 
 
Table 5.1 Optical properties of PFBV. 
 max, abs (nm) max, em (nm) (%) H2O
a (GM)800nm
b
PFBV 407 492 11.5  40 
a
 Measured in water solutions, fluorescein in NaOH water solution (pH=11) was used 
as a standard for quantum yield measurements. 
b
 TPA cross section per repeat unit of 
the PFBV at 800 nm.  
 
5.3.3 Preparation and characterization of Au NR/SiO2 and Au NR/SiO2-PFBV 
nanoparticles 
Gold nanorods were first prepared by a seed-mediated, CTAB-assisted method.
14-16
 
The prepared gold nanorods have two plasmon bands centered at 510 and 810 nm, 
respectively (Figure 5.1). Metal enhanced fluorescence has been known to depends 
on the metal-chromophore separation distance.
23-26
 The silica shell was used as spacer 
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to separate Au NR and PFBV and adjust the separation distance to achieve optimum 
enhancement. Different thickness of silica shell were coated on the surface of gold 
nanorod by using a sol-gel approach.
27
 The thickness of silica shell could be 
controlled from 8.6 to 48 nm by changing the amount of TEOS and reaction time 
(Figure 5.4). 
 The water soluble conjugated polymer was chosen to absorb onto the surface of 
Au NR/SiO2 nanoparticles owing to the following reasons: 1) the charge of water 
soluble conjugated polymer is positive, which is easily to be absorbed on the surface 
of negative charged silica coated gold nanorod due to the electrostatic attraction. 2) 
the absorption of PFBV is overlapped with the surface plasmon peaks of gold nanorod, 
which is a prerequisite for fluorescence enhancement. 3) PFBV displays large singlet 
oxygen generation efficiency, which is at the same order of magnitude of Rose Bengal 
(0.76),
28
 a typical commercial photosensitizer. 4) PFBV also presents relatively large 







Figure 5.4 TEM images of Au NR/SiO2 with different silica shell thickness: 8.6 nm a), 
11 nm b), 15 nm c), 18 nm d), 24 nm e), 30 nm f), 42 nm g), 48 nm h). 
 
 For zeta potential measurement, all the Au NR/SiO2 with different silica shell 
thickness displayed negative charge (Figure 5.5a). The positively charged PFBV 
could be absorbed onto the surface of Au NR/SiO2 by electrostatic attraction. After 
binding cationic PFBV, zeta potential of Au NR/SiO2 was increased from -16.2 mV to 
30 mV (Figure 5.5b), which indicated that PFBV was successfully absorbed onto the 

























































Figure 5.5 Zeta potential of Au NR/SiO2 with different silica thickness (a). The zeta 
potential changes of Au NR/SiO2(15 nm) before and after PFBV coating (b). 
 
5.3.4 One- and two-photon fluorescence enhancement of Au NR/SiO2-PFBV 
nanoparticles 
 Figure 5.6a-c shows the extinction, one- and two-photon fluorescence spectra of 
Au NR/SiO2-PFBV with silica thickness of 15 nm. As shown in Figure 5.6a, the 
extinction spectrum of Au NR/SiO2-PFBV shows an extra absorption peak at 408 nm 
owing to the absorption of PFBV. The relatively low amount of PFBV absorbed on 
the surface of Au NR/SiO2 is due to weak electrostatic attraction. Typical fluorescence 
spectra of Au NR/SiO2, Au NR/SiO2-PFBV and SiO2-PFBV with identical Au NRs 
and PFBV concentration are measured by spectrofluorometer excited at 408 nm. The 
one-photon fluorescence spectrum of Au NR/SiO2-PFBV did not alter peak position 
and spectrum shape under the same excitation and detection conditions compared 
with SiO2-PFBV (control sample), which displayed two emission band centered at 
489 and 520 nm. However, the fluorescence intensity of Au NR/SiO2-PFBV was 
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found to be modulated by silica shell thickness. A one-photon fluorescence 
enhancement of 0.56 was observed for Au NR/SiO2(15nm)-PFBV (Figure 5.6b) 
relative to SiO2-PFBV. The two-photon luminescence of Au NR/SiO2, Au 
NR/SiO2-PFBV and SiO2-PFBV were recorded by using an Avesta TiF-50M 
femtosecond Ti: sapphire oscillator centered at 810 nm with an average power of 50 
mW as the excitation source. The Au NR/SiO2-PFBV shows one obvious emission 
bands centered at 535 nm, which is the overlap of Au NR/SiO2 and SiO2-PFBV 
two-photon emission respectively. A significant two-photon fluorescence 
enhancement of 29 was observed for Au NR/SiO2(15nm)-PFBV (Figure 5.6c) 
relative to control sample. 
 


































































































Figure 5.6 Extinction spectra (a), one- (b) and two-photon (c) fluorescence spectra of 
SiO2-PFBV, Au NR/SiO2 and two typical Au NR/SiO2-PFBV nanoparticles with 
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silica shell thickness of 15 nm. 
 
To systematically study the distance dependent enhancement effect, we have 
prepared a series of Au NR/SiO2-PFBV nanoparticles with silica shell thickness of 8.6, 
11, 15, 18, 24, 30, 42 and 48 nm by changing TEOS amount and reaction time 
(Figure 5.4a-h). The one- and two-photon fluorescence enhancement factors of 
different Au NR/SiO2-PFBV nanoparticles in aqueous solution are summarized in 
Figure 5.6d. The optimum one-photon excitation fluorescence enhancement occurs at 
a shell thickness of 24 nm with enhancement factor of 1.5. Larger shell thickness 
result in decreased or nearly no fluorescence enhancement, e.g. enhancement factor of 
1.1 at separation distance of 48 nm. Thinner shell thickness causes less fluorescence 
enhancement or even fluorescence quenching. The two-photon excitation fluorescence 
displays similar dependence on silica shell thickness. The optimum two-photon 
fluorescence enhancement occurs at a shell thickness of 15 nm with enhancement 
factor of 29. Deviation from this optimum shell thickness resulted in a decreased 
enhancement factor.  
 Two enhancement effects exist between metal nanoparticles and fluorophores: a) 
absorption enhancement, attributed to local electric field amplification near the 
metallic surface which could enhance excitation rate ( exc ) of fluorophores and 
increase emission intensity. This enhancement effect does not change fluorescence 
lifetime of dye molecules; b) emission enhancement, ascribed to enhanced radiative 
decay rate which could increase quantum yield ( Q ) and thus increasing emission 
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intensity. However, this enhancement effect presents a decrease in the fluorophores 
lifetime. In this study, the plasmon resonance band of gold nanorod has a spectrum 
overlap with the absorption and emission spectral of T790. The one-photon and 
two-photon fluorescence enhancement mechanism of this system are the combination 
of absorption and emission enhancement effects. The extent of one-photon and 
two-photon fluorescence enhancement are modulated by the separation distance 
between gold nanorod and PFBV molecules (Figure 5.6d). The obtained silica shell 
thickness dependent one- and two-photon fluorescence intensity change is mainly 
owing to the electric field change and the competition between radiative and 
non-radiative decay rates. In very close distance, the radiative and non-radiative decay 
rates are occurred by the nearby metal particle (energy transfer process play a 
dominant role), in which non-radiative decay rate is faster than radiative decay rate, 
and thus induce less fluorescence enhancement or even quench the dye fluorescence. 
With increasing the distance between PFBV and gold nanorods, both radiative and 
non-radiative decay rates will decrease. Nevertheless, non-radiative decay rate 
decrease much faster than radiative decay rate owing to non-radiative decay rate is 
inversely proportional to fourth power of separation distance.
26
 Thus, enhanced 
radiative decay rate takes an overwhelming role, resulting in increased quantum yield 
and enhanced emission efficiency. At longer distance from the Au NRs core, the role 
of radiative decay rate is negligible, leading to a reduced quantum yield and 
enhancement factor decrease to 1. For electric field, the effect will decrease 
dramatically owing to exponentially decayed plasmon field. Overall, as the silica shell 
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thickness increase, both one- and two-photon fluorescence intensity experiences an 
increase first, reach to the maximum enhancement and then decrease to normal,
24,26
 
which is consistent with trends shown in Figure 5.6d. However, a higher fluorescence 
enhancement was observed for two-photon rather than one-photon. Two possible 
reasons ascribe for this: a) the two-photon excitation wavelength (820 nm) is 
coincidence with the longitudinal plasmon band of Au NRs. Electromagnetic-field 
will greatly amplitude around the Au nanorods and excite the PFBV fluorophores 
more powerfully; b) For one-photon, since the fluorescence intensity is the square of 
the electrical field, this effect could result in enhanced excitation near metal 
nanoparticles. However, two-photon absorption is the process that simultaneously 
absorb two long-wavelength photons, thus the rate of excitation is proportional to the 
square of the fluorescence intensity.
29,30
 This suggests that two-photon excitation 
could be enhanced much higher relative to that of one-photon, which is consistent 
with the data in Figure 5.6d. 
 
5.3.5 Two-photon imaging ability 
TPA action cross section (φδ) is usually used to evaluate the brightness of two-photon 
fluorophores, where δ is the TPA cross section and φ is the fluorescence quantum 
yield.
31,32
 So far a few reported water soluble chromophores showed TPA action cross 
section values ranging from 10 to 700 GM in water in the non-aggregated form.
33,34
 In 
the absence and present of gold nanorod, the TPA action cross section values of the 
prepared PFBV and Au NR/SiO2-PFBV were calculated to be 4.6 GM and 133.4 GM 
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per repeat unit at 800 nm excitation (Table 5.2). In practical applications, TPA action 
cross value is generally calculated base on a molecule or a nanoparticle containing 
several molecules.
35,36
 Therefore, in the present of gold nanorod, Au NR/SiO2-PFBV 
is expected to display high brightness in two-photon imaging applications. 
 
Table 5.2 Optical properties of SiO2-PFBV and Au NR/SiO2-PFBV. 
 (%) (GM) a b 
SiO2-PFBV 11.5 40 4.6 
Au NR/SiO2-PFBV 11.5 40×29 133.4 
a
 TPA cross section per repeat unit of PFBV at 800 nm. 
b
 TPA active cross section per 
repeat unit of PFBV at 800 nm.  
 
 Such large TPA action cross section of Au NR/SiO2-PFBV, makes it attractive 
candidate for two-photon imaging agents. Two-photon excitation cell imaging using 
Au NR/SiO2-PFBV, Au NR/SiO2, and SiO2-PFBV were demonstrated by HepG2 
cancer cells under excitation at 405 nm and 800 nm using one-photon and two-photon 
laser scanning confocal microscopy (Figure 5.7). Intensive two-photon fluorescence 
signals were observed from cancer cells treated with Au NR/SiO2-Polymer. However, 
relatively weak two-photon fluorescence signals were showed in cells incubated with 
Au NR/SiO2 and SiO2-PFBV under the same experimental conditions. Relatively low 
one-photon fluorescence signals were observed from cells treated with Au 
NR/SiO2-PFBV and SiO2-PFBV, while no one-photon fluorescence signal was 
showed in cancer cells incubated with Au NR/SiO2. These results consistent with their 
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relative TPA action cross section values shown in Table 5.2. Furthermore, the 
one-photon and two-photon excitation fluorescence images further demonstrate that 
Au NR/SiO2-PFBV, Au NR/SiO2 and SiO2-PFBV were effectively taken up and 
internalized into HepG2 cancer cells. Therefore, Au NR/SiO2-PFBV nanoparticle 






Figure 5.7 Transmission (a, d, g), one-photon (b, e, h) and two-photon (c, f, i) 
excitation fluorescence images of HepG2 cancer cells treated with Au NR/SiO2-PFBV 
(a, b, c), Au NR/SiO2 (d, e, f), and SiO2-PFBV (g, h, i). One-photon excitation 
wavelength: 405 nm, detection wavelength: 460-550 nm; Two-photon excitation 
wavelength: 800 nm, detection wavelength: 500-550 nm. 
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5.3.6 Two-photon photodynamic therapy 
Singlet oxygen is responsible for killing cancer cells in PDT. High singlet oxygen 
generation efficiency is required for the application of photosensitizers in PDT. Some 
water soluble conjugated polymers are known to generate singlet oxygen and could 
also be used as photosensitizers.
37,38
 Singlet oxygen generation efficiencies of PFBV, 
was examined by monitoring the characteristic emission peak of singlet oxygen at 
~1270 nm in CD3OD solution. Under excitation at their corresponding absorption 
maxima, PFBV displayed the characteristic singlet oxygen emission band at ~1270 
nm (Figure 5.8). This result confirms that the singlet oxygen generated from the 
interaction between the polymers and molecular oxygen. Using Rose Bengal in D2O 
as standard, the singlet oxygen generation yields were calculated to be 46 % for 
PFBV.  






























Figure 5.8 Phosphorescence spectra of singlet oxygen generated by PFBV in CD3OD 
under one-photon excitation. Rose Bengal in D2O was used as the standard. 
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 Two-photon induced singlet oxygen generation of the polymers in water was 
characterized by δФΔ, the product of TPA cross section and singlet oxygen generation 
efficiency.
39
 As shown in Table 5.3, δФΔ of Au NR/SiO2-PFBV is 533.6 per repeat 
unit, ~29 times higher than that of PFBV (18.4). This result indicates that Au 
NR/SiO2-PFBV could generate singlet oxygen under two-photon excitation with high 
efficiency and thus can be utilized as photosensitizers for two-photon PDT. 
 
Table 5.3 Singlet oxygen generation efficiency of conjugated polymer, Au 
NR/SiO2-PFBV. 






PFBV 40 0.46 18.4 
Au NR/SiO2-PFBV 40×29  0.46 533.6 
a 
Two-photon absorption cross section per repeat unit at 800 nm.
 b 
Singlet oxygen 
generation yield (Δ ) were calculated based on the singlet oxygen luminescence 
intensity at ~1270 nm using Rose Bengal as the standard.  
 
 Before applying Au NR/SiO2-PFBV nanoparticles in vitro for TP-PDT, good 
biocompatibility and low dark cyto-toxicity are very essential. The cytotoxicity of Au 
NR/SiO2-PFBV in dark was evaluated by monitoring the metabolic viability of 
HepG2 cells. Figure 5.9 shows the cell viability after incubation with Au 
NR/SiO2-PFBV at different concentrations for 24 h in dark. The metabolic viability of 
the cells remained nearly 100% when the concentrations of Au NR/SiO2-PFBV 
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reached up to 40 μM. The low dark cytotoxicity of the Au NR/SiO2-PFBV ensures 





















0             10            50           100         150
 
Figure 5.9 Metabolic viability of HepG2 cells after incubation with Au 
NR/SiO2-PFBV of different concentrations (in concentration of gold nanorod) for 24 
h. 
  
 Since Au NR/SiO2-PFBV display much larger δФΔ compared to PFBV, we further 
explored its potential application as a two-photon PDT photosensitizing agent. The 
viability of HepG2 cancer cells incubated with Au NR/SiO2-PFBV, Au NR/SiO2, 
SiO2-PFBV and without nanoparticles were examined after exposure to femtosecond 
laser irradiation at 800 nm with energy density of ~3.0 W·cm
-2
. The laser beam was 
unfocused with a beam size of ~0.3 cm
2
. Figure 5.10 shows irradiation time 
dependent cell viability of HepG2 cancer cells after two-photon photodynamic 
treatment. The viability of the cells without nanoparticle was found to remain nearly 
100% under laser irradiation for 10 min, indicating that the cells were not directly 
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killed by the laser irradiation. The viability of the cells treated with SiO2-PFBV under 
the same condition showed no killing effect after laser irradiation. In the presence of 
Au NR/SiO2, the viability of cells only showed little killing effect, with 20 % decrease 
in cell viability after laser irradiation for 10 min. This is attributed to that gold 
nanorod could also generate singlet oxygen under two-photon excitation.
40
 In contrast, 
the viability of HepG2 cells treated with Au NR/SiO2(15nm)-PFBV showed 
significant decrease with the increasing irradiation time: up to 63 % of cancer cells 
were killed after fs laser irradiation for 10 min. These results indicate that PFVCN can 
act as efficient photosensitizers for two-photon photodynamic treatment on cancer 





























Figure 5.10 Laser irradiation time dependent cell viability of HepG2 cancer cells 
treated with Au NR/SiO2, SiO2-PFBV and Au NR/SiO2(15nm)-PFBV after 
two-photon PDT treatment (irradiation by femtosecond laser pulses at 800 nm). 
Experiments on cells without any nanoparticles were performed under the same 
irradiation condition as the control. 
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5.4 Conclusion 
In summary, Au NR/SiO2-PFBV core-shell nanoparticles with different silica shell 
thickness from 8.6 to 48 nm were prepared to systematically investigate Au NR 
enhanced one- and two-photon excitation fluorescence of PFBV. PFBV was absorbed 
to the surface of silica coated Au NR by the electrostatic attraction. The one- and 
two-photon excitation fluorescence intensity of PFBV were found to strongly depend 
on the silica shell thickness that separates Au NR and PFBV molecules. The optimum 
OPEF enhancement was found to occur at shell thickness of 24 nm with enhancement 
factor of 1.5, while the optimum TPEF enhancement was found to occur at shell 
thickness of 15 nm with enhancement factor of 29. The OPEF enhancement is 
attributed to the competition between increased radiative and non-radiative decay 
rates, while electric field amplification gives an additional contribution to the TPEF 
enhancement. Au NR/SiO2(15nm)-PFBV, which displayed the largest TPEF 
enhancement, were also found to exhibit significantly improved singlet oxygen 
generation capability under two-photon excitation. The application of these 
nanoparticles as effective imaging agents for two-photon cell imaging and 
nano-photosensitizers for TP-PDT with improved efficiency has been demonstrated 
on HepG2 cancer cells using XTT assay. The remarkable two-photon excitation 
fluorescence enhancement property of these Au NR/SiO2-PFBV nanoparticles makes 





1. Samkoe, K. S.; Cramb, D. T., J. Biomed. Opt. 2003, 8, 410-417. 
2. Celli, J. P.; Spring, B. Q.; Rizvi, I.; Evans, C. L.; Samkoe, K. S.; Verma, S.; 
Pogue, B. W.; Hasan, T., Chem. Rev. 2010, 110, 2795-2838. 
3. Starkey, J. R.; Rebane, A. K.; Drobizhev, M. A.; Meng, F. Q.; Gong, A. J.; Elliott, 
A.; McInnerney, K.; Spangler, C. W., Clin. Cancer Res. 2008, 14, 6564-6573. 
4. Gao, D.; Agayan, R. R.; Xu, H.; Philbert, M. A.; Kopelman, R., Nano Lett. 2006, 
6, 2383-2386. 
5. Arnbjerg, J.; Jimenez-Banzo, A.; Paterson, M. J.; Nonell, S.; Borrell, J. I.; 
Christiansen, O.; Ogilby, P. R., J. Am. Chem. Soc. 2007, 129, 5188-5199. 
6. Drobizhev, M.; Stepanenko, Y.; Dzenis, Y.; Karotki, A.; Rebane, A.; Taylor, P. N.; 
Anderson, H. L., J. Am. Chem. Soc. 2004, 126, 15352-15353. 
7. Dy, J. T.; Ogawa, K.; Satake, A.; Ishizumi, A.; Kobuke, Y., Chem.-Eur. J. 2007, 
13, 3491-3500. 
8. Kim, S.; Ohulchanskyy, T. Y.; Pudavar, H. E.; Pandey, R. K.; Prasad, P. N., J. Am. 
Chem. Soc. 2007, 129, 2669-2675. 
9. DeRosa, M. C.; Crutchley, R. J., Coord. Chem. Rev. 2002, 233, 351-371. 
10. Wenseleers, W.; Stellacci, F.; Meyer-Friedrichsen, T.; Mangel, T.; Bauer, C. A.; 
Pond, S. J. K.; Marder, S. R.; Perry, J. W., J. Phys. Chem. B 2002, 106, 
6853-6863. 
11. Cohanoschi, I.; Yao, S.; Belfield, K. D.; Hernandez, F. E., J. Appl. Phys. 2007, 
101,086112. 
 162 
12. X. Q. Shen; L. Li; A. C. M. Chan; S. Q. Yao; Xu, Q.-H., Advanced Optical 
Materials 2012, accepted. 
13. Mangalum, A.; Gilliard Jr, R. J.; Hanley, J. M.; Parker, A. M.; Smith, R. C., 
Organic & Biomolecular Chemistry 2010, 8, 5620-5627. 
14. Nikoobakht, B.; El-Sayed, M. A., Chem. Mat. 2003, 15, 1957-1962. 
15. Jana, N. R.; Gearheart, L.; Murphy, C. J., J. Phys. Chem. B 2001, 105, 
4065-4067. 
16. Gou, L. F.; Murphy, C. J., Chem. Mat. 2005, 17, 3668-3672. 
17. Stober, W.; Fink, A.; Bohn, E., J. Colloid Interface Sci. 1968, 26, 62-69. 
18. He, F.; Ren, X. S.; Shen, X. Q.; Xu, Q. H., Macromolecules 2011, 44, 5373-5380. 
19. Ho, H. A.; Leclerc, M., J. Am. Chem. Soc. 2004, 126, 1384-1387. 
20. Zhao, X. Y.; Pinto, M. R.; Hardison, L. M.; Mwaura, J.; Muller, J.; Jiang, H.; 
Witker, D.; Kleiman, V. D.; Reynolds, J. R.; Schanze, K. S., Macromolecules 
2006, 39, 6355-6366. 
21. Fakis, M.; Anestopoulos, D.; Giannetas, V.; Persephonis, P.; Mikroyannidis, J., J. 
Phys. Chem. B 2006, 110, 12926-12931. 
22. Nguyen, T. Q.; Doan, V.; Schwartz, B. J., J. Chem. Phys. 1999, 110, 4068-4078. 
23. Cheng, D. M.; Xu, Q. H., Chem. Commun. 2007, 248-250. 
24. Anger, P.; Bharadwaj, P.; Novotny, L., Phys. Rev. Lett. 2006, 96, 113002. 
25. Yuan, P. Y.; Lee, Y. H.; Gnanasammandhan, M. K.; Guan, Z. P.; Zhang, Y.; Xu, Q. 
H., Nanoscale 2012, 4, 5132-5137. 
26. Bharadwaj, P.; Novotny, L., Opt. Express 2007, 15, 14266-14274. 
 163 
27. Zhao, T. T.; Wu, H.; Yao, S. Q.; Xu, Q. H.; Xu, G. Q., Langmuir 2010, 26, 
14937-14942. 
28. Lamberts, J. J. M.; Schumacher, D. R.; Neckers, D. C., J. Am. Chem. Soc. 1984, 
106, 5879-5883. 
29. Wang, H. F.; Huff, T. B.; Zweifel, D. A.; He, W.; Low, P. S.; Wei, A.; Cheng, J. X., 
Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 15752-15756. 
30. Gryczynski, I.; Malicka, J.; Shen, Y. B.; Gryczynski, Z.; Lakowicz, J. R., J. Phys. 
Chem. B 2002, 106, 2191-2195. 
31. Fang, Z.; Zhang, X. H.; Lai, Y. H.; Liu, B., Chem. Commun. 2009, 920-922. 
32. Kim, S.; Zheng, Q.; He, G. S.; Bharali, D. J.; Pudavar, H. E.; Baev, A.; Prasad, P. 
N., Adv. Funct. Mater. 2006, 16, 2317-2323. 
33. Woo, H. Y.; Hong, J. W.; Liu, B.; Mikhailovsky, A.; Korystov, D.; Bazan, G. C., J. 
Am. Chem. Soc. 2005, 127, 820-821. 
34. Woo, H. Y.; Korystov, D.; Mikhailovsky, A.; Nguyen, T. Q.; Bazan, G. C., J. Am. 
Chem. Soc. 2005, 127, 13794-13795. 
35. Wu, C. F.; Szymanski, C.; Cain, Z.; McNeill, J., J. Am. Chem. Soc. 2007, 129, 
12904-12904. 
36. Rahim, N. A. A.; McDaniel, W.; Bardon, K.; Srinivasan, S.; Vickerman, V.; So, P. 
T. C.; Moon, J. H., Adv. Mater. 2009, 21, 3492-3493. 
37. Corbitt, T. S.; Ding, L. P.; Ji, E. Y.; Ista, L. K.; Ogawa, K.; Lopez, G. P.; Schanze, 
K. S.; Whitten, D. G., Photochem. Photobiol. Sci. 2009, 8, 998-1005. 
38. Ji, E.; Corbitt, T. S.; Parthasarathy, A.; Schanzes, K. S.; Whitten, D. G., ACS Appl. 
 164 
Mater. Interfaces 2011, 3, 2820-2829. 
39. Velusamy, M.; Shen, J. Y.; Lin, J. T.; Lin, Y. C.; Hsieh, C. C.; Lai, C. H.; Lai, C. 
W.; Ho, M. L.; Chen, Y. C.; Chou, P. T.; Hsiao, J. K., Adv. Funct. Mater. 2009, 19, 
2388-2397. 
40. Zhao, T. T.; Shen, X. Q.; Li, L.; Guan, Z. P.; Gao, N. Y.; Yuan, P. Y.; Yao, S. Q.; 




Chapter 6  
pH- and Photo-Triggered Release of Photosensitizers from 
Mesoporous Silica-Coated Gold Nanorods 
 
6.1 Introduction 
Drug-delivery system is one of the most promising applications for human health care 
and represents an ever-evolving field for biomedical materials science. Among which, 
targeted delivery and controlled release of drug molecules to specific organs or cells is 
particularly important because it maintains therapeutic levels during the treatment 
period showing high therapeutic efficacy and low side effects compared to traditional 
therapies.
 1,2  
To achieve this goal, several biodegradable materials, such as polymeric 
nanoparticles, dendrimers, and liposomes have been used as “smart” drug delivery 
systems that can controllably release drugs in aqueous solution upon the structural 
degradation of the carrier triggered by various chemical factors, such as pH change 
under physiological condition. However, it is difficult to achieve “zero” premature 
release of drugs in these structurally unstable “soft” materials. In many cases, inside 
drug molecules will start leaking out these materials as soon as the system is introduced 
in water.  
Recently, research has been focused on developing structurally stable drug 
delivery systems that are able to deliver a relatively large amount of drug molecules 
without any premature release problem to targeted tissues or even intracellular 
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organelles. Among many structurally stable materials investigated for drug delivery, 
mesoporous silica materials are well known due to the unique features such as 
intrinsically highly ordered pore network, large surface area, large accessible pore 
volume, and adjustable pore size.
3
 In addition, the abundant silanol groups (Si-OH) on 
the surface facilitate the modification of the mesoporous silica materials, thereby 
simplifying the design of controlled-release mechanisms for targeted drug delivery.
4
  
For example, to increase the efficiency of targeted delivery into cells, the external 
surface of mesoporous silica nanoparticles can be modified with receptor-specific 
ligands, such as folic acid which is particularly upregulated in many cancers while 
distribution is limited in normal tissues.
5
 Therefore, considering the advantages of 
mesoporous silica materials, a series of mesoporous silica materials based 
controlled-release and targeted delivery systems have been developed that are 
responsive to distinct external stimuli such as pH, light, redox, temperature, enzyme 
and competitive binding.  
Among them, pH-responsive controlled-release systems are very attractive 
because pH in growing malignant tumors tends to be somewhat lower than that in 
surrounding normal tissues.
6
 Therefore due to the pH stimulus in tumor cells, the dose 
of released drugs will be higher compared to that in normal cells during the same 
period, displaying higher cytotoxicity toward the tumor cells and lower cytotoxicity to 
the healthy cells than free drug molecules. In recent years, several mesoporous silica 
materials based platforms have been developed with pH-responsive ability. For 
example, Xiao and co-workers designed pH-responsive carriers in which polycations 
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were grafted and acted as closed gates to store the drug within the mesopores. When 
the pH value changed, the ionized carboxylic acid groups were protonated leading to 
disruption of ionization interaction and release of drug consequently.
7
  
Besides pH-responsive drug release, photo-responsive controlled release is also 
very important because of the non-invasive nature and high spatial resolution of light.
8
  
To achieve light-responsive profiles, the mesoporous silica materials can be modified 
with certain photosensitive materials thus light of a suitable wavelength can be 
employed as trigger for controlled drug release. For example, Lin and co-workers 
designed a platform in which the pore surface was modified with appropriate 
photosensitive organic groups to allow only small molecules with certain groups to 
diffuse through the mesopores.
9
 Recently photosensitive nanoparticles, such as gold 
nanoparticles and gold nanorods have also been incorporated into the mesoporous silica 
nanomaterials to achieve light-responsive drug release. For instance, Tang and 
co-workers applied a coating of gold nanoshells on mesoporous silica nanorattles for 
cancer treatment by combining controlled drug release property of mesoporous silica 
core leading to chemotheapy and photothermal property of gold nanoshell leading to 
light-responsive drug release.
[11]
 Among these photosensitive nanomaterials which are 
combined for light-triggered drug release, gold nanorods (Au NRs) are particularly 
attractive because of their ability to convert light into heat with high efficiency and 
their tunable longitudinal plasmon band from 600 to 1000 nm which is coincident 
with the biological transparency window.
[12]
 In addition, gold nanorods are 
well-known for their nontoxicity, biocompatibility, and chemical inertness. More 
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importantly, gold nanorods have been utilized as promising two-photon imaging 
contrast agents contributing to bioimaging in vitro and in vivo.
10 
 With these in mind, we propose a dual-function nanoparticles (folic acid grafted 
mesoporous silica coated gold nanorods) combing two-photon imaging property of 
gold nanorods and pH-responsive drug delivery property of mesoporous silica shell 
(Scheme 6.1). After loading with hydrophobic porphyrin in pyridine solvent, this kind 
of nanoparticles will not release the porphyrin in the neutral aqueous solution due to the 
hydrophobic property of porphyin. However, when decreasing pH value of surrounding 
solution, the hydrophobic porphyrin will combine hydrogen ion to form porphyrin salt, 
which is soluble in the aqueous solution. Thus, porphyrin can be released by decreasing 
pH value. Therefore, such property render mesoporous silica coated gold nanorod a pH 
responsive carrier for two-photon imaging and drug delivery. On the other hand, gold 
nanorods can efficiently absorb and convert NIR light into heat as mentioned before. 
Thus with the incorporation of the gold nanorods in the delivery system, the release of 
porphyrin can also be triggered by NIR irradiation (Scheme 6.2). Our delivery system 
is associated with four important features: 1) The mesoporous silica shell consisting of 
enlarged pores offers significantly improved drug loading capacity. 2) Anticancer drugs 
can be more efficiently loaded into the mesoporous silica shell due to hydrophobic 
interactions contributing to “zero” premature release of drugs without stimuli. 3) The 
gold nanorods core with excellent thermal stability can absorb light in NIR region by 
tuning the size and be applied for two-photon imaging, thereby avoiding wasteful tissue 




The mesoporous silica shell is conjugated with folic acid (FA) which is specific for 
pathologic cells to improve cytotoxity for cancer cells and reduce side effects for 
normal cells. 
 
Scheme 6.1 pH-triggered release of porphyrin from mesoporous silica coated gold 
nanorods (Au NR/mSiO2). 
 
 





6.2 Experimental Section 
6.2.1 Materials and Instruments 
Cetyltrimethylammonium bromide (CTAB), HAu(III)Cl4, NaBH4, AgNO3, ascorbic 
acid, Tetraethoxysilane (TEOS), sodium dodecyl sulfate (SDS), sodium hydroxide, 
3-Aminopropyltriethoxysilane (APTS), Folic acid (FA) N-Hydroxysuccinimide 
(NHS), N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide (EDC), were purchased 
from Sigma-Aldrich. Meso-Tetra (4-pyridyl) porphine (TMPP) was purchased from 
Frontier Scientific Inc.. All solvents are analytical grade reagents and used without 
further purification. All aqueous solutions are made in deionized water. 
A Shimadzu UV 2450 spectrophotometer was used for recording extinction 
spectra. Fluorescence spectra were measured by using a Jobin-Yvon Fluoromax-4 
spectrofluorometer. Particle characterizations were performed using a JEOL 
JEM-3010 electron microscope (300 kV). Samples for TEM measurements were 
prepared by placing a drop of the colloidal solution on a carbon-coated copper grid. A 
CW diode laser with wavelength of 808 nm (4 W) was used for the laser irradiation 
experiment. 
 
6.2.2 Preparation of Au NR/mSiO2 
Preparation of Au NRs: Au NRs were synthesized in aqueous solution by a typical 
seed-mediated, CTAB surfactant directed procedure.
11
 Seed and growth solutions 
were made as described below. 
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Preparation of seed solution: CTAB solution (0.1 M, 9.75 mL) was mixed with 
HAuCl4 (0.01 M, 0.25 mL) by stirring. ice-cold NaBH4 (0.01 M, 0.6 mL) was added 
into the solution, which resulted in formation of a brownish-yellow solution. The 
obtained solution was stirred for another 2 min kept at room temperature for 2 h as the 
seed solution. 
 
Preparation of growth solution: HAuCl4 (0.01 M, 2 mL) and AgNO3 (0.01 M, 0.4 
mL) were added to CTAB solution (0.1 M, 40 mL) at room temperature. After gentle 
mixing of the solution, hydrochloride acid (1 M, 0.8 mL) was added to the solution. 
Then ascorbic acid (0.1 M, 0.32 mL) was added into the mixture, upon which the 
growth solution changed the color from dark yellow to colorless. the seed solution 
(100 µL) was then subsequently added to the growth solution at 27-30 ℃. The 
obtained solution was gently inversed for another 2 min. The color of the solution 
gradually changed within 10-20 min. The reaction was allowed to further proceed for 
6 h. 
The solution was then centrifuged at 8000 rpm for 15 min to remove the excess 
CTAB surfactant. The obtained Au NRs were collected and redispersed in deionized 
water (30 mL) by sonication for further use. Au NRs with different size can be 




Preparation of Au NR/mSiO2: Mesoporous silica coating was performed according 
to a previously published procedure.
13
 NaOH solution (0.1 M, 0.1 mL) was added to 
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the prepared Au NRs (10 mL) upon stirring at 45 ℃. After 5 min, TEOS in methanol 
(10%, 0.1 mL) was injected three times at a 90 min interval. The reaction was allowed 
to react overnight. The obtained Au NR/mSiO2 were then centrifuged and washed 
with methanol or ethanol at least three times to remove the CTAB molecules.
13
 The 
obtained nanoparticles were redispersed in methanol or ethanol (10 mL). 
 
6.2.3 Preparation of FA-Grafted Au NR/mSiO2.  
Preparation of APTS-grafted Au NR/mSiO2: Au NR/mSiO2 ethanol solution (5 mL) 
were sonicated for 5 min. After that, ammonia (32%, 50 µL) and APTS chloroform 
solution (25%, 25 µL) were added into nanoparticles solution. The mixture was 
stirred overnight. The obtained nanoparticles were centrifuged and redispersed in 
DMF solution for further use. 
 
Preparation of FA-Au NR/mSiO2: FA (10 mM, 500 µL), EDC (0.1 M, 50 µL) and 
NHS (0.1 M, 50 µL) were added into DMF solution (5 mL) and react at least for 1 h. 
Then, Au NR/mSiO2 DMF solution (2 mL) was added into the mixture and react 
overnight. Finally, the FA-grafted mesoporous silica coated gold nanorods (FA-Au 
NR/mSiO2) were then centrifuged and dried under vacuum. 
 
6.2.4 TMPP Loading and Release Studies 
Loading of TMPP on FA-Au NR/mSiO2: The prepared FA-Au NR/mSiO2 (33 mg) 
was dispersed in chloroform solution of TMPP (1 mg/mL) and stirred for 2 days. 
 173 
After that, the mixture was washed by acetone for one time and then washed by 
deionized water for several times. FA-Au NR/mSiO2 loading with TMPP was finally 
dispersed in deionized water (1 mL) for further use. 
 
pH-triggered release of TMPP: To study the amount of drug releasing from the 
mesoporous silica shell, one mL mixture of FA-Au NR/mSiO2 with absorbed TMPP 
was quartered and centrifuged, the solid was then dissolved in one mL PBS buffer of 
different pH value (pH= 7.4, 6, 4, 2, respectively). Under stirring, the mixture was 
centrifuged at different time interval and supernatant was taken out for UV and FL 
detection. 
 
Photo-triggered release of TMPP: A CW diode laser with wavelength of 808 nm 
(1.7 W) was used for the laser irradiation experiment. The TMPP-loaded FA-Au 
NR/mSiO2 solution was put into cuvette and illuminated by CW laser. The cuvette for 
all the tests was a standard microcuvette (1 cm×1 cm in diameter, 4 cm in length). 
The laser source was positioned 5 cm from one transparent side of the cuvette. After 
different time interval, 60 µL mixtures were taken out for fluorescence signal (520 nm) 
detection in order to monitor the release kinetics of the drug. Three parallel 
experiments were conducted under 0.7 W, 1.2 W, 1.7 W to illustrate the influence of 
temperature which was 42.6 ℃, 55.8 ℃, 62.4 ℃, respectively. 
 
6.2.5 Telmisartan Loading and Release Studies 
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Loading of Telmisartan on FA-Au NR/mSiO2: The synthesized FA-Au NR/mSiO2 
(33 mg) was dispersed in 1.7 mL DMSO solution of Telmisartan (1 mg/mL). The 
mixture was stirred overnight for further use. 
 
Photo-triggered release of Telmisartan in comparison with TMPP: 1.7 mL 
mixture of FA-Au NR/mSiO2 with absorbed Telmisartan was centrifuged and 
redispersed in 1 mL H2O. 200 µL was taken out and added to the mixture of PBS (pH 
= 7.4) and SDS (5.76 mg/mL) 1 mL. While stirring and irradiated by CW laser (1.7 
W), the mixture was centrifuged at different time interval and supernatant was taken 
out for UV and FL detection while the solid was redispersed in mixture of PBS (pH= 
7.4) and SDS (5.76 mg/mL) to continue the experiment. Two parallel experiments 
under room temperature in water without PBS or SDS and in PBS buffer containing 
SDS were conducted. For TMPP release, the process was similar. Three groups of 
parallel experiments were conducted. 
 
6.2.6 Cell Culture 
The human hepatocellular liver carcinoma cell line (HepG2) was cultured in the 
growth media (DMEM supplemented with 10% fetal bovine serum, 100.0 mg L
-1
 
streptomycin, and 100 IU mL
-1
 penicillin). Cells were incubated in a humidified 
atmosphere of 5% CO2 at 37 ℃. 
 
6.2.7 Cell Viability Assay 
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Cell viability was determined by using the XTT colorimetric cell proliferation kit 
(Roche) following the manufacturer’s guidelines. Briefly speaking, cells were grown 
to 20–30% confluence in 96-well plates. The medium was aspirated, washed with 
PBS, and then treated with 0.1 mL of the media containing different amounts of the 
FA-Au NR/mSiO2-TMPP. After 24 h incubation, cells were washed 4 times using 
PBS to remove excessive NRs. Proliferation was assayed by using the XTT 
colorimetric cell proliferation kit (read at A460 nm–A650 nm). A total of three replicas 
were performed. 
 
6.2.8 Cell Two-Photon Imaging 
HepG2 cancer cells were seeded on glass-bottom dishes (Mattek) and grown until 
70–80% confluence. The FA-Au NR/mSiO2 were added into the media and incubated 
overnight. After washing four times with the PBS buffer solution, HEPES 
buffer-containing media were added. The cell imaging was taken by using a Leica 
TCS SP5X confocal microscope system equipped with a water immersion objective 
(Leica HCX PL APO 63×/1.20 W CORR CS). Ti-Sapphire oscillator at 800 nm was 
used as two-photon excitation sources. A non-descanned detector (NDD) was used for 
the detection of two-photon fluorescence. Images were processed by using Leica 
Application Suite Advanced Fluorescence (LAS AF) software. 
 
 
6.3 Results and Discussion 
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6.3.1 Characterization of Au NR/mSiO2 
Au NRs were prepared in aqueous solutions by a typical seed-mediated, CTAB 
surfactant directed procedure. 
[16]
 Mesoporous silica coatings were achieved by a 
sol-gel process reported recently.
11,12
 After removing the excess CTAB surfactant by 
centrifugation, the as-prepared Au NRs were dispersed in an aqueous solution. The 
core-shell structured nanoparticles were formed by injecting a silica alkoxide 
precursor (tetraethyl orthosilicate, TEOS) into CTAB-capped gold nanorod solution 
and the solution were kept stirring for 24 h. The ultimate mesoporous Au NRs were 
obtained after removal of CTAB surfactant molecules by washing with methanol or 
ethanol. To completely remove the absorbed CTAB, the silica-coated nanoparticles 
were washed a minimum of 3 times in our experiments (the LSPR peak of MS coated 
Au NRs will not shift after 4-5 washings). Figure 6.1a shows the typical TEM images 
of the prepared Au NR/mSiO2. The Au NR/mSiO2 consisted of a gold nanorod core 
and a uniform mesoporous silica shell. The TEM images clearly show that silica 
shells (thickness of 20∼30 nm) were composed of disordered mesopores, similar to 
the previously reported CTAB based mesoporous silica systems. Figure 6.1b shows 
the UV/vis absorbance spectrum of Au NRs and Au NR/mSiO2. The spectrum reveals 
blue shift after coating which further proves the successful formation of silica shell. 
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Figure 6.1 a) TEM images of the prepared Au NR/mSiO2 and b) UV spectrum of 
prepared Au NRs and Au NR/mSiO2. 
 
6.3.2 Characterization of APTS-grafted and FA-grafted Au NR/mSiO2 
The surface modification of the Au NR/mSiO2 was achieved stepwise. First the Au 
NR/mSiO2 was functionalized with a layer of APTS in order to get reactive 
amino-derivated particles (Scheme 6.3). After reacting with EDC, NHS and FA, 





Scheme 6.3 APTS and NHS-folate grafting on Au NR/mSiO2. 
 
Figure 6.2 shows the TEM images of APTS-grafted and FA-grafted Au 
 178 
NR/mSiO2. The core-shell composition and mesoporous structure were well 
maintained after modification. FTIR analysis was conducted to further demonstrate 
the successful conjugation of FA to Au NR/mSiO2. As shown in Figure 2c, after 
modification with FA, the typical IR absorption peaks that are representative of FA at 
1612 and 1697 cm
-1 15,16
 were observed in the spectrum of Au NR/mSiO2, thus 
demonstrating the binding of FA molecules to the silica shell. Moreover, the vibration 
of a benzene-ring skeleton at 1520 cm
-1
 was also detected. 




































Figure 6.2 TEM images of a) APTS-grafted and b) FA-grafted Au NR/mSiO2. c) 
FTIR spectrum of Au NR/mSiO2 (black), APTS-Au NR/mSiO2 (red), pure FA (green) 




6.3.3 pH-Triggered Release of TMPP 
As mentioned before, because the pH in growing malignant tumors tends to be lower 
than that in surrounding normal tissue, an anticancer drug that is protonated and turns 
to be hydrophilic at an acidic pH but is hydrophobic at physiological pH would 
benefit from selective pH-triggered release in cancer treatment. We first studied the 
pH-responsive property of the mesoporous silica coated gold nanorods platform by 
tuning the pH value of the system. To demonstrate the stability of the structure under 
different pH condition, we also got the TEM images of the structure after incubation 
with PBS buffer of different pH value. 
 
6.3.4 pH-Triggered Release Kinetics Study 
TMPP molecules were absorbed into the pore of FA-grafted Au NR/mSiO2 due to 
their hydrophobic property while TMPP molecule was in neutral state. When the pH 
value was lower than the pKa of TMPP (2~3),
17 
TMPP molecules would be protonated 
and tuned to be soluble in aqueous solution. In other words, the hydrophobic 
interactions would be disrupted and thus TMPP molecules would be released. As 
shown in Figure 6.3a, due to the quenching effect of Au NRs, the Au 
NR/mSiO2-TMPP solutions at pH 7.4, 6 and 4 did not display obvious fluorescence.  
However, the Au NR/mSiO2-TMPP nanoparticle solution displayed strong 
fluorescence when loaded porphyrine was released to solution at pH 2. Indeed, as 
clearly shown in Figure 6.3b, both the amount and the rate of TMPP release in PBS 
buffers highly depended on the pH values. When pH equaled 4, 6 and 7.4, the drug 
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barely released. In comparison, when pH was decreased to 2, the release of TMPP 
dramatically increased with prolonged time and did not change much after 4 h.  

















































Figure 6.3 a) Release of TMPP from FA-Au NR/mSiO2 in PBS buffer at different pH 
values. b) Release kinetics of TMPP from FA-Au NR/mSiO2 in PBS buffer at 
different pH values. 
 
TEM images in Figure 6.4 demonstrated that the grafted core-shell structure 
would be well maintained after incubation in PBS buffer solution with different pH 
value which proved that the release of drug molecules was the result of disruption of 







Figure 6.4 TEM images of FA-grafted Au NR/mSiO2 after incubation for 4h in a) pH 
= 7.4 PBS buffer and b) pH = 2 PBS buffer. 
 
6.3.5 In Vitro Cytotoxicity Assay 
The cytotoxicity of the Au NR/mSiO2-TMPP without any light illumination was 
evaluated by monitoring the metabolic viability of HepG2 cells in 96 well after 
incubation with Au NR/mSiO2-TMPP. Figure 6.5 shows the cell viability after 
incubation with Au NR/mSiO2-TMPP at different concentrations for 24 h in the dark. 
The metabolic viability of the HepG2 cells nearly did not change after incubation with 
the Au NR/mSiO2-TMPP, even when the mass was as high as 11000ng/well. The low 
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Figure 6.5 Cell viability assay of HepG2 cancer cell treated with Au 
NR/mSiO2-TMPP ranged from 55 to 11000ng for 24 h in the dark. 
 
6.3.6 Two-Photon Imaging in Cells  






about 5 orders of magnitude stronger than small organic molecules (1-100 GM). 
Therefore, such Au NR/mSiO2-TMPP nanoparticles have greatly potential application 
for two-photon imaging of cell samples owing to gold nanorod unique optical 
property. Following this step, the two-photon excitation fluorescence imaging of 
living cancer cells using two-photon laser scanning confocal microscopy was 
performed under excitation at 800 nm with a 750 nm short pass emission filter. 
Figure 6.6 shows the two-photon excitation images of HepG2 cancer cells after 
incubation with Au NR/mSiO2-TMPP overnight. An intense red fluorescence signal 
was observed from the cells. By overlaying the transmission image and two-photon 
excitation fluorescence image, the Au NR/mSiO2-TMPP were found to mainly 
accumulate around the nuclear region, indicating that the Au NR/mSiO2-TMPP were 
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actively taken up and internalized into the cells by endocytosis. Thus, Au 
NR/mSiO2-TMPP nanoparticles can be optically monitored inside cells with 
two-photon cofocal fluorescence microscopy. 
a b c
Figure 6.6 a) Transmission; b) Two-photon excitation fluorescence images of HepG2 
cancer cells treated with Au NR/mSiO2-TMPP; c) The merged images. 
 
6.3.7 Photo-Triggered of TMPP 
Since the dimension of gold nanorods can be tuned to absorb in the NIR region and 
the absorbed photon energy can be converted to heat with high efficiency. We then 
studied the photo-triggered release of TMPP from the platform on the basis of the 
photothermal Au NRs to optimize cancer therapy. To mimic the photo-induced release 
of drug molecules from FA-Au NR/mSiO2, we first studied the drug release profile 
under thermal condition followed by the NIR laser irradiation experiment to 
demonstrate the release kinetics. 
 
6.3.8 Thermal-Induced Release of TMPP and Telmisartan  
Sodium dodecyl sulfate SDS (structure shown in Figure 6.7a which is a surfactant 
containing both hydrophilic and hydrophobic structure simultaneously has the ability 
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to contain TMPP due to their hydrophobic structure. And the hydrophilic part helps 
make it disperse well in aqueous solution. As shown in Figure 6.7c, the same amount 
of TMPP dispersed in PBS (containing SDS 5.76 mg/ml) had higher fluorescence 
than that in pure PBS buffer. Thus SDS was applied to help overcome the 
hydrophobic interactions under thermal conditions.  
 




















PBS buffer (pH= 7.4) + SDS(5.76mg/mL)









Figure 6.7 a) Structure of SDS. b) Structure of Telmisartan. c) FL spectrum of TMPP 
in pure PBS buffer and PBS buffer containing SDS. 
 
To demonstrate TMPP would bind closely inside the silica core, we compared 
the release properties of TMPP and another less hydrophobic drug Telmisartan 
(structure shown in Figure 6.7b) under thermal condition. Figure 8a clearly showed 
that Au NR/mSiO2-TMPP was quite stable at RT in water. When dispersed in PBS 
buffer containing SDS at RT, TMPP started to release in the assistance of SDS. 
Furthermore, release of TMPP greatly enhanced when the mixture was heated to 
70 ℃ in PBS buffer containing SDS which illustrated the importance of heat. It was 
also a proof that this system could be further applied for photo-triggered release due 
b 
 b)  
a 
 a)  
 a) 




to NIR absorption of Au NRs core which could convert the NIR light into heat. In 
comparison, Telmisartan loaded structure was not that stable. As shown in Figure 
6.8b, even at RT in water solution, large amount of Telmisartan would release from 
the silica shell. 



























































Figure 6.8 Release kinetics of a) TMPP and b) Telmisartan under different conditions 
(RT, H2O-blue; RT, PBS+SDS-green; 70℃, PBS+SDS-red). 
 
6.3.9 Photo-Triggered Release Kinetics Study 
We used the prepared mesoporous silica coated gold nanorods to study the ability to 
absorb NIR light and convert it into heat. As shown in Figure 6.9, Au NR/mSiO2 
solution remained high temperature around 60 ℃ within irradiation for three hours. 
Therefore, the synthesized Au NR/mSiO2 could be utilized for photo-triggered release 
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Figure 6.9 a) NIR light irradiation induced temperature increase due to Au NR/mSO2 
absorption versus time.  
 
To demonstrate the controlled release capability of our core-shell system, the 
release profile of captured TMPP was examined by monitoring the increasing 
fluorescence signals at known time intervals after the NRs were exposed to light 
irradiation. As shown in Figure 6.10a, only slight leaking of TMPP molecules from 
the system occurred during the first 30 min without laser irradiation, demonstrating 
the stable encapsulating capability of the core-shell structure. When the suspension of 
drug-loaded NRs was exposed to a NIR laser, a burst release of TMPP molecules 
occurred within 15 min. The payload kept releasing with prolonged exposure (120 
min). As shown in Figure 6.10b, the release enhanced with increasing power of the 
CW diode laser demonstrating the influence of temperature. 
b 
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Figure 6.10 a) Controlled release of the entrapped TMPP from Au NR/mSiO2 b) 
Release kinetics of TMPP from Au NR/mSiO2 with laser irradiation at 808nm using 
different power (blue-0.7 W; green-1.2 W; red-1.7 W). 
 
6.4 Conclusion 
In summary, a smart anticancer drug delivery system based on Au NR/mSiO2 
core–shell structure has been developed. The core–shell architecture allows to 
integrate the photothermal component (gold nanorods), that can convert NIR light to 
heat and allow for two-photon imaging, with the high-surface area component 
(mesoporous silica shell) for the loading of anticancer drug molecules (TMPP). The 
hydrophobic drug TMPP can be captured inside the mesoporous silica shell through 
hydrophobic interactions that are responsive to pH and heat. Thus the release of 
TMPP from the core–shell structure can be triggered by pH and NIR light, resulting in 
a synergistic effect for cancer cell killing. Unfortunately, the pKa value of TMPP is 
not that close to the pH of cancer cells making the pH-triggered release less efficient 
in vivo. We expect to find anticancer drugs with pKa nearby the pH of cancer cells in 
the future and study the probability for anticancer application. 
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To develop nanocomposite containing mesoporous silica and gold nanorod for 
two-photon excitation biological application such as two-photon photodynamic 
therapy and two-photon imaging and drug delivery, this thesis has advanced 
understanding in both photophysical and photochemical properties of nanocomposite 
involved in preparing nanocomposite containing mesoporous silica and gold nanorod, 
as well as demonstrating its applications in two-photon imaging, photodynamic 
therapy and drug delivery for simultaneous diagnosis and therapy. 
 First, Nanocomposites with a gold nanorod core and a photosensitizer 
(hematoporphyrin)-doped mesoporous silica shell have been successfully prepared by 
judicious choice of appropriate two-photon imaging contrast agents, photosensitizers 
and carriers. It was found that these novel composite nanoparticles were uniform in 
size and can be easily and homogeneously dispersed in aqueous solution. The gold 
nanorod core is an excellent two-photon imaging contrast agents. Meanwhile, the 
mesoporous silica shells provide spatially well-separated hematoporphyrin in 
molecules in a benign environment, making photosensitizers well-separate from each 
other. This unique design facilitates the generation and release of singlet oxygen from 
the matrix, and thus enhances singlet oxygen production efficiency compared with 
that of pure photosensitizers in aqueous solution. To the best of our knowledge, no 
successful example of composite nanoparticles possessing both two-photon imaging 
and photodynamic therapy functionality has been reported so far. The excellent 
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two-photon luminescence property of gold nanorods integrates with the enhanced 
singlet oxygen generation efficiency of doped hematoporphyrin to form a novel 
photosensitizer-loaded mesoporous silica vehicle, has been demonstrated for the first 
time. Such structure makes it a promising platform for efficient trafficking by optical 
monitoring and real-time photodynamic therapy to tumor tissue in vitro. However, it 
should be noted that the singlet oxygen generation efficiency of nanocomposite is not 
very high compared with pure photosensitizer, which would limit its application in 
vivo. The possible reason is that relative low amount of photosensitiers linked to the 
surface of nanocomposite. Further work for developing this kind of nanocomposite 
with dual capability of two-photon imaging and photosensitization, is required to be 
focused on improving the singlet oxygen generation efficiency. Two ways are needed 
to develop nanocomposite with high singlet oxygen generation efficiency. Exploring 
new photosensitizers with high singlet oxygen amount is the first method. 
Furthermore, Loading large amount of photosensitizer by modifying the preparation 
method could also be considered in the future. 
 To further explore nanocomposite containing mesoporous silica and gold nanorod 
for two-photon imaging and photodynamic therapy, a systematic study of 
metal-enhanced one- and two-photon fluorescence of AuNR/SiO2-T790 with varied 
silica shell thickness in DMF solution was investigated in Chapter 3. One kind of 
porphyrin molecule (T790) containing carboxyl group was covalently linked to the 
surface of silica coated gold nanorods by forming stable amide bond. This 
conjugation method is a universal method for incorporating any fluorephores or 
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biomolecules containing amine-reactive group onto silica shell. Compared with the 
fluorescence intensity of T790 coated silica nanoparticles (control sample), the one- 
and two-photon emission intensities of AuNR/SiO2-T790 were found to be dependent 
on the silica shell thickness between gold nanorods and T790 fluorophores. The 
enhancement is attributed to the electric field amplification and the competition 
between radiative and non-radiative decay rates, which is consistent with other reports 
(Murphy et al).  The potential application of AuNR/SiO2-T790 as effective 
two-photon fluorescence probe and photosensitizer for two-photon imaging-guided 
photodynamic therapy in vitro were demonstrated on HepG2 cell under two-photon 
irradiation. The remarkable one- and two-photon fluorescence enhancement property 
of Au NRs/SiO2-T790 nanoparticles makes it a promising platform for metal-enhanced 
fluorescence imaging and photodynamic therapy. However, in the presence of gold 
nanorods, the two-photon absorption (TPA) cross section of T790 is relatively low (~24 
GM), resulting in low singlet oxygen generation efficiency. Such low singlet oxygen 
efficiency makes Au NRs/SiO2-T790 unsuitable for photodynamic therapy. Therefore, 
exploring photosensitizers with high TPA cross section and high singlet oxygen 
generation, and integrating them into nanocomposite would be necessary in the future. 
Integrating photosensitzer into nanocomposite could increase the accumulated amount 
of photosensitizer into cancer cells, which is more effective for nanocomposite in 
photodynamic therapy. 
 To investigate drug delivery property of nanocomposties, folic acid grafted 
mesoporous silica coated gold nanorod has been developed by combing two-photon 
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imaging property of gold nanorod and pH-responsive property of drug inside 
mesoporous silica shell. The core–shell architecture integrates the two-photon contrast 
agent (gold nanorods) with the high-surface area component (mesoporous silica shell) 
for simultaneous two-photon imaging and loading of anticancer drug molecules 
(TMPP). The anticancer drug (TMPP) was trapped inside the mesoporous silica shell 
owing to hydrophobic interactions. At the same time, TMPP could combine hydrogen 
ion to form salt and release in the solution, which makes it pH sensitive to 
surrounding environment. Therefore, this nanocomposite displays more cytotoxicity 
toward tumor cells and less cytotoxicity to the healthy cells than free dug molecules, 
owing to the more acidic environment in tumor cells. The two-photon imaging 
capability of this nanocomposite was also studied in vitro by using HepG2 cancer 
cells. This study is the first to incorporate gold nanorod and mesoporous silica into 
one entity to create a new functionality: pH-controlled drug release. The 
chemotherapy of nanocomposite can be manipulated simply by changing pH value of 
surrounding solution. Such a versatile theranositc system as nanocomposite 
containing mesoporous silica and gold nanord is expected to have wide biomedical 
application and may be particularly useful for cancer therapy. Unfortunately, the pKa 
value of TMPP is not close to the pH value (5~6) of cancer cells making the 
pH-triggered release less efficient in vitro. Moreover, the applications of this 
nanocomposite in real animals are not explored because life animal testing requires 
special approval from relevant authority. Therefore, a direct extension of this work is 
to find anticancer drugs with pKa value around the pH value of cancer cells in the 
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future and study the probability for anticancer drug delivery application in real 
animals. 
 
 
 
